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1. Introduction 
 
1.1. Hypoxic pulmonary vasoconstriction (HPV) 
1.1.1. Physiological relevance of HPV 
In order to guarantee optimal pulmonary oxygen (O2) uptake and to supply tissue with sufficient O2, the 
degree of local pulmonary blood perfusion (Q) is matched to the respective level of ventilation (V)1-4. 
When lung ventilation is impaired locally, constriction of small precapillary pulmonary arteries in this 
area serves as a crucial mechanism to maintain the ventilation-perfusion ratio in the normal range (Figure 
1). This mechanism is called hypoxic pulmonary vasoconstriction (HPV) and is an essential physiological 
reaction of the pulmonary vasculature to match pulmonary blood perfusion to alveolar ventilation during 
acute hypoxia1 (Figure 1). Thus, local alveolar hypoxia, for example due to local obstruction of the 
bronchus by a lung tumor or mucus plug, leads to vasoconstriction of precapillary arteries and 
redistributes perfusion from poorly ventilated areas of the lung to better ventilated areas (Figure 1). 
However, global acute hypoxia, as occurring e.g. in exacerbation of lung diseases can lead to the 
vasoconstriction of most pulmonary arteries and may result in an acute prominent increase of the 
pulmonary arterial pressure (PAP). 
 
Pulmonary arterial
blood flow
Pulmonary venous
blood flow
Ventilation Ventilation
a) b)
Ventilation
c)
 
Figure 1. Ventilation-perfusion matching.  
a) Under physiological conditions, the alveolar ventilation (V) is equal to the perfusion (Q), 
V/Q~1. b) Local obstruction of a bronchus decreases the ventilation resulting in reduction of 
V/Q (V/Q less than 1), and enhancement of the ventilation of neighboring areas of the lung 
(redirecting airflow) increasing the V/Q ratio (V/Q higher than 1). c) HPV leads to the decrease 
of the perfusion of poorly ventilated areas in favor of better ventilated areas, thereby improving 
the ventilation-perfusion matching (V/Q~1) and systemic arterial oxygenation1, 3. 
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In contrast to the pulmonary vessels, most systemic arteries dilate in response to local hypoxia in order to 
provide the hypoxic organ with more O2 by an increase of blood flow1. An exception is the fetal 
vasculature in the placenta5. These vessels, like pulmonary arteries, constrict in response to hypoxia 
redirecting the fetal flow from insufficiently oxygenated areas of the placenta toward regions with better 
maternal perfusion5.  
The trigger for a flurry of investigations in the research area of HPV was the publication of one of the 
most important articles about HPV in 1946 by von Euler and Liljestrand6. They found an increase of PAP 
in cats within few seconds during ventilation with 10.5% O26. After that initial finding, HPV has been 
confirmed in different animal species7-9 and humans10. The HPV response differs among animal species 
with regard to the sensitivity to the hypoxic stimulus, as well as a magnitude of the response11, e.g. the 
threshold for HPV in isolated lungs of rats is ~60 mmHg12 and around 75 mmHg in isolated lungs of 
rabbits13. In isolated and perfused rabbit lungs, HPV starts after a few seconds of the acute hypoxic 
challenge and has a biphasic shape. The first maximal increase of mean PAP (mPAP) occurs at ~5 
minutes (first phase), called acute hypoxic response, then a small decline in mPAP is observed, and 
afterwards mPAP again gradually increases with the second maximum of mPAP at ~90 minutes (second 
phase), called sustained hypoxic response9. The same biphasic response occurs in human where mPAP 
increases to a first maximum within 15 minutes and to a second maximum at ~2h3. The biphasic HPV 
response is associated with a biphasic rise in cytosolic (intracellular) calcium ([Ca2+]i) in pulmonary 
artery smooth muscle cells (PASMC)14. However, some studies indicate that the second phase is 
dependent on endothelium and activation of Rho-associated protein kinase (ROCK) and not on a rise of 
[Ca2+]i15. Activation of ROCK plays a key role in the sustained response of the pulmonary vasculature to 
hypoxia by an increase of the sensitization of myosin light chains (MLC) to [Ca2+]i15. Other studies do not 
demonstrate the second phase of HPV at all16. The explanation for this discrepancy is still unknown3.   
The trigger of HPV is alveolar hypoxia, since inhalation of a hypoxic gas mixture evokes HVP even in 
conditions when the lungs are perfused with normally oxygenated perfusate or blood9, 17. Local arterial 
hypoxia also can be a trigger of HPV in view of the fact that forward perfusion with hypoxic blood 
stimulates the elevation of mPAP in rats18. In contrast, reverse perfusion of the pulmonary circulation 
with hypoxic blood via the left atrium does not trigger HPV, therefore the venous part of the pulmonary 
circulation can be excluded as a sensor of HPV18. Experiments in the isolated perfused lung9, in 
pulmonary arteries isolated from lungs19 or within lung slices20, as well as in isolated PASMC21 have 
demonstrated that the effector and sensor cell type of HPV is located in precapillary PASMC and that 
HPV does not depend on neural or humoral influences from outside the lung1. Additional confirmation 
that HPV is a physiological adaptive mechanism attributed to the lung itself is shown by a study 
presenting that HPV was preserved in patients after the bilateral lung transplantation22.  
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The role of the endothelium in acute HPV is not clear. Early studies in isolated pulmonary arteries 
demonstrated that removal of the endothelium preserved the acute HPV response, however, later studies 
showed that endothelium-denuded arteries lost the vasoconstrictor response to the acute hypoxic stimulus 
while maintaining a contractile response to other antagonists3. Despite this controversy it is clear that the 
endothelium can modulate the acute HPV response via alterations of the release of vasoconstrictors and 
vasodilators3. In contrast to acute HPV (first phase), in which the role of endothelium is not clear, most 
investigations have found that the endothelium plays an essential role during sustained HPV23, 24. 
Removal of the endothelium significantly attenuates sustained HPV, but does not have any effect on 
[Ca2+]i concentration within the PASMC. This finding suggests that the endothelium regulates Ca2+ 
sensitization of precapillary PASMC during sustained hypoxia23. 
 
1.1.2. Mechanisms of HPV 
Despite the intensive research of the mechanism of HPV in the past decades, the exact O2 sensor and the 
underlying signal transduction pathway have not been fully identified and significant controversy 
remains1, 25. Within the molecular mechanism of HPV, three main parts such as O2 sensors, mediators and 
effectors have been distinguished (Figure 2)3. As possible O2 sensors mitochondria13, 26, 27, nicotinamide 
adenine dinucleotide phosphate (NADPH)-oxidases28, 29, cytochrome P45030 and potassium channels31 
have been proposed. The mitochondria or NADPH-oxidases use O2 as substrate; therefore they could 
directly sense the lack of O21, 3. On the other hand, O2 can interact with different proteins, e.g. heme-
containing protein32 or can directly modify the sulphur-containing residues of proteins (including 
organelles and proteins described above)31 leading to reversible alteration of their structure and/or 
conformation that may initiate the HPV signaling pathway1. Many potential O2 sensors have been tested 
in experiments during acute hypoxia. Roth et al.33 provided evidence that a deletion of the heme-
oxygenase-2 (HO-2) gene, an enzyme that catalyses heme degradation, does not abolish HPV in mice. 
The studies on the role of NADPH oxidases in genetically modified mice have demonstrated conflicting 
results. Archer et al. published evidence that knockout of gp91phox, the heme-containing protein of the 
NADPH oxidase, did not have any influence on acute HPV29. In contrast, Weissmann et al. demonstrated 
a significant reduction of the hypoxic response in isolated perfused mouse lungs from mice with genetic 
knockout of the cytosolic p47 subunit of NADPH oxidases, whereas the response to a thromboxane 
mimetic was preserved in those mice28.  
Reactive oxygen species (ROS)13, the cellular redox state34, the adenosine monophosphate (AMP) - 
adenosine triphosphate (ATP) ratio35, and Ca2+ homeostasis have been suggested as mediators of HPV21. 
The effectors of HPV are ion channels (e.g. Kv (potassium) channels), intracellular Ca2+ stores and 
different protein kinases3. In particular, increase of [Ca2+]i concentration is a key event in the HPV 
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response3. [Ca2+]i can be increased by both influx of extracellular Ca2+ via SOCC (store-operated calcium 
channels) and VOCC (voltage operated calcium channels), or release of Ca2+ from intracellular stores 
such as sarcoplasmic reticulum (SR) via RyR (ryanodine-sensitive receptors)36 during acute hypoxia. 
Ultimately, the acute hypoxia-induced increase of cytosolic [Ca2+]i concentration activates myosin light 
chain kinase causing actin-myosin interaction and PASMC contraction. Mitochondria can be O2 sensor 
organelles and can mediate HPV via the alteration of the ROS production, [Ca2+]i and ATP homeostasis1, 
2, 13, 36-38. One obvious and important conclusion that can be made from the available literature about HPV 
is that PASMC contain all three parts of the HPV mechanism: the initial sensor of hypoxia, its mediator 
and the effector mechanism1, 3.  
 
 
Figure 2. Mechanisms of acute hypoxic pulmonary vasoconstriction (HPV).  
The trigger, acute hypoxia, is sensed by various possible O2 sensors and translated by different 
mediators to effectors ultimately resulting in actin-myosin interaction within PASMC, and 
finally leading to the vasoconstriction of the small precapillary pulmonary arteries1, 3. 
Abbreviations: AMP/ATP ratio - adenosine monophosphate/adenosine triphosphate ratio; 
Ca2+ - calcium; Kv channels - potassium channels; NADPH oxidase - nicotinamide adenine 
dinucleotide phosphate-oxidase; O2 - oxygen; ROS - reactive oxygen species. 
 
1.2. Pulmonary hypertension (PH) 
1.2.1. Definition and characteristics of PH 
In contrast to acute hypoxia, chronic hypoxia results in pathological alterations of the pulmonary 
vasculature and can lead to the development of pulmonary hypertension (PH)1, 25, 39-41 (Figure 3). Chronic 
hypoxia may be the result of respiratory diseases such as COPD (Chronic Obstructive Pulmonary 
Disease), lung fibrosis, or residence in high altitude and etc1. At an altitude of 3000m, which is often 
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encountered in ski resorts, the inspired pO2 (partial pressure of O2) is only about 70% of that at sea level 
and at an altitude of 5000m, the highest point at which humans can live, the inspired pO2 is 50% of that at 
sea level42. By definition, a mean PAP greater than 25 mmHg at rest is considered as PH43. Besides 
chronic hypoxia, a number of different pathological stimuli can lead to the development of PH44. 
Therefore, PH is defined as a severe progressive disorder which is the outcome of different causes and is 
characterized by the extensive narrowing of the pulmonary vascular bed, leading to an increase in 
pulmonary vascular resistance, which ultimately produces compensatory right ventricular (RV) 
hypertrophy and may result in heart failure and premature death45.  
 
 
Figure 3. Effect of acute and chronic hypoxia on the pulmonary vasculature.  
Acute hypoxia is a trigger of HPV for optimization of the ventilation/perfusion ratio. Chronic 
hypoxia leads to pathological thickening of the vascular wall resulting in narrowing of the 
vascular lumen (pulmonary vasculature remodeling), increase of pulmonary pressure and PH25, 
41. HPV is a completely reversible process, whereas pulmonary vasculature remodeling is only 
partially reversible46.  
Green - endothelial cells, red - smooth muscle cells and brown - fibroblasts.  
Abbreviations: HPV – hypoxic pulmonary vasoconstriction; PH – pulmonary hypertension. 
 
Pulmonary arterial hypertension was first described by Romberg in 1881. The term “primary pulmonary 
hypertension” was used to define the clinical features and hemodynamics of patients who had an 
increased PAP without evident etiology of PH47. Primary pulmonary hypertension is now referred to as 
idiopathic pulmonary arterial hypertension (IPAH). IPAH is a very rare disease affecting only a few 
persons per million and most frequently affecting otherwise normal middle aged women48. Prior to the 
development of treatments for PH, IPAH was a fatal disease with a poor prognosis and average survival 
of 2.8 years49. Other forms of PH occur more frequently than IPAH. For example PH can occur in 
50.2%50, 51 of patients with severe COPD which affects approximately 6% of the total population in 
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USA52. Moreover, PH in COPD is an independent prognostic factor associated with low survival rate53. 
Additionally, 10% of patients with systemic sclerosis which has a rate of approximately about 7-489 
cases per million population, will develop PH54, 55.  
The main histopathological finding in PH is pulmonary vascular remodeling (Figure 4). Pulmonary 
vascular remodeling is an imbalance between proliferation (hyperplasia) and apoptosis, where 
proliferation of endothelial cells (EC), PASMC and fibroblasts is increased, while apoptosis of those cells 
is decreased39, 41. Recently, it has been suggested that in early stages of PH increased apoptosis can be 
initial trigger for the selection of apoptosis-resistant EC56. The impact of different vascular cells on 
pulmonary vasculature remodeling is dependent on the form, severity and stage of PH. In addition, 
pulmonary vascular remodeling is characterized by hypertrophy (increased cell growth) of vascular cells, 
migration of PASMC, as well as recruitment and differentiation of local fibroblasts, pericytes, 
mononuclear cells and EC41. It has been shown that bone marrow-derived cells can be incorporated into 
the pulmonary vasculature (neoplasia)57. Besides these mechanisms, remodeling is aggravated by the loss 
of precapillary vessels58 and in situ thrombosis59. 
 
 
Figure 4. Morphological changes of pulmonary arteries in pulmonary hypertension (PH).  
PH is characterized by pulmonary vasculature remodeling which is a result of thickening of the 
arterial wall. All lung samples are stained by elastic van Gieson where elastic fibres are 
blue/black/brown; nuclei are black/brown; collagen fibers are red; media, epithelia, nerves, 
erythrocytes are yellow. Pictures were made by microscopy with 40x magnification. Blue 
arrows depict medial layer hypertrophy; green arrows depict EC proliferation; red arrows depict 
adventitial layer remodeling. 
Abbreviations: Control - lungs from control (healthy) animals and donor human lung; IPAH - 
idiopathic pulmonary arterial hypertension; Chronic hypoxia - chronic exposure of rats or mice 
to 10% O2 hypoxia; MCT - monocrotaline-induced PH in rats; Hypoxia + SU-5416 - exposure 
of rats to chronic hypoxia combined with SU-5416 injection (VEGF 2 receptor antagonist).  
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Patients with IPAH and other specific forms of PH, e.g. PH associated with left-to-right shunt or human 
immunodeficiency virus (HIV) have a very specific vasculopathy with the appearance of plexiform 
lesions, which consist of a network of vascular channels surfaced by EC that completely obliterate the 
vascular lumen39. 
 
1.2.2 Classification of PH 
The first classification of PH was proposed in 1973 at the international conference on primary PH 
sanctioned by the World Health Organization44, 60, and divided PH only in two categories, primary PH 
with unknown specific causes or risk factors of PH and secondary PH with the presence of specific causes 
or risk factors of PH39. The updated Dana Point classification for PH (2008, the Fourth World 
Symposium on PH) is based on the consensus of an international assembly of experts (Table 1).  
This new classification scheme stratifies PH into 5 groups by considering similarities into 
pathophysiological mechanisms, clinical manifestations, and therapeutic approaches. These groups are: 1st 
- pulmonary arterial hypertension; 2nd - PH associated with left-sided heart diseases; 3rd - PH related with 
hypoxia/lung diseases, 4th - thromboembolic PH and 5th - PH with unclear multifactorial mechanisms44 
(Table 1). In 2013, at the Fifth World Symposium on PH held in Nice (France), a new classification of 
PH was proposed with only minor modifications to the Dana Point classification. However, the exact 
recommendations from this symposium have not yet been published. 
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Table1 Updated Clinical Classification of Pulmonary Hypertension, Dana Point, 200860 
1. Pulmonary arterial hypertension (PAH) 
1.1. Idiopathic PAH 
1.2. Heritable PAH 
1.2.1. BMPR2 
1.2.2. ALK1, endoglin (with or without hereditary hemorrhagic telangiectasia) 
1.2.3. Unknown 
1.3. Drug- and toxin-induced PAH 
1.4. PAH associated with 
1.4.1. Connective tissue diseases 
1.4.2. HIV infection 
1.4.3. Portal hypertension 
1.4.4. Congenital heart diseases 
1.4.5. Schistosomiasis 
1.4.6. Chronic hemolytic anemia 
1.5 Persistent pulmonary hypertension of the newborn 
1’. Pulmonary veno-occlusive disease (PVOD) and/or pulmonary capillaryhemangiomatosis (PCH) 
2. Pulmonary hypertension owing to left heart disease 
2.1. Systolic dysfunction 
2.2. Diastolic dysfunction 
2.3. Valvular heart disease 
3. Pulmonary hypertension owing to lung diseases and/or hypoxia 
3.1. Chronic obstructive pulmonary disease 
3.2. Interstitial lung disease 
3.3. Other pulmonary diseases with mixed restrictive and obstructive pattern 
3.4. Sleep-disordered breathing 
3.5. Alveolar hypoventilation disorders 
3.6. Chronic exposure to high altitude 
3.7. Developmental abnormalities 
4. Chronic thromboembolic pulmonary hypertension (CTEPH) 
5. Pulmonary hypertension with unclear multifactorial mechanisms 
5.1. Hematologic disorders: myeloproliferative disorders, splenectomy 
5.2. Systemic disorders: sarcoidosis, pulmonary Langerhans cell histiocytosis: 
lymphangioleiomyomatosis, neurofibromatosis, vasculitis 
5.3. Metabolic disorders: glycogen storage disease, Gaucher disease, thyroid disorders 
5.4. Others: tumoral obstruction, fibrosing mediastinitis, chronic renal failure on dialysis 
Abbreviations: BMPR2 - Bone morphogenetic protein receptor 2; ALK1 - activin receptor-like kinase 1 
 
1.2.3. Animal models of PH 
Currently, various techniques are used in different animals to induce experimental PH, including the 
application of pharmacologic and toxic agents [e.g. bleomycin, monocrotaline (MCT), and smoke 
exposure], genetic manipulations, and exposure to environmental factors (e.g. hypoxia) or surgical 
interventions (e.g. closure of the ductus arteriosus)39. All of these approaches are proposed to simulate the 
different groups of PH (Table 2)39.  
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Table 2. Animal models of PH and PH classification* 
PH Group Animal Models 
1. Pulmonary arterial hypertension 
Monocrotaline injection (MCT)61; MCT + 
pneumonectomy62; BMPR2 knockout63; 
IL-6 Tg+mice64; IL-13 Tg mice65, Fawn-
hooded rat34; S100A4 overexpressing 
mice66; SHIV-nef-infected macaques67; 
Chronic hypoxia + SU-541668; 
Schistosomiasis69; Left-to-right shunt70, 
closure of the ductus arteriosus71 
2. Pulmonary hypertension owing to left 
heart disease Congestive heart failure models
72 
3. Pulmonary hypertension owing to lung 
diseases and/or hypoxia 
Chronic hypoxia73, chronic hypoxia + SU-
541668; Intermittent hypoxia74; Cigarette 
smoke exposure75; Bleomycin76; 5-HTT 
overexpression77 
4. Chronic thromboembolic pulmonary 
hypertension 
Repeated microembolization with 
microspheres78 
5. Pulmonary hypertension with unclear 
multifactorial mechanisms ? 
*modified from Pak O. et al39. 
 
Abbreviations: BMPR2 - Bone morphogenetic protein receptor 2; IL-6 Tg+ - transgenic mice over-
expressing Interleukin 6; IL-13 Tg - transgenic mice over-expressing Interleukin 13; S100A4 
overexpressing mice - mice over-expressing S100A4, a member of the S100 family of small calcium 
binding proteins; SHIV-nef-infected macaques - macaques infected with a chimeric viral construct 
containing the HIV (Human immunodeficiency virus) nef (Negative Regulatory Factor) gene; SU-5416 - 
VEGF (Vascular Endothelial Growth Factor) 2 receptor antagonist; 5-HTT -5-Hydroxytryptamine 
transporter protein. 
 
The most universally used animal models of PH, the so-called classical animal models of PH, are the 
chronic exposure of different animals to normobaric/hypobaric hypoxia and the injection of MCT in 
rats39. Chronic exposure (usually 4-5 weeks) of animals to hypoxia leads to an elevation in PAP, vascular 
remodeling and RV hypertrophy33 (Figure 4). The MCT model in rat was first suggested more than 50 
years ago by Lalich and Merkow79. MCT is a phytotoxin, which is present in the seed and vegetation of 
the plant Crotalaria spectabilis and is activated by mixed function of oxidases (mostly by the cytochrome 
P450) in the liver to form the reactive compound MCT-pyrrole which affects the pulmonary vasculature 
and triggers the remodeling process in rats39 (Figure 4). In contrast to the hypoxic model that mimics 
group III of the Dana Point classification of PH, the MCT model has some features of group 1 of this 
classification39  
All classical models of PH (MCT injection and chronic hypoxic exposure) lack the specific pathological 
characteristics of IPAH, namely the plexiform lesions and neointima formation39. Therefore, it was 
suggested that the combination of an alteration of VEGF (Vascular Endothelial Growth Factor) signaling 
and exposure to chronic hypoxia might mimic the neointima formation. It was successfully demonstrated 
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that pharmacologic inhibition of the VEGF receptor 2 combined with chronic hypoxia results in severe 
PH, which has, similar to human PH, vasculopathy - neointima formation68 (Figure 4). Inhibition of the 
VEGF receptor 2 in this model serves as the initiating factor leading to apoptosis of EC and therefore to 
selection of apoptosis-resistant EC which can contribute to plexiform lesion formation56.    
Although the animal models described above have been proven to be useful for the investigation of 
signaling pathways which contribute to pulmonary vascular remodeling in PH, there is no “ideal” animal 
model of PH39. All existing animal model of PH lack some important features displayed in the human 
disease39.  
 
1.2.4 Pathogenesis of PH 
The past few decades have witnessed a remarkable increase in the knowledge of the cellular and 
molecular mechanisms that are responsible for pulmonary vascular remodeling in PH, especially after 
Cournand and Richards pioneered right-heart catheterization80. However, the complex picture of PH 
pathogenesis is still not completely resolved25. Despite the diverse etiology of PH and its underlying 
signaling pathways, morphologically all groups of PH share similarities and are characterized by 
abnormal pulmonary vasculature remodeling affecting all three layers of the blood vessel wall: the 
adventitia, the media and the tunica intima, with  maximal impact on the medial layer81, 82 (Figure 4). 
Genetic mutations83-85, an imbalance of vasoconstrictors and vasodilators86-88, growth factors89, cytokines 
and chemokines90, 91 could all be initial triggers of pulmonary vasculature remodeling in PH (Figure 5). 
These initial triggers of PH determine which of the numerous underlying molecular pathways are at play, 
including an activation of various transcriptional factors [e.g. HIF (hypoxia inducible factor)34, FOXO1 
(forkhead box protein O1)92, NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells)93, 
PPARγ (peroxisome proliferator-activated receptor)94], change of [Ca2+]i concentration40, alterations of 
mitochondrial function34 , etc. For example, various vasoconstrictors increase the concentration of [Ca2+]i 
which is a key regulator of PASMC contraction and proliferation in PH37, 40, 95 (Figure 5). In the 
molecular pathways of pathogenesis of PH the mitochondria can play an important role via inhibition of 
respiration, modification of mitochondrial membrane potential (Δψm), cellular metabolism (control 
anaerobic glycolysis) alteration of ROS production and Ca2+ homeostasis37, 40, 82, 96 (Figure 5).  
It was shown that ~60% of patients with familial pulmonary arterial hypertension (FPAH) and 10-20% of 
patients with sporadic IPAH were heterozygous for a mutation in bone morphogenetic protein receptor 
type II (BMPRII)83, 84. The presence of BMPRII mutations is much less frequent in patients (up to 6-8%) 
with PH due to congenital left-to-right shunt85. BMPRII is a member of the TGF-β (transforming growth 
factor-beta) superfamily and can translate a pathological signal through SMAD (a family of proteins 
related to Drosophila ”mothers against decapentaplegic” (Mad) and Caenorhabditis elegans Sma)97, p38 
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(p38 mitogen-activated protein kinases)98, pERK (phosphorylated extracellular signal-regulated kinase), 
JNK (c-Jun N-terminal kinases) and AKT (protein kinase B)99. Mutations in the activin-receptor-like 
kinase 1 (ALK1) gene that is also a part of the TGF-β superfamily can also trigger PH development in 
association with hereditary hemorrhagic teleangiectasia100. One downstream effector of the BMPRII 
pathway is PPARγ which has anti-proliferative, anti-inflammatory, proapoptotic, and direct vasodilatory 
effects in the vasculature94. Recently, it has been demonstrated that altered PPARγ signaling can 
participate in development of PH94.  
Polymorphisms in genes that differ from normal by a single alternative nucleotide resulting in a change of 
the function/location of the encoded protein (SNPs, single nucleotide polymorphisms) may also explain 
the susceptibility to PH among humans. For example, a correlation between I/D (insertion/deletion) 
polymorphism of ACE (angiotensin converting enzyme) and high altitude PH was shown in the Kyrgyz 
population101. Yu et al. published a study demonstrating that 54(C→G) SNP of TRPC6 (Transient 
receptor potential cation channel, subfamily C, member 6) gene may predispose individuals to an 
increased risk of IPAH by linking the aberrant TRPC6 transcription polymorphism with abnormalities in 
NF-kB and inflammatory pathways93. 
An imbalance between pulmonary artery vasoconstrictors and vasodilators has been suggested as a 
mechanism for PH pathogenesis40. In patients with IPAH the level of vasodilators [prostaglandin I286 and 
nitric oxide (NO)87] was reduced whereas the level of vasoconstrictors (thromboxane86 and endothelin-
188) was increased. Experimental studies in chronic hypoxia-induced PH documented that endothelin-1 
was important for an increase of PASMC proliferation102.  
Several growth factors could play an important role in vascular remodeling in PH such as VEGF103, 
PDGF (platelet-derived growth factor)104, EGF (epidermal growth factor)105, bFGF (insulin-like growth 
factor)106 and IGF-1-( insulin-like growth factor)107. For example, expression of PDGF and its receptor 
(PDGFRs, platelet-derived growth factor receptors) was increased in the pulmonary vasculature of IPAH 
patients89 and application of tyrosine kinase inhibitors reversed the experimental remodeling in chronic 
hypoxia-induced PH and MCT-induced PH in rats89, 104. 
In addition, inflammation appears to play a significant role in the chronic hypoxia-induced remodeling 
process in human disease82 and in experimental models of PH108, 109. Increased circulating levels of 
monocyte chemoattractant protein-1, tumor necrosis factor, IL (interleukin)-1β and IL-6 were discovered 
in IPAH patients82. Overexpression of IL-6 induced severe PH64, while IL-6 deficiency protected mice 
against chronic hypoxic exposure109. Moreover, lung-specific IL-13 over-expressing transgenic (Tg) mice 
demonstrated a spontaneously developing PH phenotype with increased expression and activity of 
arginase 2 (Arg2)65. Arg2 is an enzyme that utilizes the arginine, and therefore decreases NO synthesis by 
the NO synthase in precapillary PASMC (L-arginine is a substrate for nitric oxide synthase). Several 
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chemokines have an impact on PH, e.g. chemokine ligand 2 increases a migration and proliferation of 
PASMC of IPAH patients110.  
Various therapies of PH have become available; however, modern treatments can alleviate the symptoms 
and even revert the characteristic vascular remodeling process, but cannot cure the disease39.  
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Figure 5. Role of pulmonary arterial smooth muscle cells (PASMC) in the pathogenesis of  
pulmonary vasculature remodeling in PH. Pulmonary vasculature remodeling is a result of 
an imbalance between proliferation and apoptosis of all three layers of the pulmonary arterial 
wall25, 39, 41. The most prominent remodeling occurs within the medial layer of pulmonary 
vessels40. Different pathological triggers stimulate the various molecular pathways 
(inflammation, Ca2+ homeostasis, growth factors, disbalance of vasoconstrictors and 
vasodilatators, mitochondria, transcription factors including HIF and etc.) within endothelial 
cells (EC), PASMC and fibroblasts to promote their proliferation and attenuate apoptosis25, 39-
41, 58, 82. Dysregulation (vasoconstriction) of the vascular tone can contribute to the severity of 
PH82. 
 Mitochondria play an important role in pulmonary vasculature remodeling. Factors triggering 
the development of PH may alter the level of mitochondrial ROS and ATP production, 
oxidative phosphorylation and release of proapoptotic proteins37, 38, 40, 95. Ca2+ and ROS can be 
mediators of different molecular pathways linking the alteration of mitochondrial function 
with the increased proliferation of PASMC. For example, alterations in the redox state may 
lead to HIF stabilization which may promote metabolic alterations, including the increase of 
anaerobic glycolysis38, 40, 95.  
 Abbreviations: VEGF - vascular endothelial growth factor; PDGF - platelet-derived growth 
factor; EGF - epidermal growth factor; IGF-1 -insulin-like growth factor; bFGF - basic 
fibroblast growth factor; BMPRII - bone morphogenetic protein receptor type II; CREB - 
cAMP response element-binding protein; Ca2+ - calcium; cGMP - cyclic guanosine 
monophosphate, cAMP - cyclic adenosine monophosphate, FOXO1 - Forkhead box protein 
O1; HIF-1α - alpha subunit of hypoxia inducible factor; NFAT - Nuclear factor of activated 
T-cells , NF-κB - nuclear factor kappa-light-chain-enhancer of activated B cells; NO – nitric 
oxide; pERK - phosphorylated extracellular-signal-regulated kinases; MLC - myosin light 
chain; ROS - reactive oxygen species; Δψm - mitochondrial membrane potential; K+ - 
potassium; Kv - potassium channels; IP3 - Inositol trisphosphate; PPARγ - peroxisome 
proliferator-activated receptor gamma, ROCK - Rho-associated protein kinase. 
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1.3. Role of mitochondria in HPV and PH 
For some time, mitochondria have been suggested to be O2 sensing organelles in hypoxia-dependent 
regulatory processes like HPV and chronic hypoxia-induced PH1, 38. The idea that mitochondria could act 
as O2 sensors arose from the fact that mitochondria consume more than 90% of O2 within the cell111, 112. 
O2 limitation can affect different aspects of mitochondrial function such as respiratory rate, concentration 
of ATP, cytosolic [NADH]/[NAD+] redox state (reduced form of nicotinamide adenine 
dinucleotide/nicotinamide adenine dinucleotide), mitochondrial Ca2+ uptake and alterations in ROS 
production1, 38. An additional argument in favor of the importance of functional mitochondria in O2 
sensing comes from studies of immortalized neonatal adrenomedullary chromatin cells with normal 
functional or impaired mitochondria. Those cells, which lack functional mitochondria, fail to respond to 
the hypoxia113, 114.  
Hence, mitochondria have been considered important factors in non-hypoxia dependent pulmonary 
vascular remodeling because they participate in numerous proliferative and antiapoptotic signaling 
pathways1. Further support for the role of mitochondria comes from the observation of a child with a 
mitochondrial A3243G point mutation exhibiting severe PH115 and from patients with mitochondrial 
respiratory chain abnormalities showing PH116.  
 
1.3.1. Mitochondrial membrane potential (Δψm) 
Mitochondrial respiration and ATP synthesis are two crucial pathways lying at the heart of cellular 
metabolism117. During respiration, energy derived from electrons passing along multi-subunit enzyme 
complexes of the electron transport chain (respiratory chain), which are embedded in the inner 
mitochondrial membrane (IMM), is used to pump the protons (H+) against their concentration gradient 
from the matrix to the intermembrane space across the non-permeable IMM118, 119. Protons extrusion 
generates the electrochemical proton gradient (ΔµH+) across the IMM that results in accumulation of net 
protons within the intramembrane space. Ten protons are extruded for each electron pair passing from 
NADH to O2 by complexes, I, III and IV of the electron transport chain118. In bioenergetics, ΔµH+ is a 
thermodynamic measure of the energy that is necessary to remove a proton gradient from equilibrium and 
is expressed in kilojoule per mole (kj mol-1). The unit of ΔµH+ (kj mol-1) can be transferred into the unit 
of electric potential (mV) which is referred to as proton-motive force (Mitchell’s “proton-motive force”) 
and expressed by the symbol Δp119. Δp consists of an electrical, Δψm (mitochondrial membrane potential, 
∼150-180 mV) and a chemical component, ΔpHm (mitochondrial pH gradient, ~30-60 mV) across the 
IMM. Thus Δp is equal approximately to 180-220 mV117 (Figure 6). Because it is more easily measured 
in various cells, Δψm is often incorrectly used for expression of Δp. As written above, the Δψm is the 
predominant force (or central intermediate) in the oxidative phosphorylation and contributes 
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approximately 80-85% of Δp120, 121. In addition to being the central intermediate of aerobic energy 
production, Δψm is a driving force of other physiological process within mitochondria, including Ca2+ 
uptake and heat production in brown fat122.  
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Figure 6. Mitochondrial membrane potential (Δψm).  
Δψm is the most important part of Mitchell’s “proton motive force” (makes up to 85%) and is 
produced by extrusion of protons (H+) from the mitochondrial matrix to the intermembrane 
space, using an energy gradient from electrons passing along the respiratory chain119-121. The 
proton motive force (Δp) drives the synthesis of ATP by ATP synthase119. Some protons can 
escape the intermembrane space via either uncoupling proteins (UCPs) or passive proton leak 
back to the matrix that decreases Δψm123. Thus, the proton circuit consist of three modules: 1) 
Complex I-IV, the “substrate oxidation” module, 2) Complex V, the “ATP turnover” module 
and 3) the “Proton leak” module118.   
Abbreviations: I, II, III, IV and V - respiratory chain complexes; Q - coenzyme Q; Cyt C - 
cytochrome c; Δψm - mitochondrial membrane potential; ΔpH - proton gradient; Δp is 
Mitchell’s “proton-motive force”; ADP - adenosine diphosphate; ATP - adenosine 
triphosphate; NAD+ - nicotinamide adenine dinucleotide; NADH - reduced form of NAD+; Pi  
- phosphoric acid; UCPs -uncoupling proteins. 
 
Controlled return of protons along their gradient into the mitochondrial matrix through the F0F1 ATP 
synthase, complex V of the respiratory chain, drives the conversion of adenosine diphosphate (ADP) into 
ATP119. This process is called chemiosmosis and Peter Mitchell who first described this process, was 
awarded by the 1978 Nobel Prize in Chemistry. Some protons can return back into the mitochondrial 
matrix via a proton “leak” [either passive proton leak or through uncoupling proteins (UCPs - 
UnCoupling Protein)] that uncouples mitochondrial respiration from ATP synthesis123 (Figure 6). 
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Complexes I, III and IV of the electron transport chain together with complex V and the proton leak 
create a proton circuit across the IMM that is the center of bioenergetics. 
 
1.3.2. Mitochondria as source of reactive oxygen species (ROS) 
The term ROS describes a family of chemical species that are the result of incomplete reduction of O2124. 
The first description of ROS was made by Gomberg in 1900125. ROS includes highly reactive free oxygen 
radicals such as superoxide anion (O2•-), hydroxyl radical (HO•) and non-radicals that are either oxidizing 
agents and/or easily converted into radicals, such as hypochlorous acid (HOCl), ozone (O3), singlet 
oxygen (1O2), and “diffusible” hydrogen peroxide (H2O2). There are numerous potential sources of ROS 
within cells such as NADPH oxidases (Nox 1-5 and Duox 1-2)73, xanthine oxidases126, cyclooxygenases, 
cytochrome P450 enzymes127, lipoxygenases128, NO synthases129 and mitochondria1 (Figure 7).  
 
 
Figure 7. Scheme of possible sources of reactive oxygen species (ROS) within cells.  
The cell has variety of potential sources of ROS and some of them are indicated in the scheme: 
mitochondria, NADPH oxidases (NOX 1, 2 and 4), lipoxygenase (LO), heme oxygenase (HO), 
xanthine oxidases (XO), nitric oxide synthase (NOS) and cytochrome P450 enzymes (Cyto 
P450) 1, 73, 124, 126-129. The ROS-defense systems within cells comprises several enzymes 
specialized on removal of O2•- or H2O2 including superoxide dismutase 2 (mitochondrial 
SOD2), superoxide dismutase 1 (cytosolic SOD1), catalase (Cat), and glutathione 
peroxidases(Gpx)130, 131. 
Abbreviations: H2O2 - hydrogen peroxide; HO•·- Hydroxyl radical; Fe - ferrum; O2•- 
superoxide anion; OONO- peroxynitrite; NO - nitric oxide. 
  
Previously, more than 50 years ago, ROS were considered only as toxic substances, but recently, evidence 
has been published suggesting that ROS can participate in a wide range of different physiological cellular 
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processes including maintenance of intracellular homeostasis, adaptation to cellular stress, and 
participation in whole organ function124, 130, 132, 133. In these processes an increase or decrease of ROS can 
ultimately result in enhancement of proliferation or migration of cells instead of their damage73, 124. 
Despite the fact that the research field about ROS as a messenger molecule is rapidly expanding, many 
aspects of cellular ROS metabolism are not yet well understood. Mitochondria are generally considered to 
be the most important source of ROS within a cell1, 38 (Figure 8). In particular, it is a well-known fact that 
one-electron reduction of O2 is thermodynamically favorable for most oxidoreductases132. The first report 
showing that mitochondria can produce ROS was published in 1966134. During energy transduction, a 
small number of electrons “leak” to O2 forming the O2•- by one-electron reduction of O2. Reduction of 
molecular O2 that has two unpaired electrons with parallel spin in different antibonding orbitals leads to 
transfer of a lone electron to its antibonding orbital. Approximately 90-95% of the O2 consumed by 
mammalians is utilized to supply cellular energy through oxidative phosphorylation111, 112 and ~0.2% to 
1-2% of O2 consumed by the mitochondrial electron transport system is used to produce ROS135. The 
concentration of O2•- within the mitochondrial matrix is in the range 10-200 pM130. This wide variance in 
the range reported of what percentage of cellular O2 consumption ultimately is used for ROS production 
can be explained by the discrepancy in methodological approaches used to measure these values. The data 
from in vitro experiments based on isolated mitochondria indicate that 1-2% of cellular O2 is used to 
produce ROS, while more physiological experiments in whole cells show that only 0.2% of cellular O2 
consumption results in ROS emission within mitochondria136. This discrepancy may at least in part be 
caused by the presence of ROS detoxifying systems in intact cells and concentration of ROS regulatory 
components like Ca2+, NADH/NAD or the ∆ψm. The specific sites of electron leakage are not known with 
certainty, but most scientific literature suggests that complexes I and III are predominantly responsible for 
O2•- production within mitochondria131. Complex I (NADH:ubiquinone oxidoreductase, composed of ~45 
subunits) produces O2•- probably only into the matrix of mitochondria and complex III 
(Ubiquinol:cytochrome c oxidoreductase, composed 11 subunits) can generate O2•- on both sides of the 
IMM into the matrix and/or into the intermembrane space of mitochondria137. The relative importance of 
these two sites varies in different tissue and species138. In mitochondria isolated from heart and lung, 
complex III is thought to be responsible for most of ROS production, and in mitochondria isolated from 
brain, complex I appears to be the primary source of ROS under normal conditions132. In addition, there 
are some publications showing that complex II of the respiratory chain also can generate O2•- under 
certain conditions139. There are other sites of ROS production in the mitochondria, beyond the electron 
transport chain including α-ketoglutorate dehydrogenase and dihydroorotate dehydrogenase,130. However, 
their impact on mitochondrial ROS generation is low and their physiological significance unclear. O2•- 
produced by mitochondria is too highly charged to readily cross the IMM. However, O2•- that is produced 
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by complex III and released into the intermembrane space may be carried to the cytoplasm via voltage-
dependent anion channels (VDAC)140. The discovery of a specific mitochondrial superoxide dismutase 
(SOD2) confirmed the biological significance of mitochondria in O2•- production within cells.  
The ROS-defense systems within mitochondria comprise several enzymes specialized in the removal of 
O2•- or H2O2 and non-enzymatic antioxidants130 (Figure 8). SOD2, a manganese-dependent enzyme in the 
mitochondrial matrix, and superoxide dismutase 1 (SOD1), a copper or zinc-dependent enzyme in the 
cytosol and the intermembrane space convert O2•- into H2O2 that is further deactivated by catalase to water 
and O2130, 131. Additionally, H2O2 can be deactivated by the various glutathione peroxidases to reduced 
glutathione and water and by the peroxiredoxins to water131. Thus, O2•- is the primordial mitochondrial 
ROS. H2O2 is more stable than O2•- and capable to move across membranes121. Cytochrome c of the 
respiratory chain has antioxidant property itself and it can scavenge O2•-141.  
With regard to the above described mitochondrial ROS related systems, one should distinguish among the 
amount of ROS generated by mitochondria under specific conditions (physiological, pathological or 
artificially induced conditions), the mitochondrial location of ROS release, ROS removal by antioxidant 
defense systems and finally, ROS emission into different cellular compartments which is the net result of 
ROS production, ROS removal and ROS diffusion capacity across the mitochondrial membranes133. A 
summarized scheme of possible ROS sources and ROS-defense systems in mitochondria is shown in 
Figure 8.  
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Figure 8. ROS and ROS-defense systems in mitochondria.  
Complexes I and III are shown as main source of ROS131, 132. Complex I releases O2•- into the 
matrix131, 137. Complex III can release O2•- in both directions into the matrix and into the 
intermembrane space131, 137. Complex II likely also produces O2•- under certain 
circumstances139. O2•- produced during oxidative phosphorylation can diffuse via VDAC into 
the cytosol or can be transformed to H2O2 by SOD2 within the intermembrane space and the 
mitochondrial matrix, and by SOD1 within cytosol140. H2O2 is more stable than O2•- and is  
capable of moving across mitochondrial membranes121. The ROS-defense systems within 
mitochondria comprises several enzymes specialized on removal of O2•- or H2O2 and non-
enzymatic antioxidants130. Cytochrome c of respiratory chain has antioxidant property itself and 
it can scavenge O2•-141. 
Abbreviations: I, II, III, IV and V - complexes of respiratory chain; O2•-- superoxide; H2O2 - 
hydrogen peroxide; Q - coenzyme Q; Cyt C -- cytochrome c; SOD1, 2 -- superoxide dismutase 
1 and 2; Cat - catalase; Gpx glutathione; Prx 1-5 - peroxiredoxins; VDAC - Voltage-dependent 
anion channels.  
 
1.3.3. Δψm and ROS 
Most experimental studies demonstrate a direct relationship between the Δψm and ROS production, and 
show that even a slight increase of the Δψm enhances ROS emission, while a decrease of Δψm attenuates 
ROS release142-144. In 1971, Loschen et al. performed a pioneering experiment leading to the widely 
accepted concept that Δψm control ROS production in isolated mitochondria145. They observed a total 
inhibition of the succinate-induced increase of ROS production after application of an uncoupler 
(pentachlorophenol)145. An increase of Δψm by each 10mV interval doubles the mitochondrial rate of 
ATP production, while the rate of mitochondrial ROS emission rises exponentially in isolated 
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mitochondria 122. Furthermore, Rottenberg et al. showed that the correlation between Δψm and the O2•- 
generation rate was much stronger than between O2•- generation and the proton-motive force (Δp)146. 
More recently, Starkov et al. verified the relationships between ROS production, NADH/NAD+ ratio and 
Δψm in rat brain mitochondria 147. He proposed that the ROS production by mitochondria was regulated 
both by Δψm and by the NADPH redox state147. Δψm can regulate the rate of ROS production in complex 
I147 as well as in complex III of the respiratory chain146. For example, ROS production by complex III 
increases exponentially in yeast mitochondria at a Δψm above 140mV146. Additionally, ROS production 
within complex I caused by reverse electron flow is highly dependent on Δψm 148. It disappears as 
mitochondria are uncoupled, and it cannot occur if Δψm is blocked by an inhibitor148. The same 
connection between a rise of Δψm and the increase of ROS emission was described in intact cells (for 
example, the uncoupler, 2,4-dinitrophenol (DNP) attenuated ROS production in rat cardiomyocytes) 149. 
In summary, most scientific literature suggests that Δp provides the driving force for ATP production, 
while the Δψm provides the charge gradient for mitochondrial Ca2+ sequestration, and regulates ROS, thus 
controlling cellular functions117.  
There are, however, experiments that question the connection between Δψm and ROS150, 151. The main 
problem of this controversial finding is that an increase of Δψm induces the increase of ROS only under 
specific conditions. Under normal physiological conditions, mitochondria are in a state with non-
maximum Δψm (as is always the case when ATP is being synthesized)150. In this scenario, ROS 
production is minimal, but under special conditions, the increase of Δψm can initiate an increase of 
mitochondrial ROS production, as has been shown in vitro142-144 and in vivo152-154 studies. Therefore, an 
increase of Δψm leads to an increase of ROS production by mitochondria most probably only under 
special conditions (e.g. stress)142-144.  
It is interesting that mitochondrial ROS production is more sensitive to uncoupling-induced changes in 
Δψm than the ATP synthesis148. Therefore, the proton leak which uncouples the respiration from ATP 
synthesis may be a defensive mechanism to attenuate O2•- generation in conditions when the Δψm is 
high132, 155. Skulachev et al. proposed that mitochondria possess a special mechanism that prevents a 
strong increase in electrochemical proton gradient (ΔµH+) when ADP is exhausted123. He called this 
mechanism - “mild” uncoupling. This mechanism is particularly important in state 4 of mitochondrial 
respiration123. State 4 respiration is defined as the amount of O2 consumption that persists during 
inhibition of the ATP synthase, e.g. in the absence of ADP119. During state 4, Δψm is high with 
concomitant high electron pressure which increases the probability of ROS emission. This distinguishes 
the condition from a situation when respiration (electron flow) and ATP synthase activity are high, e.g. in 
metabolic active cells.  Korshunov et al. showed that low concentrations of uncouplers abolished the 
H2O2 production in state 4 respiration in heart muscle mitochondria142. Teleologically it could be 
Introduction  36 
concluded for that reason that the proton leak is maximal when the mitochondria are hyperpolarized121. 
Therefore, it is important to keep in mind that the proton leak may be particularly high when the cellular 
ATP level is high or ADP levels are low. The mechanism of the increase of the proton leak is not clear118. 
The total proton leak can be thought of as the sum of two process: basal leak (unregulated proton leak) 
and inducible proton leak (regulated by specific proteins located within IMM)121, 156. Passive proton leak 
was first described in isolated rat liver mitochondria where there was no ATP turnover (state 4, see 
explanation above )157. In this situation, state 4 respiration (O2 consumption) increases disproportionally 
as ∆p rises (Δψm is the main component of ∆p), which can be explained by a passive proton leak across 
the IMM158. This proton leak behaves in a non-ohmic manner, because it is correlated with the driving 
force (Δψm) in a nonlinear fashion, therefore disobeying Ohm’s Law156, 159. Importantly, this non-ohmic 
proton leak is also apparent in intact cells, demonstrating that this process is not caused by damage to the 
IMM during isolation of mitochondria156 and thus is essential for cellular function158. The rate of the basal 
leak accounts for 20-30% of the resting metabolic rate of hepatocytes and up to 50% of the respiration of 
rat skeletal muscle156. The proton leak significantly correlates with the membrane phospholipid content of 
the polyunsaturated fatty acid, docosahexaenoic acid160. Another explanation for the disproportionate 
increase in respiration at high ∆p (state 4) is “electron slip”, whereby electrons are transferred through the 
complexes of the respiratory chain without the pumping of protons across IMM156. However, this process 
(electron slip) has not been persuasively confirmed experimentally to occur under physiological 
condition156.  
On the other hand, the inducible proton leak can occur through special proteins of IMM, such as UCPs158. 
Nowadays, inducible proton leak is considered to be a major mechanism to adjust the Δψm to 
mitochondrial ROS emission155. UCP1, the most studied UCPs, acts as an uncoupler and dissipates Δψm 
in brown fat tissue to generate heat in mammals during non-shivering thermogenesis158. Dlaskova et al 
found that mitochondria isolated from brown fat tissue of UCP1 knockout mice were characterized by 
increased Δψm as well as by the increased ROS production161. Activity and expression of UCP1 is 
regulated by fatty acid, noradrenaline stimulation, thyroide hormone receptor activation transcriptional 
factors and PPARγ158. As a regulatory mechanism, increased ROS production may induce a proton leak to 
reduce the Δψm in a feedback manner121. ROS-induced oxidative stress has been shown to activate mild 
uncoupling, resulting in dissipation of Δψm without influencing ATP synthesis, but with a significant 
decrease of ROS formation123. The mechanism of ROS-induced mitochondrial depolarization is also not 
yet clear. Skulachev et al. demonstrated that uncoupling proteins can be responsible for this protective 
mechanism in the acute phase of oxidative stress123. Thus, proton leak and ROS generation can correlate 
with each other via a feedback loop159. Additionally, uncoupling of mitochondria prevents dielectric 
breakdown of the mitochondrial membrane118.      
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In conclusion, higher Δψm probably initiates higher ROS production. Therefore, proton leaks are 
analogous to a “pressure valve” in the sense that they decrease Δψm to limit ROS production and 
therefore protect cells against oxidative stress162. However, under pathological conditions or upon stress, 
the alteration of Δψm and therefore the modulation of mitochondrial ROS emission may serve as a sensor 
mechanism to adjust to the new conditions or, if adaptation failed, lead to the development of disease.  
Another mechanism, which may regulate the interaction between Δψm and ROS, is the allosteric 
regulation of the cytochrome c oxidase by phosphorylation163. Under basic (normal) conditions 
cytochrome c oxidases are phosphorylated which reduces their activity163. This decrease of activity results 
in a decrease of Δψm and ROS production163. Different pathological triggers dephosphorylate or 
phosphorylate complex IV, and therefore modulate the level Δψm and ROS production.  
 
1.3.4. Mitochondria and HPV 
As mentioned before, mitochondria are one possible candidate for the O2 sensor that triggers HPV1. In 
our previous study, we showed an increase of Δψm and O2•- release, most probably by complex III of the 
respiratory chain and inhibition of the mitochondrial electron chain at complex IV (inhibition cytochrome 
c and aa3) during HPV13. These data support the “ROS hypothesis” and contradict the “Redox 
hypothesis” of HPV. The ROS hypothesis (Figure 9c) suggests that acute hypoxia triggers the increased 
mitochondrial ROS production which results in Ca2+ release from the SR possibly via the oxidation of the 
cysteine residues of RyR and opening of IP3 (inositol trisphosphate)-gated calcium store3, 164. The 
hypoxia-induced release of Ca2+ from SR can be a trigger of capacitative Ca2+ entry via SOCC and/or 
VOCC that further increases the [Ca2+]i24. Alternatively, increased ROS could provoke the influx of 
extracellular Ca2+ through TRPC6 channels21. According to this theory, a paradoxical increase of ROS 
production during acute hypoxia may occur within complex III of the respiratory chain26. In contrast, the 
redox hypothesis proposes an inhibition of the mitochondrial respiratory chain by acute hypoxia which 
may result in a more reduced cytosolic redox state and a decrease of ROS concentration, causing 
inhibition of Kv channels, subsequent PASMC cell membrane depolarization, Ca2+ influx via the VOCC 
and finally vasoconstriction31, 165 (Figure 9a). Kv channels in this model play a key role. In normoxia, 
cysteine residues of Kv channels are oxidized by ROS maintaining them in open state, while reduction of 
these residues by acute hypoxia leads to their closure and subsequent depolarization of cell membrane34, 
165. The discrepancy of these theories remains unclear1, 3, 36. We should keep in mind that existing 
approaches to measure ROS have many pitfalls including lack of specificity and sensitivity that can 
explain difficulties in evaluation of the ROS level upon acute hypoxia1. Application of antioxidants 
during HPV did not reveal the role ROS in HPV36. The lack of antioxidants that specifically act within 
mitochondria can be a reason for these controversial results. The same controversial results have been 
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obtained from studies investigating the influence of mitochondrial inhibitors on vascular tone in normoxia 
and during HPV1.  
Little is known about the role of Δψm in HPV and only a few studies have investigated the effect of acute 
hypoxia on the Δψm. As mentioned above, Sommer et al. descibed a hyperpolarization of mitochondria 
upon an acute hypoxic stimulus in precapillary PASMC isolated from rabbits13. The inhibition of the 
mitochondrial electron chain at complex IV could be the reason for mitochondrial hyperpolarization via a 
yet unknown mechanism. Michelakis et al. described the same effect of acute hypoxia on Δψm in rat 
PASMC 96. He found that hypoxia evoked a mitochondrial hyperpolarization in PASMC, while the 
mitochondria from renal artery smooth muscle cells (SMC) depolarized96. However, Kang et al. proposed 
the opposite theory166, 167. According their theory, acute hypoxia leads to depolarization of mitochondria 
that decreases the mitochondria’s ability to buffer Ca2+ and thereby increases a hypoxic-induced rise of 
[Ca2+]i. This theory reflects his observation from application of FCCP (carbonyl cyanide 4-
(trifluoromethoxy)phenylhydrazone) to rabbit PASMC during an acute hypoxic stimulus, where an 
administration of FCCP augmented a rise of [Ca2+]i via SR release and capacitative Ca2+ entry. 
Nevertheless, in this study, PASMC from larger pulmonary arteries were used and Δψm was not been 
measured. Additional an argument against Kang’s study is a publication that demonstrated the inhibitory 
effect of chemical uncouplers, DNP and FCCP, on HPV at high concentrations168.  
Another proposal for the HPV mechanism suggests that mitochondria can sense the lack of O2 via 
changes of the intracellular AMP/ATP ratio (Figure 9b) resulting in activation of AMPK (AMP-activated 
protein kinase)169 and subsequently increased concentration of cADPR (cyclic ADP ribose), which causes 
Ca2+ release from the SR through the RyR170. Additionally, it has been shown that AMPK modulates Kv 
channel function in a similar manner to hypoxia171 and the non-selective AMPK antagonist, compound C, 
blocks sustained HPV35. There is a potential link between a hypoxic elevation of ROS and AMPK (Figure 
9b), in which ROS and OONO- (peroxynitrite)172, 173 can activate the AMPK possibly via a change of the 
intracellular AMP/ATP ratio174.  
Mitochondria might not only be a trigger of HPV, but also could be a mediator of the HPV transduction 
pathway3. Alterations in [Ca2+]i concentration act as a main signal for PASMC contraction3. Mitochondria 
have long been known for their role in [Ca2+]i metabolism175. Under normal conditions, the concentration 
of Ca2+ within the mitochondrial matrix [Ca2+]m is equal to the cytosolic [Ca2+]i. Different pathological or 
physiological stimuli lead to mitochondrial uptake of Ca2+ driven electrophoretically by the Δψm from the 
cytosol through the mitochondrial calcium uniporter (MCU). An increase of [Ca2+]m can change activity 
of TCA (tricarboxylic acid cycle) enzymes, respiratory complexes, and opening of the permeability 
transition pore176. Mitochondria release Ca2+ into cytosol through several different routes175. However, the 
contribution of the mitochondria to the Ca2+ homeostasis in PASMC during acute hypoxia is poorly 
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understood177. It was shown that mitochondrial Ca2+ uptake may attenuate the hypoxia-induced rises in 
[Ca2+]i in rabbit PASMC during hypoxia. In contrast, Wang et al. reported that acute hypoxia caused the 
Ca2+ release from mitochondria of rat PASMC178.  
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Figure 9. Possible role of mitochondria in HPV.  
Mitochondria can act as O2 sensor or modulate the course of HPV.  
a) Redox hypothesis. Acute hypoxia leads to a more reduced cytosolic redox state and 
decreases ROS concentration because of impaired mitochondrial respiration. Decreased redox 
state and ROS inhibit Kv channels, causing depolarization of the cellular membrane and the 
activation of voltage-gated calcium channels, influx of Ca2+, and/or release of Ca2+ from the SR. 
b) The role of AMP-activated kinase (AMPK) in HPV. Acute hypoxia increases the AMP/ATP 
ratio that activates the AMPK, which results in an increase of the cADPR concentration and the 
opening of calcium channels of the SR.  
c) ROS hypothesis. Acute hypoxia increases ROS levels resulting in the opening of the Ca2+ 
stores via oxidation of ryanodine-sensitive receptors and/or influx of Ca2+ through the TRPC6 
channels.  
Abbreviations: AMP/ATP ratio - adenosine monophosphate/adenosine triphosphate ratio; 
AMPK - 5' adenosine monophosphate-activated protein kinas; cADPR - cyclic adenosine 
diphosphate ribose; Ca2+ - calcium; L-type VOCC- voltage operated calcium channels; Kv - 
potassium channels; SOCC - store-operated calcium  channels; SR - sarcoplasmic reticulum; 
TRPC6 - transient receptor potential cation channels; RyR - ryanodine-sensitive receptors; ROS 
– reactive oxygen species; Δψm – mitochondrial membrane potential. 
Modified from J. T. Sylvester et al. 
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1.3.5. Mitochondria and PH  
Mitochondria can play an important role in the pathogenesis of PH via the regulation of [Ca2+]i 
homeostasis, mitochondrial ROS production, release of proapoptotic proteins and alteration of cellular 
metabolism37, 38, 40, 82, 96 (Figure 10).  
Modulation of mitochondrial ROS may play an essential role in pulmonary vascular remodeling in PH37, 
179, 180 Similar to mitochondrial ROS in HPV; there are two antithetic opinions about the role of ROS in 
PH development. One group of scientists have found a decrease of ROS emission95 (Figure 10 pathway 
"1a"), whereas other groups have found a large body of evidence suggesting an increase of ROS (Figure 
10 pathway "1b") is a cause of PH development via the alteration of hypoxia-inducible factor 1 (HIF-1α) 
stabilization38, the function of ROS sensitive proteins172, 173 and cellular Ca2+ homeostasis3, 164. Severe 
hypoxia leads to the activation of different transcription factors including (HIF1), which was first 
described by Semenza et al. in 1995181. The importance of HIF in PH was proven using mice with partial 
deficiency of HIF-1α (HIF-1α+/-)182. These mice were characterized by attenuation of the increase of PAP 
and RV hypertrophy upon chronic hypoxic exposure182. HIF1 is a heterodimer of two proteins: HIF-1α 
and HIF-1β (or ARNT - aryl hydrocarbon nuclear trans-locator)181. In well-oxygenated conditions, HIF-
1α is maintained in a hydroxylated state by PHD (prolyl hydroxylase) leading to proteasomal degradation 
of HIF-1α, which is mediated by the E23 ubiquitin ligase von Hippel-Lindau (VHL). Chronic hypoxia 
stabilizes HIF-1α through an alteration of PHD2 function and lack of O2 that is the substrate for PHD2181. 
The exact mechanism of hypoxia-induced stabilization of HIF-1α is under investigation, but it has been 
suggested that mitochondrial ROS can mediate the stabilization of HIF-1α 38, 183. Evidence for increased 
ROS inducing HIF-1α stabilization are the following: overexpression of catalase (which leads to removal 
of H2O2) abolished the HIF-1α protein accumulation in response to hypoxia, and H2O2 application in 
normoxic conditions stabilized HIF-1α38. Arguments for decreased ROS inducing HIF-1α stabilization 
are from a study that demonstrated that downregulation of SOD2 by siRNA, which decreases H2O2 
concentration, activated the HIF-1α translocation to the nucleus183. However, it is possible that an 
increase of O2•- as the result of SOD2 downregulation is actually responsible for HIF-1α stabilization and 
not the decrease in H2O2 concentration. After stabilization, the HIF1α is translocated into the nucleus, 
binds to HIF-responsive elements (HREs) and turns on various genes to stimulate immediate and long-
term responses to chronic hypoxia including expression of enzymes of the anaerobic glycolysis such as 
pyruvate dehydrogenase kinase isozyme 1 (PDK1)184, lactate dehydrogenase A (LDHA)185, glucose 
transporter (Glut1)186 and etc. Therefore, in hypoxia cellular ATP production is shifted from an oxidative 
(aerobic) to a less efficient glycolytic (anaerobic) metabolism, which is called "metabolic shift" (Figure 
10 pathway 3). A metabolic shift has also been observed in non-hypoxic PH187. MCT-induced PH leads to 
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the same metabolic shift as in chronic hypoxia through stabilization of HIF-1α188. Additionally, vascular 
cells isolated from IPAH patients are also characterized by increased anaerobic glycolysis189. However, 
the mechanism of non-hypoxic stabilization of HIF-1α is still unknown. It is possible that ROS also could 
play a role in this process38, 190. The increased anaerobic glycolysis is linked to increased proliferation and 
attenuated apoptosis by still not completely clear molecular pathways (Figure 10 pathway 3)181, 191, 192. 
The restoration of glucose oxidation by deletion of the gene for malonyl-coenzyme A decarboxylase and 
subsequent blocking of the fatty acid oxidation, leads to prevention of PH development in mice upon 
chronic hypoxia193. Moreover, dichloroacetate (DCA) treatment also prevented the development of PH194, 
195. DCA is an inhibitor of the PDK1 and thus increases glucose substrate supply to the mitochondria, 
which decreases anaerobic glycolysis. The metabolic shift, which was found in PH, shows similarities to 
the metabolic changes occurring in cancer cells (called the "Warburg effect"). In cancer cells a high rate 
of anaerobic glycolysis provides several advantages for proliferating cell: 1) it allows cells to use the most 
abundant extracellular nutrient, glucose, to produce abundant ATP; 2) glucose degradation provides cells 
with the intermediates needed for biosynthetic pathways, including ribose sugars for nucleotides, glycerol 
and citrate for lipids, nonessential amino acids192.  
As written before, mitochondria are a reservoir for excess [Ca2+]i40, 196 and changes in [Ca2+]i 
concentration play a significant role in remodeling of the pulmonary vasculature via activation of Ca2+ 
dependent enzymes (e.g. PKC197), receptors (e.g. ryanodine-sensitive receptors )3, 164 and transcription 
factors (e.g. CREB198, NFAT199) (Figure 10 pathway 2). Little is known about [Ca2+]m and PH and further 
investigations are necessary. The interplay of mitochondria with the endoplasmic reticulum (ER) is an 
important component of mitochondrial Ca2+ regulation. Recently, it has been shown that the disruption of 
the ER-mitochondria contact attenuates apoptosis of PASMC by decreasing the ER-to-mitochondria 
phospholipid transfer and intermitochondrial Ca2+ that leads to an excess of pulmonary vascular 
remodeling in chronic hypoxia-induced PH in mice200. The decrease of [Ca2+]m leads to inhibition of 
Ca2+-sensitive mitochondrial enzymes which decreases mitochondria-dependent apoptosis200. In addition 
to ROS-mediated alteration of HIF-1α stabilization, mitochondrial ROS also can modulate [Ca2+]i 
homeostasis via the oxidation/reduction of different Ca2+ channels and ROS-sensitive enzymes165, 201 
(Figure 10 pathway 2). In this regard downstream targets of ROS may be TRPC3 (transient receptor 
potential cation channel, member 3) channels that have been shown to be activated by ROS in porcine 
aortic EC 201.  
Mitochondria induce cell death by releasing proapoptotic mediators and thus initiating apoptosis37. 
Release of proapoptotic proteins can be dependent on Δψm37. Mitochondrial depolarization promotes 
apoptosis while mitochondrial hyperpolarization locks cells into an apoptosis-resistance state37 (Figure 10 
pathway 4). Therefore, preserved Δψm can be a sign of higher proliferative and less proapoptotic cells as 
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in the case of cancer cell lines202. The decrease of apoptosis plays an essential role in the vascular 
remodeling of the medial layer in PH; however, the exact mechanism of triggering of apoptosis in PH is 
still not fully understood37, 56, 165. It has been shown that the metabolic shift in PH can suppress Kv1.5 
expression, leading to an attenuation of apoptosis of PASMC165 (Figure 10 pathway 4). Additionally, 
BMPR2 mutations in mice (BMPR2-mutant mice) lead to an increase of ROS of mitochondrial origin and  
a decrease of mitochondria-induced apoptosis which is the cause of pulmonary vasculature remodeling203. 
In contrast, in early stages of experimental PH, EC apoptosis could be an initiating trigger, leading either 
directly to the degeneration of pre-capillary arterioles or to the selection of hyperproliferative, apoptosis-
resistant EC that may contribute to "angioproliferative" plexiform lesions56. Consequently, apoptosis 
could play a dual cellular-specific or course-specific role in pathogenesis of PH165.  
As written above, one of the key characteristics of normal function of “happy” mitochondria is the ∆ψm. 
Studies investigating the contribution of Δψm to PH development have shown controversial results. Some 
investigators find an increase34 (i.e. hyperpolarization) and others a decrease (i.e. depolarization) of 
Δψm204 in experimental models of PH and IPAH. Chen et al. found significant hyperpolarization of 
human PASMC during chronic hypoxia that was connected with the decrease of mitochondrial 
permeability and attenuated apoptosis205. Conversely, another study that used the same cell line (human 
PASMC), experimental conditions (5% O2 and 24h incubation) as well as the same fluorescent approach 
(Rhodamine-123) for Δψm measurement reported a depolarization of the Δψm during the chronic hypoxic 
exposure concomitant with increased H2O2 production204. These authors found that hypoxia induced an 
opening of mitoKATP channels (mitochondrial ATP-dependent potassium channels) leading to 
depolarization of mitochondria that inhibited the release of cytochrome c into cytosol and the activation 
of caspase-dependent mechanisms, therefore decreased human PASMC apoptosis204. MitoKATP 
depolarizes mitochondria via influx of potassium into mitochondria in the opposite direction to proton 
movement. Increase of mitochondrial H2O2 production is also explained by the opening of mitoKATP 
channels. However, the exact mechanism by which mitoKATP channels affects the production of H2O2 and 
cytochrome release has not been elucidated. Additional evidence for the hyperpolarization in PH comes 
from Bonnet et al and Paulin et al. 34, 206. They also demonstrated the increase of Δψm in experimental PH 
that was associated with simultaneous decrease of ROS, the attenuation of apoptosis34, 206 and the 
decrease of intermitochondrial Ca2+ concentration200, 206. The sequence of these events in PH is 
completely unclear. Even more, it is not certain how an increase of Δψm is connected with a decrease of 
ROS in this model.  
In summary, the role of Δψm in hypoxia- and non-hypoxia dependent molecular pathways of PH needs to 
be further elucidated.  
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Figure 10. Role of mitochondria in the pathogenesis of PH.  
 Mitochondria can play an important role in the pathogenesis of PH by participating in 
different molecular signaling pathways including the regulation of [Ca2+]i homeostasis, 
mitochondrial ROS production, release of proapoptotic proteins and alteration of cellular 
metabolism38.  
 Numbers depict the pathways: 
1) Mitochondria are the main source of ROS within cells. There are two main theories about 
the role of ROS in PH: 1A) Triggers of PH decrease mitochondrial respiration and thus ROS 
production. Decreased ROS triggers HIF-1α stabilization and Kv 1.5 downregulation95. Kv 1.5 
downregulation leads to decreased apoptosis of PASMC165. 1B) Triggers of PH increase 
mitochondrial ROS production that initiates Ca2+ release from SR201, HIF-1α stabilization38 
and activation of different proteins38 (e.g. Src enzyme172, pERK207, 208). HIF-1α is a 
transcriptional factor that activates expression of various proteins including growth factors 
(e.g. VEGF) and key enzymes for activation of anaerobic glycolysis184-186.  
2) The change in [Ca2+]i concentration, probably, plays an important role in remodeling of the 
pulmonary vasculature via activation of Ca2+ dependent enzymes (e.g. PKC197), receptors 
(e.g. RyR) 3, 164 and transcriptional factors (e.g. CREB198, NFAT199). Mitochondria act as key 
regulator of [Ca2+]i concentration. They uptake Ca2+ via the MCU and release it to cytosol via 
different exchangers (e.g. Na/Ca2+ exchanger)175.  
3) Cellular metabolism in PH is characterized by a metabolic shift from aerobic to anaerobic 
glycolysis187. The stabilization of HIF-1α is an essential initiating event in this process182. The 
increased anaerobic glycolysis is linked to an increased proliferation and attenuated apoptosis 
by still not completely clear molecular pathways181, 191, 192. The restoration of glucose 
oxidation leads to prevention of PH development193-195. 
4). Mitochondria induce cell death by releasing proapoptotic mediators and thus initiating  
apoptosis37. Decrease of apoptosis plays an essential role in pulmonary vasculature 
remodeling of the medial layer in PH165. 
 Abbreviations: ER - endoplasmic reticulum, Kv - potassium channels; HIF-1α - hypoxia 
inducible factor 1a, PDH - pyruvate dehydrogenase, ROS - reactive oxygen species, MCU - 
mitochondrial calcium uniporter, NCX sodium-calcium exchanger, TRPC - transient receptor 
potential cation channels, RyR - ryanodine-sensitive receptors; SERCA - sarco/endoplasmic 
reticulum Ca2+-ATPase, NFAT - nuclear factor of activated T-cells; CREB - cAMP response 
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element-binding protein; PKC - protein kinase C; SRC - v-src sarcoma (Schmidt-Ruppin A-2) 
viral oncogene homolog (avian); pERK - extracellular signal-regulated kinases; HIF-1α - 
hypoxia-inducible factor 1-α; Ca2+ - calcium; ROS – reactive oxygen species; Δψm – 
mitochondrial membrane potential. 
 
1.4. Uncoupling protein 2 (UCP2) 
1.4.1. Definition, molecular structure and tissue distribution 
As stated before, proton leak through the IMM towards the intermembrane space may occur through 
different classes of small mitochondrial membrane proteins, called UCPs209. Thus, UCPs may regulate the 
Δψm and ROS production210. Mammals express five UCPs homologues, UCP1-UCP5211. UCP2, a IMM 
protein, is widely expressed in different organs including the brain, lung, spleen, kidney, liver and heart, 
and was discovered in 1996 through its sequence homology and 59% amino-acid identity to the brown fat 
specific UCP1 that was found in 1976212. It should be remembered that the pattern of mRNA expression 
of UCP2 is not identical to its protein expression pattern211. UCP1 is responsible for heat generation by 
increasing the permeability of the IMM to protons in brown adipose tissue213. In contrast to UCP1, which 
is the only UCP for which a function in increasing proton conductance has been proven211, the role of 
UCP2 is still not clear151. However, UCP1 knockout mice overexpress UCP2 mRNA five-fold in brown 
adipose tissue which suggests that UCP2 can act in a similar fashion to UCP1160. The molecular structure 
of UCP2 is not known. Recently, Berardi et al., suggested that the structure of UCP2 closely resembles 
the bovine ADP/ATP carrier, determined by NMR (nuclear magnet resonance) molecular fragment 
searching214. Structurally, UCPs are homodimers and contain three repeats of approximately 100 amino 
acids that form the alpha helices that are connected with long hydrophilic loops oriented towards the 
matrix side, whereas the amino and carboxyl termini extend into the intermembrane space215. In humans, 
the UCP2 and UCP3 genes are both located on chromosome 11q13 and transcription initiation of UCP2 is 
only 7-8 kb downstream from the UCP3 stop codon216. There are 8 exons in the UCP2 gene and exon 1 
and 2 are untranslated216. In various genetic studies, a relationship between UCP2 and obesity, fatty acid 
metabolism or diabetes mellitus type II216 has been found, but there are no published investigations about 
the role of UCP2 polymorphisms in PH.  
 
1.4.2. Mechanism of action 
Although the precise physiological/pathological functions of UCP2 are still not fully understood, 
scientific evidence has described UCP2 as a negative regulator of Δψm and mitochondria-derived ROS 
emission, especially upon different stimuli. Currently, four different mechanisms of UCP2 function are 
suggested (Figure 11). Historically, UCP2 has been considered to be a pure uncoupling protein that 
mediates a proton leak toward to the intermembrane space and therefore decrease the Δψm217, 218 and ROS 
production219-221 (Figure 11, b). Negre-Salvayre et al. first described that inhibition of UCP2 with 
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guanosine diphosphate (GDP) resulted in a sharp increase of mitochondrial ROS219. Recently, attenuation 
of ROS production after overexpression of UCP2 was shown220, 221, and UCP2 knockout results in an 
increase of mitochondrial ROS emission222. Additionally, it has been described that increased ROS could 
activate UCP2 through the oxidation of lipids of the IMM223 or directly increase proton flow through 
UCP2 pores224. In this scenario, UCP2 serves as a counter-regulatory mechanism against the increased 
ROS production within mitochondria.  
However, several publications could not demonstrate the uncoupling effect of UCP2212, 213, mainly 
because they could not find increased respiration by activation of UCP2 which would be expected by its 
uncoupling property. Bouillaud et al. suggested an alternative theory, ”the metabolic hypothesis” 
concerning the physiological function of the UCP2225 (Figure 11c). In this theory, UCP2 plays a role as a 
“metabolic switch” which restrains mitochondrial glucose metabolism via inhibition of pyruvate entry 
into the mitochondrial matrix and compensatory increase of fatty acid metabolism226. The term 
“metabolic switch” should be not confused with the term “metabolic shift” that was described above and 
corresponds to effect of chronic hypoxia on cellular metabolism. Fatty acids stimulate the expression of 
UCP2/3227, and UCP2 promotes the feeding of the TCA cycle with products of fatty acid oxidation226. 
Thereby UCP2 could decrease ROS production by inhibiting the entry of pyruvate into the oxidative 
pathway resulting in attenuation of the enormous redox pressure of pyruvate225. In connection with this 
theory, it was suggested that UCP2 serves as a pyruvate anionic uniporter that pumps the excess pyruvate 
from the mitochondrial matrix into the intermembrane space and therefore restricts the pyruvate 
availability for mitochondrial respiration213, 225 (Figure 11d). Additionally, Hurtaud et al. showed in 
macrophages that UCP2 is mandatory for efficient mitochondrial oxidation of glutamine, an alternative 
fuel for the respiratory chain in absence of glucose228. These articles support the “metabolic theory” and 
suggest that in addition to fatty acids, other molecular pathways feed the respiratory chain in conditions of 
a lack of glucose. In conclusion, the “metabolic theory” suggests that UCP2 activity results in a condition 
similar to the Warburg effect, decreasing pyruvate oxidation and promoting anaerobic glycolysis in 
presence of O2225.  
One group from Graz, Austria, suggested that UCP2/3 is the conductive subunit of a Ca2+ selective 
mitochondrial ion channel at the IMM229 (Figure 11a). They showed that knockdown of UCP2 by specific 
siRNA or their overexpression dramatically changes the mitochondrial Ca2+ capacity, as well as the 
velocity of mitochondrial Ca2+ sequestration229. The increase of the Ca2+ influx into mitochondria 
associates with a decrease of the Δψm as a result of accumulation of positively charged Ca2+ ions within 
the mitochondrial matrix230. However, these data should be confirmed by other scientific groups225  
especially in light of the fact that the introduction of mammalian UCPs into yeast fails to provide 
evidence of the MCU presence in these eukaryotic microorganisms225. 
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Although the molecular mechanism of UCP2 remains to be resolved, it is widely accepted that UCP2 
decreases ROS production and alters proliferation213. 
 
 
 
 
Figure 11. Hypothetical functions of uncoupling protein (UCP2) and its effects on Δψm and ROS 
production.  
a) UCP2 is a conductive part of the MCU that increases influx of Ca2+ ions into the 
mitochondrial matrix229. 
b) UCP2 acts as protonophore that uncouples Δψm and ATP synthesis resulting in decreased 
Δψm and ROS production219-221.  
c) UCP2 acts as “metabolic switch” between glucose and fatty acid metabolism. The excess 
of fatty acid or lack of glucose activates entry of fatty acid into the mitochondrial matrix and 
causes a compensatory decrease of pyruvate uptake by mitochondria225. These processes 
could decrease electrons entry into the respiratory chain and thus decrease Δψm and ROS 
production225. 
d) UCP2 acts as pyruvate anionic uniporter that pumps pyruvate out of the matrix towards the 
intermembrane space213, 225 .  
Abbreviations: I, II, III; IV and V - complexes of respiratory chain; ADP - adenosine 
diphosphate; ATP - adenosine triphosphate; ANT - adenine nucleotide translocase; CPT1 and 
2 - Carnitine palmitoyltransferase I and II; MCU - mitochondrial calcium uniporter; NADH - 
reduced form of NAD+ (nicotinamide adenine dinucleotide); LDHA - lactate dehydrogenase 
A; Q - coenzyme Q, C - cytochrome c; PDH - Pyruvate dehydrogenase; TCA cycle - 
tricarboxylic acid cycle; Pyr - pyruvate; UCP2 - uncoupling protein 2; Ca2+ - calcium O2•-- 
superoxide; H+; Δψm – mitochondrial membrane potential. 
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1.4.3. UCP2 and cellular function 
An increasing number of reports point to the relevance of UCP2 in important physiological and 
pathophysiological pathways, such as insulin secretion, neuronal activity, immune response, obesity, 
diabetes, and cancer210, 213. Therefore, the presence of UCP2 has both favorable and unfavorable effects 
depending on the disease225. For example, the most accepted function of UCP2 in β-cells of the pancreas 
indicates that UCP2 acts as a negative regulator of insulin secretion231. In pancreatic β-cells, fluctuations 
of nutrients cause alterations in both expression and activation of UCP2231. In this context, increase of 
UCP2 expression and/or UCP2 activity decreases the ∆ψm that reduces the generation of ATP and 
subsequently decreases ATP/ADP ratio within β-cells. The decrease of the ATP/ADP ratio attenuates the 
closing of the ATP-sensitive K+ channel in the plasma membrane, which prevents membrane 
depolarization, opening of VDCC, and influx of Ca2+ into the cytosol of β- cells, which subsequently 
stops the exocytosis of granules containing insulin231.  
The role of UCP2 in the signaling pathway of HPV and PH to date has not been investigated. UCP2 could 
influence these processes by interaction with ROS, Ca2+ and ATP regulated pathways, as well as by 
interference with proliferation and apoptosis. In this regard, Derdak et al. described that UCP2-deficient 
mice (UCP-/-) exhibit increased oxidative stress along with enhanced NF-kB activation that induces 
proliferation and decreases apoptosis of intestinal epithelial cells232. In line with this article, Nino Fong et 
al. demonstrated that UCP2-/- mice display increased transactivation of NF-kB which may contribute to 
enhanced expression of antiapoptotic genes such as Tnfaip3 (Tumor necrosis factor, alpha-induced 
protein 3) and pro-proliferative genes such as Ccnd2 (G1/S-specific cyclin-D2) in pancreatic β-cells233. 
Pecqueur and colleagues also showed that UCP2 knockdown is associated with increased proliferation of 
mouse embryonic fibroblasts (MEFs) and T cells226. Possibly, UCP2 knockout increases proliferation via 
activation of p38 and ERK234. In contrast, overexpression of UCP2 in Chinese hamster ovary (CHO-K1) 
cells, cells that normally do not express any of the UCPs, in chick embryo fibroblasts and in HeLa cells 
(cervical cancer cells taken from Henrietta Lacks) decreases their proliferation235. Additionally, UCP2 
can modulate the production of important pro-proliferative cytokines, e.g. mast cells of UCP2 knockout 
mice exhibited higher histamine release and interleukin-6 (IL-6) production while overexpression of 
UCP2 demonstrated an opposite effect236. Furthermore, UCP2 expression is necessary for full 
differentiation of human pluripotent stem cells237. Chen et al. showed that UCP2 downregulation was 
important for myogenic differentiation238.  
On the other hand, the anti-cancer effects of paclitaxel in the melanoma cell line a375 and BLM are 
associated with downregulation of UCP2, increase of mitochondrial ROS production and activation of 
JNK, p38 and ERK239. UCP2 deficiency significantly decreases cell proliferation of progenitor cells from 
Introduction  48 
bone marrow at the erythropoietin-dependent phase of erythropoiesis240. A discrepancy of the role of UCP 
in cellular proliferation can be attributed to cell- or trigger-specific effects of UCP2 functions.  
In our laboratory it has been shown that UCP2 knockout (UCP2-/-) magnifies the HPV response in 
isolated lung experiments. However, the exact mechanisms have not been elucidated (unpublished thesis 
of Timm Hoeres, Giessen).  
 
1.5. Aims of this study 
Despite a long history of research, the role of mitochondria in the response of the pulmonary vasculature 
to acute and chronic hypoxia, resulting in HPV and PH, still remains unknown. Alterations in the ∆ψm 
may be crucial in both processes. UCP2, a mitochondrial uncoupling protein, is known to modulate 
several mitochondrial functions including the Δψm, ROS and glucose metabolism, although the exact 
molecular mechanism of its action has not yet been completely elucidated. It was previously shown that 
lungs of UCP2-/- mice exhibit increased HPV and increased pulmonary vascular remodeling under 
baseline conditions.  
 
Against this background, the aims of this study were 1) to identify the role of Δψm in HPV and PH, 2) to 
investigate if increased HPV and pulmonary vascular remodeling in UCP2-/- mice are related to 
alterations in Δψm, and 3) to decipher up- and downstream signaling mechanisms of Δψm alterations 
(Figure 12). In order to answer these questions, the following investigations were performed: 
 
• Alterations of Δψm were investigated in isolated precapillary PASMC during acute hypoxia and in 
animal models of PH, as well as in human PAH. 
• The physiological relevance of Δψm alterations was tested in isolated PASMC of UCP2-/- mice 
and after knockdown of UCP2 by siRNA during acute hypoxia and in PASMC proliferation. 
• Upstream and downstream signaling mechanisms of alterations in Δψm, including ROS 
metabolism, were investigated in models of PH and during UCP2 knockdown on cellular level. 
The effect of a proliferative stimulus (chronic hypoxia) was tested in UCP2-/- cells. 
 
The hypothesis tested is that during acute hypoxia and PH, Δψm is increased, resulting in HPV and 
pulmonary vascular remodeling. Knockout of UCP2 should exhibit augmented Δψm hyperpolarization, 
thus increasing HPV and pulmonary vasculature remodeling. As a downstream mediator for this pathway, 
increased ROS production is proposed. Under a proliferative stimulus (e.g. chronic hypoxia), UCP2-/- 
may additionally exert anti-proliferative functions and attenuate pulmonary vasculature remodeling, as it 
may counteract the metabolic switch by increasing pyruvate metabolism of the mitochondria.  
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Figure 12. Aims of the study.  
A) Is acute hypoxia associated with Δψm alterations and are these alterations of physiological 
significance in these processes? Does the knockout of UCP2 (UCP2-/-) magnify the acute 
hypoxia-induced Δψm alterations and ROS production? 
B) Is PH associated with Δψm alterations and are these alterations of physiological 
significance in PH? Does UCP2-/- augment Δψm /ROS production and therefore increase 
pulmonary vasculature remodeling under baseline conditions? Does UCP2-/- decrease 
pulmonary vasculature remodeling via the attenuation of the metabolic switch in hypoxia-
induced PH?  
Abbreviations: Black arrows depict the hypothetical pathway of HPV and PH, solid lines 
represent proven and dashed lines unproven interactions. Red arrows depict the possible 
mechanism of augmentation of HPV and pulmonary vascular remodeling by UCP2-/-. Blue 
lines depict the possible mechanism of attenuation of pulmonary vascular remodeling by 
UCP2-/-.  
Δψm - mitochondrial membrane potential; UCP2-/- - knockout of uncoupling protein 2; ROS - 
reactive oxygen species; HPV - hypoxic pulmonary vasoconstriction; MCT - induced PH. 
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2. Material and methods 
 
2.1. Reagents 
[3H]-Thymidine  GE Healthcare, Little Chalfont, UK 
2-Mercapto-ethanol  Sigma-Aldrich, St. Louis, USA 
Acetic Acid, Glacial 99%  Sigma-Aldrich, St. Louis, USA 
Acetone 99,5%  Sigma-Aldrich, St. Louis, USA 
ADP  Sigma-Aldrich, St. Louis, USA 
Albumin, Bovine serum  Sigma-Aldrich, St. Louis, USA 
Alexa fluor 488 labeled antibody against DIG 
antigen 
Roche Applied Science, Penzberg, Germany 
Anti-cyclin D1 antibody Cell Signaling Technology, Danvers, USA 
Anti-DDK antibody OriGene, Rockville, USA 
Anti-human von Willebrand factor antibody  Dako, Hamburg, Germany 
Anti-LDHA antibody Cell Signaling Technology, Danvers, USA 
Anti-PDK1 antibody Cell Signaling Technology, Danvers, USA 
Anti-α-smooth muscle actin antibody  Sigma-Aldrich, St. Louis, USA 
Anti-β-actin antibody Sigma-Aldrich, St. Louis, USA 
Anti-UCP2 antibody Santa Cruz Biotechnology, Santa Cruz, USA 
Atimycin A Sigma-Aldrich, St. Louis, USA 
Bongkrek acid Sigma-Aldrich, St. Louis, USA 
CaCl2 Sigma-Aldrich, St. Louis, USA 
CMH (1-Hydroxy-3-methoxycarbonyl-
2,2,5,5-tetramethylpyrrolidine)  
Alexis Corporation, San Diego, USA 
Collagenase type IV  Sigma-Aldrich, St. Louis, USA 
Complete  Roche Applied Science, Penzberg, Germany 
Crystal violet Sigma-Aldrich, St. Louis, USA 
Cy3-labeled α-smooth muscle actin antibody Sigma-Aldrich, St. Louis, USA 
Denhardt’s reagent Sigma-Aldrich, St. Louis, USA 
Dextran sulphate Sigma-Aldrich, St. Louis, USA 
DMSO (Dimethyl Sulfoxide) Sigma-Aldrich, St. Louis, USA 
ECL plus western blot detecting system  GE Healthcare, Little Chalfont, UK 
EDTA (Ethylenediamine-tetraacetic acid) Sigma-Aldrich, St. Louis, USA 
EGTA (Ethylene glycol-bis(ß-amino-
ethylether)-N,N,N',N'tetraacetic acid) 
Sigma-Aldrich, St. Louis, USA 
Ethanol (70%, 95%, 99,6%) SAV LP GmbH, Flintsbach, Germany 
FCCP (Carbonyl cyanide 4-
(trifluoromethoxy)phenylhydrazone) 
Sigma-Aldrich, St. Louis, USA 
FCS (Fetal calf serum) Invitrogen, Carlsbad, USA 
Fe3O4 (Iron particles) Sigma-Aldrich, St. Louis, USA 
Formaldehyd alcohol free 3.7% Otto Fischar GmbH&Co, Saarbrücken, 
Germany 
H2O2 30% Merck, Darmstadt, Germany 
HCl  Sigma-Aldrich, St. Louis, USA 
Heparin  Rathiopharm GmbH, Ulm, Germany 
Hepes (2-(-4-2-hydroxyethyl)-piperazinyl-1-
ethansulfonate) 
Sigma-Aldrich, St. Louis, USA 
HyPer Evrogen Company, Moscow, Russian 
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Federation 
iScript cDNA Synthesis Kit Bio-Rad, Hercules, USA 
Isoflurane Forene® Abbott, Wiesbach, Germany 
Isopropanol (99,8%) Fluka Chemie, Buchs, Swithland 
iTaq SYBR Green supermix with ROX Bio-Rad, Hercules , USA 
JC1 (5,5’,6,6’-tetrachloro-1,1’,3,3’-
tetraethylbenzimidazolylcarbocyanine iodide) 
Sigma-Aldrich, St. Louis, USA 
Ketavet (Ketamin hydrochloride)  Pfizer, Karlsruhe, Germany 
KH2PO4 Sigma-Aldrich, St. Louis, USA 
LB Agar Invitrogen, Carlsbad, USA 
LNA™ mRNA Detection Probes Exiqon, Vedbaek, Denmark 
Low melting agarose  Sigma-Aldrich, St. Louis, USA 
M199 medium  Invitrogen, Carlsbad, USA 
Medetomidin  Pfizer, Karlsruhe, Germany 
Medical X-Ray film  Agfa, Mortsel, Belgium 
Medium for human SMC (smooth muscle 
cells) 
PromoCell, Heidelberg, Germany 
Methanol Fluka Chemie, Buchs, Swithland 
MgCl2 Sigma-Aldrich, St. Louis, USA 
Milk powder Carl ROTH, Karlsruhe, Germany 
Mini-PROTEAN vertical electrophoresis 
system 
Bio-Rad, Hercules, USA 
MitoSox Invitrogen, Carlsbad, USA 
MnTBAP (Mn(III)tetrakis(4-benzoic 
acid)porphyrin Chloride) 
Sigma-Aldrich, St. Louis, USA 
Monocrotaline Sigma-Aldrich, St. Louis, USA 
Myc-DDK-tagged ORF clone of Mus 
musculus UCP1 plasmide 
OriGene, Rockville, USA 
Myc-DDK-tagged ORF clone of Mus 
musculus UCP2 plasmide 
OriGene, Rockville, USA 
NAC (N-acetyl-L-cysteine) Sigma-Aldrich, St. Louis, USA 
NaCl Sigma-Aldrich, St. Louis, USA 
NaH2PO4 Sigma-Aldrich, St. Louis, USA 
NaOH Sigma-Aldrich, St. Louis, USA 
Nuclear Fast Red Sigma-Aldrich, St. Louis, USA 
Oligomycin Sigma-Aldrich, St. Louis, USA 
OPTI-MEM medium  Invitrogen, Carlsbad, USA 
Paraformaldehyde, 4% Merck, Darmstadt, Germany 
pMD2.G Addgene, Boston, USA 
PMSF  Sigma-Aldrich, St. Louis, USA 
Proteinase K Sigma-Aldrich, St. Louis, USA 
pSOD (peg superoxide dismutase)   Sigma-Aldrich, St. Louis, USA 
psPAX2 Addgene, Boston, USA 
PVDF membrane  Pall Corporation, Dreieich, Germany 
pWPXL  Addgene, Boston, USA 
Pyruvate Sigma-Aldrich, St. Louis, USA 
Pyruvate assay kit Cayman, Ann Arbor, USA 
Rhod2 Invitrogen, Carlsbad, USA 
RNeasy RNA extraction kit  Qiagen, Hilden, Germany 
ROCK Rho-associated protein kinase 
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Rotenone Sigma-Aldrich, St. Louis, USA 
Rotiphorese Gel 30 Acrylamide Roth, Karlsruhe, Germany 
Scrambled siRNA Biospring, Frankfurt, Germany 
SDS (Sodium dodecyl sulfate) Sigma-Aldrich, St. Louis, USA 
Sodium vanadate  Sigma-Aldrich, St. Louis, USA 
Succinate Sigma-Aldrich, St. Louis, USA 
SYBR® Safe DNA gel stain Invitrogen, Carlsbad, USA 
Taurine Sigma-Aldrich, St. Louis, USA 
TEMED (N,N,N',N'-Tetramethyl-1-,2-
diaminomethane)  
Sigma-Aldrich, St. Louis, USA 
TEMPO (2,2,6,6-tetramethylpiperidine-N-
oxyl) 
Sigma-Aldrich, St. Louis, USA 
Thromboxane mimetic, U 46619  Sigma-Aldrich, St. Louis, USA 
TMRE (etramethylrhodamine, Ethyl Ester, 
Perchlorate) 
Sigma-Aldrich, St. Louis, USA 
Trypsin PAN, Aidenbach,Germany 
Turbofectin 8 OriGene, Rockville, USA 
Tween-20  Sigma-Aldrich, St. Louis, USA 
UCP2 siRNA (Rat, mouse)  Biospring, Frankfurt, Germany 
WT-ovationTM Pico RNA Amplification 
System 
NuGEN, San Carlos, USA 
Xtreme transfection reagent  Roche Applied Science, Penzberg, Germany 
Xylazine  Bayer Healthcare, Leverkusen, Germany 
Yeast tRNA Sigma-Aldrich, St. Louis, USA 
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2.2. Equipment 
1.4F micromanometer catheter Millar Instruments, Houston, USA 
Autoregulatory control unit (model 4010, O2 
controller) 
Labotect; Göttingen, Germany 
Biemer microvessel clip Aesculap, Tuttlingen, Germany 
Cell culture incubator, Hera Cell Heraeus Thermo Fisher Scientific, Waltham, USA 
Closed perfusion chamber PeCon, Erbach, Germany 
Confocal microscope, Leica TCS SP5X  Leica Microsystems, Manheim, Germany 
Digital camera microscope DC 300F  Leica Microsystems, Wetzlar, Germany 
Electrophoresis chambers Biometra, Göttingen, Germany 
Flattening bath for paraffin sections, HI 1210  Leica Microsystems, Wetzlar, Germany 
Flattening table, HI 1220  Leica Microsystems, Wetzlar, Germany 
Fluid-filled force transducer B. Braun Melsungen AG, Melsungen, 
Germany 
Homeothermic plate control unit AD Instruments, Spechbach, Germany 
Homogenplus   Schuett-biotec GmbH, Göttingen Germany 
Inverted microscope (IX70) Olympus, Hamburg, Germany 
Laser microdissection system, Leica LMD7000 Leica Microsystems, Bernried, Germany 
Makro for muscularization degree, wall 
thickness, septum 
Leica Microsystems, Wetzlar, Germany 
Medical X-Ray film processor (curix 60) Agfa, Mortsel, Belgium 
Microplate reader Infinite m200 Tecan Group Ltd, Männedorf, Switzerland 
Mini-PROTEAN vertical electrophoresis 
system 
Bio-Rad, München, Germany 
MiniVent type 845 Hugo Sachs Elektronik, March-Hugstetten, 
Germany 
MS 100 spectrometer Magnettech, Berlin, Germany 
Mx3000P QPCR Systems Agilent Technologies, Santa Clara, USA 
NanoDrop PeqLab, Erlangen, Germany 
Opened heated chamber PeCon, Erbach, Germany 
Oxygraphy-2K Oroboros Instruments, Innsbruck, Austria 
Peristaltic pump, ISM834A V2.10 Ismatec, Glattbrugg, Switzerland 
Polychrome II monochromator and IMAGO 
CCD camera 
Till Photonics, Munich, Germany 
Precelly®24 homogeniser PeqLab, Erlangen., Germany 
Rectal thermometer Indus Instruments, Houston, USA 
Scintillation counter, TRI-CARB 2000 Canberra-Packard, Meriden, USA 
Software Q Win V3 Leica Microsystems 
Nussloch, Germany 
Leica Microsystems, Wetzlar, Germany 
Stereo light microscope Leica Microsystems, Wetzlar, Germany 
Surgical instruments Martin Medizintechnik, Tuttlingen, Germany 
Table Top Laboratory Animal Anesthesia 
System 
VetEquip Inc, Pleasanton, USA 
Tissue embedding machine, EG 1140H  Leica Microsystems, Wetzlar, Germany 
Tissue processing automated machine, TP 
1050 
Leica Microsystems, Wetzlar, Germany 
Top Laboratory Animal Anesthesia System VetEquip Inc, Pleasanton, USA 
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2.3 Consumable 
48-well cell culture plates Greiner bio-one, Frickenhausen,Germany 
Blotting papers Bio-Rad, München,Germany 
Cover slips 24x36mm Menzel, Germany 
Falcon Tubes 15 and 50 ml Greiner bio-one, Frickenhausen,Germany 
Glass Bottles: 0.1; 0.2; 1L Schott Duran, Germany 
Glass Pipetes  Greiner bio-one, Frickenhausen,Germany 
Medical adhesive bands 3M  Durapore® St. Paul, MN, USA 
Napkins Tork, Mannheim, Germany 
Needle (20G, 11/2",0.9x40mm BD Microlance, Becton Dickinson, Germany 
Neelde (18G,11/2",1.20x38mm) Unolok, Horsham,U.K 
Pipette filter tips, 10µl Eppendorf, Hamburg, Germany 
Plastic Syringe (1,3,5, 10ml and 20ml)  Braun Melsungen,Germany 
Single use gloves Transaflex® Ansell, Surbiton, UK 
Single use syringes Inject Luer®, 1ml, 2ml, 
5ml, 10ml Braun, Melsungen, Germany 
Tissue Culture Dish 100mm  Greiner bio-one, Frickenhausen,Germany 
Tissue Culture Flask 250mm Greiner bio-one, Frickenhausen,Germany 
Feather disposal scalpel Pfmmediacl, Köln, Germany 
Tissue Culture Flask 750mm Greiner bio-one, Frickenhausen,Germany 
Petri dishes Greiner bio-one, Frickenhausen,Germany 
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2.4. Methods: 
2.4.1 Experimental animals  
All animal experiments were approved by the local authorities and ethics committee. Adult male Sprague-
Dawley rats and C57BL/6J mice of either sex were studied. UCP2-/- mice were obtained from the Jackson 
Laboratory241. All animal studies were approved by the local authority for animal research 
(Regierungspräsidium Giessen, reference number - GI 20/10 Nr. 105/2010 and GI 20/10 A34/2011). All 
animal manipulations before the death of the animals by circulatory arrest were performed by Karin Quanz, 
Alexandra Pichl and Prof. Dr. Norbert Weißmann. Afterwards the cell isolation was performed by the 
author of this thesis. The protocol for human tissue donation was approved by the ethics committee at the 
faculty of medicine, Justus-Liebig university of Giessen, in accordance with national legislation and the 
guidelines for good clinical practice / international conference on harmonization under the numbers 31/93 
and 10/06.  
 
2.4.2. Anesthesia 
Mice were deeply anesthetized intraperitoneally by ketamine (100 mg/kg, Pfizer, Karlsruhe, Germany) 
and xylazine (8 mg/kg, Bayer Healthcare, Leverkusen, Germany). Rats were anesthetized 
intraperitoneally by ketamine (50mg/kg) and medetomidin (100µg/kg, Pfizer, Karlsruhe, Germany). In 
vivo cardiac hemodynamic measurement was performed under isoflurane (Forene® Abbott, Wiesbach, 
Germany) anesthesia with an inhalation system (Table Top Laboratory Animal Anesthesia System, 
VetEquip Inc, Pleasanton, USA).  
 
2.4.3. MCT (monocrotaline) injection and chronic hypoxia  
Adult male Sprague-Dawley rats (300-350g in body weight; Charles River Laboratories) were treated 
with injection of saline or 60 mg/kg MCT (Sigma-Aldrich, St. Louis, USA) to induce PH89. All rats were 
examined after 21 days of MCT injection.  
Chronic hypoxic pulmonary vascular remodeling was induced by exposure of mice (C57BL/6J mice or 
UCP2-/- mice) to 28 days of normobaric chronic hypoxia (10% O2) in a ventilated chamber33 (Figure 13). 
The level of hypoxia was held constant by the autoregulatory control unit (model 4010, O2 controller, 
Labotect; Göttingen, Germany) supplying either nitrogen (N2) or O2. Excess humidity in the recirculating 
system was prevented by condensation in a cooling system. CO2 was continuously removed by soda lime. 
Cages were opened for a short time once per day for cleaning as well as for food and water resupply. 
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Figure 13. Hypoxic chamber and oxygen (O2) pressure monitor.  
 Abbreviations: A - gas balloon with nitrogen (N2); B - O2 monitor; C - hypoxic chamber. 
 
2.4.4. Invasive hemodynamic measurements 
In vivo cardiac hemodynamic studies were preformed under isoflurane (Forene® Abbott, Wiesbach, 
Germany) anesthesia with an inhalation system (Table Top Laboratory Animal Anesthesia System, 
VetEquip Inc, Pleasanton, USA)242. Maintenance of anesthesia was provided by continuous inhalation of 
1.5% isoflurane mixed with O2 (Air Liquid, Siegen, Germany). After endotracheal intubation, mice were 
placed supine on a homeothermic plate (AD Instruments, Spechbach, Germany) and connected to a small 
animal ventilator MiniVent type 845 (Hugo Sachs Elektronik, March-Hugstetten, Germany). Body 
temperature was controlled by the rectal probe connected to the control unit (AD Instruments, Spechbach, 
Germany) and was kept at 37°C during the catheterization. 
 
2.4.4.1 Right heart catheterization 
The right external jugular vein was carefully exposed and afterwards, careful removal of the connective 
tissue surrounding the jugular vein was performed242. The tip of a high fidelity 1.4F micromanometer 
catheter (Millar Instruments, Houston, USA), presoaked with physiological saline solution for 30 min, 
was inserted in the caudal direction into the vein. Afterwards, the catheter was quickly moved into the 
right atrium and then right ventricle (RV). After stabilization of the signal, the pressure was recorded. All 
data were collected and analyzed using PowerLab data acquisition systems and LabChart 7 for Windows 
software (MPVS-Ultra Single Segment Foundation System, AD Instruments, Spechbach, Germany). The 
parameters measured were heart rate, right ventricular systolic pressure (RVSP), end-diastolic pressure 
(RVEDP), and the maximal and minimal first derivative of ventricular pressure (dP/dtMax and dP/dtMin, 
respectively). 
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2.4.4.2. Left heart catheterization 
The right carotid artery was carefully exposed. A Biemer microvessel clip (Aesculap, Tuttlingen, 
Germany) was placed on the proximal part of the carotid artery. A tiny incision was made near the distal 
end of the artery. The tip of the 1.4F micromanometer catheter was inserted into the vessel. 
Simultaneously, the clip was released and the catheter was quickly moved into the left ventricle (LV) 
until the typical pressure signal was displayed on the monitor. After stabilization of the signal, the 
pressure was recorded.  
At the end of the experiment, the mice were sacrificed and their hearts were harvested for further 
examination. 
 
2.4.5. Assessment of vascular remodeling and right ventricular hypertrophy 
After systolic arterial pressure and RVSP were recorded, the animals were exsanguinated. Afterwards the 
lungs were flushed with saline solution through the pulmonary artery, and perfused through the 
pulmonary artery and tracheae with a mixture of 3.5-3.7% formaldehyde (Otto Fischar GmbH&Co, 
Germany) with a constant pressure of 22 cm H2O and 11 cm H2O, respectively. The lungs and the heart 
were removed as a block. The lung lobes were embedded in paraffin blocks, and 3 µm sections were cut 
from all lobes.  
For estimation of medial wall thickness (MWT) 3 μm lung sections were stained for elastica using 
common histopathological procedures (Van Gieson's stain) and nuclei were counterstaining by Nuclear 
Fast Red (Sigma-Aldrich, Saint Louis, USA)243. MWT was defined as the distance between the lamina 
elastica interna and lamina elastica externa. Percentage of MWT was examined by light microscopy using 
a computerized morphometric system (Qwin, Leica Microsystems, Wetzlar, Germany) and was calculated 
by the formula: 
 
% MWT = (2 x wall thickness/external diameter) x 100 
 
The muscularization of small peripheral pulmonary vessels was assessed by staining with an Anti-α-
smooth muscle actin antibody (dilution 1:900, clone 1A4, Sigma-Aldrich, St. Louis, USA) and 
counterstaining with methyl green. 
The RV was dissected from the LV and septum (LV+S), and these dissected samples were dried for 3 
days at 50°C and weighed to obtain the right to LV plus septum ratio (RV/LV+S) or RV and LV mass to 
body weight. 
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2.4.6. Isolation of pulmonary artery smooth muscle cells (PASMC) 
PASMC (Figure 14) were isolated from pulmonary precapillary arteries and cultured as described 
previously13. Briefly, the pulmonary artery was cannulated by a handmade cannula and M199 (Medium 
199, Invitrogen, Carlsbad, USA) growth medium containing 5mg/ml glow melting point agarose, 5mg/ml 
Fe3O4, 1% penicillin, and 1% streptomycin was injected into rats (12 ml) and mice (3 ml). In this mixture, 
iron particles do not pass through capillaries and therefore only precapillary arteries were filled with the 
rapidly solidifying agarose and iron. Lung tissue was minced with scissors for 5 min in 1ml PBS 
(phosphate buffered saline). The tissue mixture was then suspended in 10ml PBS in a falcon tube, which 
was placed in a magnetic holder. The pulmonary arteries containing the iron particles and agarose 
accumulate on the tubing walls. The supernatant was aspirated and the arteries, after rinsing 3 times with 
PBS, were transferred into Petri dishes containing 10ml of M199 with 80U/ml collagenase and were then 
incubated at 37°C for 60 min. The tissue mixture was disrupted by drawing it through 15 and 18 gauge 
needles 5-6 times each. The resulting suspension, containing the medial layer of the arteries attached to 
iron particles, was placed in clear plastic tubes and rinsed three times with M199 containing 10% FCS 
(fetal calf serum) in the magnetic holder, as described above. The medial layer of the pulmonary artery 
attached to iron was finally re-suspended in medium, transferred to culture flasks and incubated at 37°C 
in the cell incubator for 4 to 5 days. Upon reaching 80% confluence, the grown cells were trypsinized and 
divided into the fresh culture flasks.  
 
 
Figure 14. Representative picture of PASMC isolated from small precapillary pulmonary vessels of 
the mice.  
Precapillary PASMC were labeled with an antibody against α-smooth muscle actin 
conjugated with Cy3 (red fluorescence) and the nuclei were stained by DAPI (4'-6-
Diamidino-2-phenylindole, blue fluorescence). 
 
Mouse PASMC (2-1 passage) were cultured in human medium for SMC (PromoCell, Heidelberg, 
Germany) with 15% FCS (PromoCell, Heidelberg, Germany) and rat PASMC (2-1 passage) were 
cultured in M199 (Invitrogen, Carlsbad, USA) with 10% FCS. For experimental procedures, the cells 
were incubated with MnTBAP (Manganese (III) tetrakis (4-benzoic acid)porphyrin chloride) and 
bongkrek acid (BA) in a dose of 50.0µM, DCA in a dose of 500.0µM, with FCCP doses of 1.0µM, 
2,5µM, 5.0µM and with a ROS scavengers mixture consisting of 25.0µM NAC (N-acetyl-L-cysteine) and 
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1.0µM TEMPO (2,2,6,6-tetramethylpiperidine-N-oxyl). All reagents were purchased from Sigma-
Aldrich, St. Louis, USA. 
 
2.4.7. Measurement of Δψm 
Δψm was investigated by using JC1 (5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethylbenzimidazolylcarbocyanine 
iodide)13. JC-1 is a lipophilic, cationic dye that can selectively enter into mitochondria and reversibly 
change the emission spectrum from green (530nm) to red (590nm) upon excitation at 490nm as Δψm 
increases (Figure 15a).  
JC1 aggregate
Hyperpolarization
JC1 monomer
530nm 590nm 
Depolarization
a)
 
 
 
 
Figure 15. Scheme of the effect of mitochondrial depolarization and hyperpolarization on the 
characteristics of JC1 fluorescence (a). Example of Δψm evaluation by FCCP-stimulated 
mitochondrial depolarization (b and c).  
Depolarization of mitochondria leads to release of JC1 into the cytosol in form of JC1 
monomers that emit light at 530nm and hyperpolarization of mitochondria results in 
accumulation of JC1, which aggregate within mitochondria and emit light at 590nm (a). 
Application of 0.5µM FCCP induces mitochondrial depolarization, thereby increasing the 
green fluorescence emission and decreasing the red fluorescence emission (b) and 
subsequently decreases the red/green ration (c). The difference between the baseline Δψm and 
Δψm after FCCP stimulation was calculated in percentage (Figure15 c). Data presented as 
mean±SEM, n=36 of precapillary PASMC.  
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Precapillary PASMC seeded on coverslips were incubated in 50nM JC1 diluted in medium for 20min and 
were then transferred in an opened heated chamber (PeCon, Germany) which was filled with 500µl 
Hepes-Ringer buffer buffer (HRB; 136.4 mM NaCl, 5.6 mM KCl, 1 mM MgCl2, 2.2 mM CaCl2, 10 mM 
Hepes [4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid], 5 mM glucose, pH 7.4). FCCP at a dose of 
0.5µM was used to induce the collapse of Δψm (mitochondrial depolarization) that is characterized by an 
increase of green fluorescence emission and decrease of red fluorescence emission (Figure 15 b). As the 
result, the red/green ratio was decreased upon FCCP application (Figure 15c). The difference between the 
baseline Δψm and Δψm after FCCP stimulation was calculated as a percentage and used as additional 
parameter for an evaluation of the Δψm (Figure15 c). 
Fluorescent signal was analyzed using a Polychrome II monochromator and IMAGO CCD camera (Till 
Photonics, Germany) coupled to an inverted microscope (IX70; Olympus, Germany). Ratio of red and 
green fluorescent signals and percent of Δψm drop induced by FCCP compared to baseline was analyzed. 
To study the effect of acute hypoxia, precapillary PASMC loaded with 1µg/ml JC1 were transferred in a 
closed perfusion chamber (PeCon, Germany) and acute hypoxia was induced by switching from normoxic 
perfusion buffer (with a flow of 1 ml/min) to hypoxic buffer, which had been pregassed with N2 (Figure 
16). For control experiments the normoxic perfusion buffer was switched to a second normoxic perfusion 
buffer. All reagents were purchased from Sigma-Aldrich, St. Louis, USA. 
 
1
2
3
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Figure 16. Set-up of acute hypoxic experiments in isolated PASMC.  
Acute hypoxia was induced by switching the perfusing buffer of the closed perfusion chamber 
from normoxic buffer to hypoxic buffer gassed with N2, resulting in a decrease of pO2 to ~18 
mmHg. 1 -the temperature control of the heating system; 2 - the inverted microscope 
(Olympus IX70) connected to the fluorescent light source and CCD camera; 3 - heated 
perfusion reservoirs with buffer; 4 - tube that connects reservoir with N2 (7); 5 - computer 
with Till Photonics software; 6 - closed perfusion chamber (PeCon); 7 - source of N2.   
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JC1 measurements during acute hypoxia were confirmed by measurements with the fluorescent dye 
TMRE (tetramethylrhodamine, Ethyl Ester, Perchlorate) using confocal microscopy (TCS SP5X, Leica 
Microsystems, Manheim, Germany). TMRE is a lipophilic, cationic fluorescent dye that accumulates 
within mitochondria according to their Δψm in a Nernstian fashion244. There are two alternative 
approaches to measure Δψm in cells by TMRE. One is to use a high concentration of TMRE (quenching 
mode), more than 100nM, to induce quenching of the fluorescent signal upon hyperpolarization of 
mitochondria due to accumulation of TMRE within mitochondria. We used in this study the alternative 
approach, which is measurement with low dose TMRE (non-quenching mode). Cells were loaded with, 
10 nM TMRE for 30 minutes in HRB. Afterwards, buffer was exchanged. Δψm hyperpolarization caused 
an increase of mitochondrial TMRE concentration245, 246, which resulted in increased emission of light at 
580nm, when excited with 550 nm.  
 
2.4.8. Measurement of ROS 
2.4.8.1. Measurement of mitochondrial superoxide (O2•-) release by MitoSOX 
For acute hypoxic experiments, 5µM MitoSOX (Invitrogen, Carlsbad, USA) was used for detection of 
mitochondrial ROS in an experimental setting as described for the JC1 measurements of Δψm13. Before 
the acute hypoxic exposure precapillary PASMC were incubated for 15 min in 5µM MitoSOX diluted in 
HRB buffer at 37°C. After accumulation in mitochondria, MitoSOX becomes fluorescent upon oxidation 
by O2•-. Excitation of MitoSOX was 510nm and emission was measured at 580nm. 
 
2.4.8.2. Determination of cytosolic hydrogen peroxide (H2O2) concentration by HyPer 
For intracellular H2O2 detection, the coding information for the H2O2-sensitive, enhanced yellow 
fluorescent protein variant HyPer (Hydrogen Peroxide sensor) from Evrogen Company (Moscow, 
Russian Federation)247 was subcloned under the control of the EF-1α (human elongation factor-1 alpha) 
enhancer/promoter into the pWPXL plasmid (distributed by Addgene, Boston, USA) and packed with a 
second-generation lentivirus transduction system with pMD2.G, as the envelope and psPAX2, as a 
packing vector (Addgene, Boston, USA). Lentiviral transduction was carried out with a titer of at least 
1×107 particles according to established protocols (see http://tronolab.epfl.ch/ for more details). 
Experiments were carried out as outlined for the ∆ψm imaging in precapillary PASMC seeded on 
coverslip 3 days after lentiviral transduction. HyPer has two excitation peaks with maxima at 420 nm and 
500 nm, and one emission peak with a maximum at 516 nm. H2O2 increases the excitation at 500nm and 
decreases the excitations at 420nm of the HyPer construct, thus ratiometric measurements are possible  
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2.4.8.3. Measurement of O2•- release by electron spin resonance (ESR) spectroscopy 
Intracellular and extracellular O2•- levels in precapillary PASMC were measured by ESR spectroscopy 
(electron spin resonance or electron paramagnetic resonance) using the spin probe 1-Hydroxy-3-
methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine (CMH, Alexis Corporation, San Diego, USA) and a MS 
100 spectrometer (Magnettech, Berlin, Germany)248. Precapillary PASMC in passages 2-1 were counted 
and divided in two samples (control and sample with pSOD [polyethylen-glycol conjugated SOD, Sigma-
Aldrich, St. Louis, USA] 100 000 cells each). One sample was incubated with 0.1M pSOD for 2h. After 
pSOD incubation 0.5mM CMH was added to both samples. O2•- portion was determined as the 
differences of the ESR signal of the samples with and without pSOD. 
 
2.4.9. Laser-assisted microdissection 
Cryosections (8 μm) from lung tissue were mounted on glass slides. After hemalaun staining for 45 
seconds, the sections were subsequently immersed in 70% and 96% ethanol and stored in 100% ethanol 
until used. Intrapulmonary arteries with a diameter of less than 100 μm were selected and microdissected 
under optical control using the Laser Microdissection System (LMD7000, Leica Microsystems, Wetzlar, 
Germany). Vessels were collected by gravity into a reaction tube containing 300 μl of RNA (ribonucleic 
acid) lysis buffer. RNA was isolated using the RNeasy Micro Kit (Qiagen N.V., Hilden, Germany). 
mRNA (messenger RNA) was converted into cDNA (complementary deoxyribonucleic acid) and 
amplified by WT-ovationTM Pico RNA Amplification System (NuGEN, San Carlos, USA ). 
 
2.4.10. RNA isolation and real-time polymerase chain reaction (PCR) 
Total RNA (1µg), extracted from isolated PASMC or lung homogenate by RNeasy Micro Kit (Qiagen 
N.V., Hilden, Germany) was reverse-transcribed using the iScript cDNA Synthesis Kit (Bio-Rad, 
Hercules, USA). Afterwards, total cDNA including the cDNA obtained from laser microdissected vessels 
was used to carry out real-time PCR (polymerase chain reaction) using a master mix for RT PCR (iTaq 
SYBR Green supermix with ROX, Bio-Rad, Hercules, USA) and Mx3000P QPCR Systems (Agilent 
Technologies, Santa Clara, USA). Housekeeping genes were HPRT (Hypoxanthine 
phosphoribosyltransferase) for MCT-induced PH and β2M (β2-microglobulin) for chronic hypoxic 
experiments. A list of primers is provided below in Table 3. 
The cycling protocol was 1×(95°C, 10 min) and 45×(95°C, 5s; 62°C, 5s, 72°C, 10s). The data for the 
amplification curves were acquired after the extension phase at 72°C. The threshold value was set for 
each gene in the middle of the overlapping region of the exponential phases. Each gene was measured in 
duplicate. The formation of the specific products was verified by dissociation curves and by analysis on 
an agarose gel with SYBR® Safe DNA gel stain (Invitrogen, Carlsbad, USA). The ΔCt values were 
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calculated by subtracting the Ct values of the target gene from the endogenous control (ΔCt = Ct[ 
endogenous control] - Ct[ target]) and the fold change 2ΔΔCt comparing experimental and control 
conditions was calculated as described previously249. 
 
Table 3. List of primers for real time PCR. 
Species Primer Orientation Sequence Accessing 
number 
Mice Acot1/2  Sence TGAAGAAGCCGTGAACTACCTG NM_012006.2 
NM_134188.3 Antisence CCTTCAGGAAGGAGGCCATA 
Slc25a20 Sence CCCTGGACACGGTCAAGGTCCG NM_020520.4 
Antisence GGCGCAGCCATGCCCCGATA 
Ehhadh Sence GGCTAGAGCCCTGCAGTACGCC NM_023737.3 
Antisence GCGATGCCTCGGCCCATCGT 
Cpt2 Sence CCTGCCCAGGCTGCCTATCCCTAA NM_009949.2 
Antisence TGCGCATGCAGCTCCTTCCCAAT 
Cpt1b  Sence CCTCCGAAGCAGGAGCCCCCT NM_009948.2 
Antisence TCACGGTCCAGTTTGCGGCGA 
LDHA  Sence CCATCATCTCGCCCTTGAGT NM_010699.1 
Antisence GGCCATCGGCCTGAGCGTGG 
PDK1 Sence CGTCACGCTGGGCGAGGAGG NM_172665.4 
Antisence GGGGCACAGCACGGGACGTT 
Pfkfb3 Sence TTGCATCCTCTGACCTCTCCCGGTG NM_001177757.1 
Antisence  GATTTTGAGCACCGCATGCCCCG 
Pkm Sence AATGTGGCTCGGCTGAATTT NM_011099.3 
Antisence CGCAACAGGACGGTAGAGAA 
Glut1 Sence TGTGGAGCAACTGTGCGGCCC NM_011400.3 
Antisence CTGCCGGAAGCCGGAAGCGA 
UCP2 Sence AAGGGCTCAGAGCATGCAG NM_011671.4 
 Antisence TGGAAGCGGACCTTTACCAC 
β2M Sence AGCCCAAGACCGTCTACTGG NM_009735.3 
 Antisence TTCTTTCTGCGTGCATAAATTG 
Rat LDHA  Sence GATGTGCACAAGCAGGTGGT NM_017025.1 
Antisence TCACGGTCCAGTTTGCGGCGA 
PDK1 Sence ATTGCCCATATCACGCCTCT NM_053826.2   
Antisence TCGATGGACTCCGTTGACAG 
HPRT Sence CTCAGTCCCAGCGTCGTGAT NM_012583.2 
Antisence AGCACACAGAGGGCCACAAT 
β2M Sence 
Antisence 
CGGTGACCGTGATCTTTCTG NM_012512.2 
AGGAAGTTGGGCTTCCCATT 
Abbreviations: pfkfb3 - 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3; Pkm - pyruvate kinase, 
muscle form; LDHA - lactate dehydrogenase; Glut1 - glucose transporter 1; PDK1 - pyruvate 
dehydrogenase kinase 1; acot1/2 - acyl-CoA thioesterase 1 and 2; cpt1b - carnitine palmitoyltransferase 
1b; cpt2 - carnitine palmitoyltransferase 2; Slc25a20 - carnitine/acylcarnitine translocase; ehhadh - enoyl-
Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase; UCP2 - uncoupling protein 2; β2M - 
β2-microglobulin; HPRT - hypoxanthine  phosphoribosyltransferase. 
 
 
Material and methods  64 
2.4.11. RNA interference by synthetic siRNA  
Selective targeting of UCP2 was performed using a pool of specific siRNAs (small interfering RNA) 
(Table 4). As a control, a siRNA sequence (scrambled) was employed that does not target any gene in the 
rat and mouse genome. The siRNAs were synthesized commercially (BioSpring GmbH, Frankfurt am 
Main, Germany). Transfection of UCP2 siRNA was performed in low-serum and antibiotic-free medium 
(1% FCS in M199). The medium was changed 4h before transfection. 100 nM of UCP2 siRNA was 
transfected using 1µl X-tremeGENE siRNA Transfection Reagent (Roche Applied Science, Penzberg, 
Germany) per cm2 of the well. Both siRNA and transfection reagent were diluted in OPTI-MEM medium 
(Invitrogen, Carlsbad, USA). After five hours of transfection, the medium was changed to 20% FCS 
human medium for SMC (PromoCell, Heidelberg, Germany) containing antibiotics (1% penicillin and 
streptomycin).  
 
Table 4. List of siRNA sequences against UCP2 
Species siRNA Duplex sense-antisense 
Mice UCP2_1 AA*CA*GU*UC*UA*CA*CC*AA*GG*GC*U- 
A*GC*CC*UU*GG*UG*UA*GA*AC*UG*U 
UCP2_2 AA*AG*AU*AC*UC*UC*CU*GA*AA*GC*C- 
G*GC*UU*UC*AG*GA*GA*GU*AU*CU*U 
UCP2_3 AA*CG*UA*GU*GA*UG*UU*UG*UC*AC*C- 
G*GU*GA*CA*AA*CA*UC*AC*UA*CG*U 
Rat UCP2_1 AA*CU*GU*AC*UG*AG*CU*GG*UG*AC*C- 
G*GU*CA*CC*AG*CU*CA*GU*AC*AG*U 
UCP2_2 AA*AG*AU*AC*UC*UC*CU*GA*AA*GC*C- 
G*GC*UU*UC*AG*GA*GA*GU*AU*CU*U 
UCP2_3 AA*CG*UA*GU*AA*UG*UU*UG*UC*AC*C-
G*GU*GA*CA*AA*CA*UU*AC*UA*CG*U 
* 2’OMe (methylated) nucleotide 
 
2.4.12. UCP1 and UCP2 overexpression in mouse precapillary PASMC  
UCP1 and UCP2 overexpression was performed using the TrueORF vector system250 that over-expressed 
the open reading frame (ORF) of the UCP1 or UCP2 mouse gene with two epitope tags (C-terminal Myc 
(sequence is N-EQKLISEEDL-C) and DDK (sequence is DYKDDDDK epitope) under the strong 
eukaryotic CMV (cytomegalovirus) enhancer/promoter (OriGene, Rockville, USA). Mouse precapillary 
PASMC from passage 2-1 were seeded in 48-well plates at a density of 6 × 103 cells/well for proliferation 
and 40 × 103 cells/well in 6-well plates in 20% FCS/human medium for SMC (PromoCell, Heidelberg, 
Germany) for western blot. Next day cells were transfected with 0.25µg/cm2 plasmid DNA at a 1:3 ration 
with transfection reagent turbofectin 8 (OriGene, Rockville, USA) diluted in OPTI-MEM medium 
(Invitrogen, Carlsbad, USA). After 6h of transfection, the medium was changed to normal cultured 
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medium. Western blot and proliferation assays were performed as described below 2 days after 
transfection.  
 
2.4.13. Western blot analysis  
Tissue extracted by Precelly®24 Homogeniser (Peqlab, Erlangen., Germany), or cell lysates from 
precapillary PASMC were separated on a 10 % SDS (sodium dodecyl sulfate) polyacrylamide gel, 
followed by electrotransfer to a 0.45µm PVDF (polyvinylidene fluoride) membrane (Pall Corporation, 
Dreieich, Germany). After blocking with 5% non-fat dry milk in TBS-T buffer (Tris Buffer Saline + 0.1% 
Tween 20) for 1 hour, the membrane was incubated overnight at room temperature with one of the 
following antibodies: anti-PDK1 (rabbit antibody, dilution 1:1000, Cell Signaling Technology, Inc. 
Danvers, USA), anti-LDHA (rabbit antibody, dilution 1:1000, Cell Signaling Technology, Inc. Danvers, 
USA), anti-DDK (mouse monoclonal antibody, dilution 1:1000, OriGene, Rockville, USA), anti-cyclin 
D1 (rabbit antibody, dilution 1:1000, Cell Signaling Technology, Inc. Danvers, USA), anti-UCP2 (goat 
antibody, dilution 1:200, Santa Cruz Biotechnology, Santa Cruz, USA) and monoclonal mouse anti-β-
actin (dilution 1:50000, Sigma-Aldrich, St. Louis, USA). After washing the membranes in TBS-T buffer, 
specific immunoreactive signals were detected by enhanced chemiluminescence (GE Healthcare, Little 
Chalfont, UK) using a proprietary secondary antibody coupled to horseradish-peroxidase diluted 1:5000.  
 
2.4.14. Measurement of precapillary PASMC proliferation 
2.4.14.1. [3H]-Thymidine proliferation assay of PASMC  
For assessment of proliferation, mouse precapillary PASMC from passage 2 were seeded in 48-well 
plates at a density of 8 × 103 cells/well in 20% FCS/human medium for SMC (PromoCell, Heidelberg, 
Germany). Cells were rendered quiescent by incubation in 5% FCS in human medium for SMC for 24 
hours. Subsequently, they were stimulated with 20% FCS/human medium to induce cell cycle re-entry. 
[3H]-Thymidine (GE Healthcare, Little Chalfont, UK) was used at a concentration of 0.5 μCi per well. 
Subsequently, cells were washed 3x with ice-cold PBS and lysed with 0.5M NaOH (sodium hydroxide) 
on a shaker for 4 h. The [3H]-Thymidine concentration of the cell lysates was assessed by a scintillation 
counter (Canberra-Packard, TRI-CARB 2000, Meriden, USA).  
 
2.4.14.2. Evaluation of PASMC growth rate based on crystal violet staining 
Mouse precapillary PASMC from passage 2-1 were seeded in 48 well plates at a density of 10 x 103 
cell/well in 20% FCS/human medium for SMC (PromoCell, Heidelberg, Germany). Cells were rendered 
quiescent by incubation in 5% FCS in human medium for SMC for 24 hours. Subsequently, they were 
stimulated with 20% FCS/human medium for SMC to induce cell cycle re-entry for 24h. Seeded cells 
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were washed with PBS and fixed in 4% paraformaldehyde (Merck, Whitehouse Station, USA) for 15 min, 
then stained with 0.1% crystal violet (Sigma-Aldrich, St. Louis, USA) for 20 min. After removing the 
supernatant, plates were dried and 10% acetic acid (Sigma-Aldrich, St. Louis, USA) was added to each 
well for 20 min incubation with shaking. Absorbance was measured at 590 nm by multimode plate reader 
Infinite m200 (Tecan Group Ltd, Männedorf, Switzerland).  
 
2.4.15. Non-isotopic in situ hybridization on mouse lung sections 
Non-isotopic in situ hybridization was performed on 8μm thick TissueTek®-embedded mouse lung 
cryostat sections from wild type and UCP2-/- mice as described previously73. The sections were incubated 
with DIG-labeled (digoxigenin-labeled) UCP2 probes (LNA™ mRNA Detection Probes, Exiqon, 
Vedbaek, Denmark) in 2x hybridization solution [1M NaCl, 0.02M Tris,pH7.5, 2 x Denhardt’s reagent, 
2mM EDTA (ethylenediamine-tetraacetic acid), 2g dextran sulphate, 0.2mg/ml yeast tRNA (transfer 
RNA)] at 55°C for overnight. The following day, slides were washed with buffer ranging from low to 
very highly stringent conditions as follows: on shaking platform 2x SSC (saline-sodium citrate buffer) for 
1h at room temperature, 0.1x SSC at 60°C. The sections were treated with blocking buffer (2% Blocking 
reagent, Roche Applied Science, Penzberg, Germany) for 30 min, followed by incubation with a Alexa 
fluor 488 labeled antibody against DIG antigen (Roche Applied Science, Penzberg, Germany) in a 
dilution of 1:20 for 2h at room temperature. After antibody incubation, sections were washed in TBT 
buffer (50mM, 1M Tris-HCl,pH 7.5, 150mM NaCl and 0.1% Triton X-100) three times for 15min each. 
Afterwards, slides were incubated with a mouse monoclonal Cy3-labeled α-smooth muscle actin antibody 
(Sigma, Hamburg, Germany) at a dilution of 1:500 in PBS, for 1h. After washing (3 x 3min) in PBS, 
sections were mounted in carbonate-buffered glycerol (pH-8.6). In situ hybridization was evaluated with 
appropriate filter sets for Cy3 and Alexa fluor 488 with Leica microscope (Leica Microsystems, Wetzlar, 
Germany).  
 
2.4.16. Isolation of pulmonary mitochondria 
Lung mitochondria were isolated as described previously with some modifications251. Briefly, after deep 
anesthesia with ketamine/xylazine, as described above, the thorax of the mouse was opened and the lung 
washed with ice-cold PBS buffer via the pulmonary artery. The lung was removed from the thoracic 
cavity together with the heart as one bloc and transferred to a dish with medium A (250mM sucrose, 
0.5mM Na2EDTA, 10mM Tris, pH7.4). The lung was separated from the heart and mediastinum and 
moved into a homogenizer tube (inner diameter 1.9 cm and distance between tube and pestle 0.5-1.0mm). 
Lung tissue was homogenized using the "schütt homogenplus" homogenizer  (Schuett-biotec GmbH, 
Göttingen Germany) with 200-300rpm. The homogenate was centrifuged at 660g for 10min at 4°C. The 
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supernatant was centrifuged at 10000g for 10 min at 4°C and the pellet resuspended in medium A with 
1g/l BSA (bovine serum albumin). After centrifugation, the pellet was resuspended in medium MiRO5 
(0.5mM EGTA, 3mM MgCl2, 60mM K-lactobionate, 20mM Taurine, 10mM KH2PO4, 20mM Hepes, 
110mM sucrose and 1g/l BSA). 
 
2.4.17. Evaluation of intracellular pyruvate concentration and in lung mitochondria 
Pyruvate concentration in precapillary PASMC (48well plates with a density of 10 x 1010) was measured 
after 24h 20% FCS stimulation. Mitochondria were isolated as described before and stimulated with 5mM 
pyruvate for 2min. Pyruvate was oxidized by pyruvate oxidase to acetyl phosphate. The product of this 
reaction, H2O2, reacts with 10-acetyl-3,7,-dihydroxyphenoxazine in presence of horseradish peroxidase to 
produce the fluorescent resorufin. Resorufin fluorescence was measured with excitation 535nm and 
emission 590nm by Infinite m200 (Tecan Group Ltd, Männedorf, Switzerland) microplate reader. 
 
2.4.18. Evaluation of mitochondrial calcium ([Ca2+]m) concentration 
[Ca2+]m concentration was measured by fluorescent microscopy using 5µM Rhod2 AM (cell-permeant 
acetoxymethyl (AM) ester form of rhod2 (1-[2-Amino-5-(3-dimethylamino-6-dimethylammonio-9-
xanthenyl)phenoxy]-2-(2-amino-5-methylphenoxy)ethane-N,N,N',N'-tetraacetic acid) from Invitrogen, 
(Carlsbad, USA). Experiments were performed as described for the JC1 measurements of Δψm. Rhod 2 is 
a derivative of rhodamine 123 that accumulates into mitochondria electrophoretically. Once inside the 
matrix, mitochondrial esterases cleave the AM ester to liberate Rhod 2 free acid. Rhod2 is non-
fluorescent before Ca2+ binding, but becomes fluorescent with increasing Ca2+ concentrations exhibiting 
an emission maximum at 580nm when excited at 590nm252. 
Additionally, [Ca2+]m was measured with the multimode microplate reader, Infinite m200 (Tecan Group 
Ltd, Männedorf, Switzerland). Precapillary PASMC from passages 2-1 were seeded in 48well plates at a 
density of 10 x 1010. After loading precapillary PASMC with 5µM Rhod2 for 20 min, fluorescence was 
measured by the reader.  
 
2.4.19. High-resolution respirometry 
O2 consumption was determined at 37°C using Oxygraphy-2K (Oroboros Instruments, Innsbruck, 
Austria)13. Rat precapillary PASMC from passage 2 were trypsinized and resuspended in M199 
(Invitrogen, Carlsbad, USA). A standard protocol using oligomycin (2.0 μg/ml), FCCP (0.45 μM), 
rotenone (0.5 μM) and antimycin A (2.5 μM) was used for measurement of cellular respiration. To check 
the effect of pyruvate on mitochondrial respiration, the following protocol was chosen: 1) for isolated 
mitochondria – 1.0mM ADP, 5.0mM pyruvate, 1.0µM rotenone, 10.0mM succinate, 0.5µM FCCP and 
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2.5µM antymicin A; 2) for rat precapillary PASMC after transfection with siRNA against UCP2 – 1.0mM 
ADP, 5.0mM pyruvate, 1.0µM rotenone, 10.0mM succinate, 2.0µg/ml oligomycin, 0.5µM FCCP, and 
2.5µM antimycin A. O2 consumption was calculated from the recorded data as the time derivative of the 
O2 content in the chamber, using DatLab software (Oroboros Instruments, Innsbruck, Austria). 
 
2.4.20. Statistics 
Values are given as means ± SEM. Statistical significance of the data was calculated by Student's t test 
with Welsh's correction or analysis of variance (one way ANOVA) with Bonferroni post hoc test as 
appropriate. For a multiple comparison of more than four groups, ANOVA with Tukey post hoc test was 
performed. A p value less than 0.05 was considered to be significant. 
 
Results  69 
3. Results 
 
3.1. Δψm and HPV 
3.1.1. Effect of acute hypoxia on Δψm and ROS release in precapillary PASMC 
Δψm was increased during perfusion with hypoxic buffer (“acute hypoxia”) in precapillary PASMC 
isolated from wild type (WT) mice (Figure 17). Δψm was measured by fluorescence microscopy with JC1 
fluorescent dye. Figure 17a depicts a representative measurement of the JC1 fluorescent signal during an 
acute hypoxic challenge in mouse precapillary PASMC, where the green line depicts the 530nm 
fluorescence signal, the red line depicts the 590nm fluorescence signal of JC1 fluorescent dye and the 
blue line depicts the red/green ratio. Figure 17b demonstrates a time course of hypoxia-induced increase 
of Δψm in mouse precapillary PASMC.  
 
Figure 17. Δψm alteration upon acute hypoxia in mouse precapillary PASMC measured by JC1.  
Representative picture of the JC1 fluorescent signal. Intensity of light emission of JC1 
calculated relative to the baseline value: green line represents light emission at 530nm 
corresponding to JC1 monomers in depolarized mitochondria, red line represents light 
emission at 590nm corresponding to JC1 aggregates in hyperpolarized mitochondria and blue 
line depicts the 590/530 ratio. b) Δψm hyperpolarization upon acute hypoxia in wild type 
precapillary PASMC. Data are presented as the change of 590/530 ratio compared to baseline. 
Acute hypoxia was applied by switching the normoxic perfusion buffer to the hypoxic (pre-
bubbled by N2) buffer at 1 min. Data were obtained from ≥4 independent precapillary 
PASMC cell isolations. n=51 PASMC.  
* p<0.05, compared to baseline with Student's t test. 
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To confirm that acute hypoxia led to hyperpolarization of mitochondria in precapillary PASMC, data 
from JC1 experiments were compared to measurements of Δψm by TMRE fluorescence staining and 
confocal microscopy. The acute hypoxic challenge caused an increase of TMRE accumulation within 
mitochondria measured by a rise of the TMRE fluorescent emission signal at 580 nm corresponding to 
hyperpolarization of mitochondria (Figure 18).  
 
 
Figure 18. Δψm alteration upon acute hypoxia in mouse precapillary PASMC measured by TMRE.  
Data are given as percent of Δψm change during acute hypoxic perfusion compared to 
normoxic control. Acute hypoxia was applied by switching the normoxic perfusion buffer to 
the hypoxic (pre-bubbled by N2) buffer at 1 min. Data were obtained from ≥4 independent 
precapillary PASMC cell isolations. n=25 PASMC.  
*** p <0.001 with Student's t test.  
 
Mouse precapillary PASMC showed an increase of O2•- concentration within the mitochondrial matrix 
after changing the perfusion from normoxic buffer to hypoxic buffer. O2•- concentration was measured by 
the fluorescent dye MitoSOX (Figure 19).  
 
Figure 19. Alteration in mitochondrial superoxide (O2•-) concentration upon acute hypoxia in 
mouse precapillary PASMC measured by MitoSOX.  
The intensity of light emitted by MitoSOX at 580nm corresponds to an increase of 
fluorescence upon O2•- induced oxidation of MitoSOX during acute hypoxia. Data are 
presented as the change of MitoSOX fluorescence compared to baseline. Data were obtained 
from ≥4 independent precapillary PASMC cell isolations. n=19 PASMC.  
* p<0.05 compared to baseline with Student's t test. 
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Furthermore, acute hypoxia stimulated the increase of H2O2 concentration within the cytosol of 
precapillary PASMC isolated from WT mice (Figure 20) measured by the HyPer construct.  
 
 
Figure 20. Alteration in intracellular hydrogen peroxide (H2O2) concentration upon acute hypoxia 
in mouse precapillary PASMC measured by HyPer.  
H2O2 increases excitation at 500nm and decreases excitation at 420nm of the HyPer construct. 
The level of cellular H2O2 is presented as the change in the ratio of excitation intensity at 
500nm and 420nm of HyPer compared to baseline. Data were obtained from ≥4 independent 
precapillary PASMC cell isolations. n=31 PASMC. 
*** p<0.001 compared to baseline with Student's t test. 
 
The same results were obtained from rat precapillary PASMC (Figure 21). Both rat and mouse 
precapillary PASMC responded with an increase of Δψm and ROS (both mitochondrial O2•- and 
intracellular H2O2) to the acute hypoxic challenge compared to normoxic control, measured by 
fluorescence microscopy (Figure 21).  
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Figure 21. Increase of Δψm (a), mitochondrial O2•- (b), and cytosolic H2O2 concentration (c) in 
precapillary PASMC isolated from different animal species upon acute hypoxia.  
Data were obtained from ≥4 independent precapillary PASMC cell isolations and ≥15 
individual cells each. Data are presented as percent of change compared to normoxic value. 
* p<0.05; ** p<0.01; *** p<0.001 compared to normoxic control with Student's t test. 
 
To elucidate if increased ROS was upstream of Δψm alterations and possibly causing Δψm alterations 
during the acute hypoxic challenge, Δψm was measured during acute hypoxia in the presence of the 
unspecific ROS scavengers 25µM NAC (N-acetyl-L-cysteine) and 1µM TEMPO (2,2,6,6-
tetramethylpiperidine-N-oxyl) in mouse precapillary PASMC. The ROS scavengers did not alter the acute 
hypoxia-induced hyperpolarization of mitochondria in precapillary PASMC isolated from WT mice 
(Figure 22).  
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Figure 22. Effect of ROS scavengers on hyperpolarization of Δψm during acute hypoxia in mouse 
precapillary PASMC.  
JC1 measurement of Δψm during acute hypoxia in the precapillary PASMC isolated from WT 
mice in the absence (Control) or presence of ROS scavengers (NAC, TEMPO). Data are 
given as percent of Δψm change during acute hypoxic superfusion compared to normoxic 
control. Data were obtained from ≥4 independent precapillary PASMC cell isolations and 
≥50 individual cells each.  
* p<0.05 compared to normoxic control with Student's t test. 
 
3.1.2. Effect of UCP2 knockout (UCP2-/-) on acute hypoxic responses of precapillary PASMC 
To investigate the role of Δψm and ROS in HPV we studied genetically modified UCP2-/- mice in which 
full length UCP2 mRNA was not expressed241. It has been shown before that acute HPV was significantly 
higher in isolated perfused lungs of UCP2-/- mice compared to WT mice. In contrast, the vasoconstrictor 
response to the thromboxane mimetic U46619 did not differ between UCP2-/- and WT mice (unpublished 
thesis of Timm Hoeres, Giessen). The hypothesis that the increase of acute HPV in UCP2-/- mice was 
caused by increased Δψm during acute hypoxia was tested.  
 
3.1.2.1. Effect of UCP2-/- on Δψm and O2•- emission in precapillary PASMC during acute hypoxia  
First, the mRNA expression pattern of UCP2 in mouse lungs was investigated by in-situ hybridization. In 
figure 23, representative pictures of mRNA UCP2 expression in mouse lungs are shown. PASMC of 
small pulmonary arteries show the prominent expression of mRNA of UCP2. Lungs of UCP2-/- mice 
show no sign of expression of mRNA of UCP2. 
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Figure 23. mRNA expression of UCP2 in mouse lung.  
Representative pictures of in situ hybridization of mouse lungs of wild type (WT) and UCP2 
knockout mice (UCP2-/-).  
I) Staining of mouse lung cryosections with Cy3-labelled antibody directed against α-smooth 
muscle actin (green fluorescence).  
II) Hybridization of the UCP2 specific probe to the same mouse lung cryosections (red 
fluorescence).  
III) Overlay of the images I) and II) is depicting the predominant co-localization of UCP2 
transcripts within the smooth muscle cell layer of the pulmonary artery (yellow fluorescence). 
The pulmonary artery is depicted by arrow.  
 
Gene deletion of UCP2 amplified the effect of 5 min acute hypoxic superfusion on the acute hypoxia-
induced hyperpolarization as measured by JC1 fluorescent dye (Figure 24a), as well as by the increase of 
mitochondrial O2•- release measured by MitoSOX fluorescent dye in isolated precapillary PASMC 
compared to WT PASMC (Figure 24b).  
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Figure 24. Δψm and O2•- release in precapillary PASMC from wild type (WT) and UCP2 knockout 
(UCP2-/-) mice upon acute hypoxia compared to normoxic control.  
a) Δψm hyperpolarization in percent in precapillary PASMC from UCP2 knockout (UCP2-/-) 
and wild type (WT) mice during acute hypoxia. Data are given as percent of Δψm change 
during hypoxic superfusion compared to the normoxic control. b) Increase of O2•- release in 
% in precapillary PASMC from UCP2-/- and WT mice during acute hypoxia. Data are given 
as percent MitoSOX fluorescence of normoxic control. Data were obtained from ≥4 
independent precapillary PASMC cell isolations and ≥13 individual cells each.  
* p <0.05 compared to normoxic control and ## p<0.01 compared to acute hypoxic WT 
precapillary PASMC with Student's t test. 
 
Alterations of Δψm in precapillary WT PASMC during acute hypoxia were not influenced by ROS 
scavengers (figure 22). In line with result from precapillary WT PASMC, the presence of ROS 
scavengers (25µM NAC and 1µM TEMPO) in the hypoxic perfusion buffer did not alter the acute 
hypoxia-induced hyperpolarization of mitochondria in precapillary PASMC isolated from UCP2-/- mice 
(Figure 25).  
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Figure 25. Effect of ROS scavengers on mitochondrial hyperpolarization during acute hypoxia.  
JC1 measurement of Δψm in precapillary PASMC isolated from UCP2 deficient mice in the 
absence (UCP2-/-) and in the presence of ROS scavengers (NAC, TEMPO). Data are given as 
percent of Δψm change during hypoxic superfusion compared to normoxic control. Data are 
obtained from ≥4 independent precapillary PASMC cell isolations and ≥31 individual cells 
each.   
* p <0.05 compared to appropriate normoxic control with Student's t test.  
 
3.2. Δψm and PH 
3.2.1. Evaluation of Δψm in IPAH and in animal models of PH  
In order to investigate the role of Δψm in PH, Δψm was measured in PASMC isolated from animals with 
different forms of experimental PH and from patients with IPAH. Mitochondria were found to be 
hyperpolarized in PASMC isolated from IPAH patients compared to PASMC isolated from healthy 
(donor lungs) controls (Figure 26a). PH induced either by MCT injection in rats or by chronic hypoxia in 
mice (10% O2, 28 days) resulted in an increase of Δψm in precapillary PASMC isolated from such 
animals (Figure 26a). In addition, in vitro exposure of rat precapillary PASMC to an atmosphere of 1% 
O2 for 48h (chronic hypoxia) increased ∆ψm (Figure 26a). To prove that mitochondria were 
hyperpolarized, 0.5µM of the uncoupling agent FCCP was applied to stimulate a Δψm collapse. The 
FCCP-stimulated decrease of Δψm (maximal uncoupling) in PASMC was significantly higher in IPAH 
patients and experimental PH models than in respective controls, which corresponded to a higher ∆ψm 
(Figure 26b).  
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Figure 26. Δψm of precapillary PASMC in PH.  
a) 590/530 nm ratio of JC1 during measurement of basal Δψm in PASMC isolated from 
patients with idiopathic pulmonary arterial hypertension (IPAH) or healthy donor controls 
(Donor), from rats with MCT-induced PH (MCT) or untreated rats (Control), from mice with 
chronic hypoxia-induced PH (4w Chr. Hypoxia) or normoxic mice (Normoxia), and from 
untreated rats after exposure of the precapillary PASMC to 1% O2 chronic hypoxia (48h 
Hypoxia) or normoxia (Normoxia). b) Δψm presented as percent of maximal FCCP-induced 
drop of Δψm in those cells. Data were obtained from ≥4 independent precapillary PASMC cell 
isolations and 4 human samples, respectively. n ≥23 individual cells in each group.* p<0.05, 
**p<0.01, ***p<0.001, compared to respective controls with Student's t test.  
 
3.2.2. Mechanism of mitochondrial hyperpolarization in PH  
3.2.2.1. Correlation of respiration and glucose metabolism with mitochondrial hyperpolarization in 
PH 
To evaluate, if changes in Δψm could be related to the alteration of cellular metabolism, mitochondrial 
respiration was measured using high-resolution respirometry, and the level of key metabolic enzymes was 
studied by the determination of mRNA and protein quantities in animal models of PH. Furthermore, the 
Δψm and the cellular metabolism was tested in rat precapillary PASMC after exposure to 48 h 1% O2 
hypoxia and MCT-induced PH after treatments that can reverse PH in animal models (re-exposure to 
normoxia and DCA, respectively). Following in vitro exposure to 1% O2 hypoxia for 48h, rat PASMC 
were used in these experiments for the following reasons: 1) exposure to 48h 1% O2 is an accepted model 
of chronic hypoxia-induced PH and leads to similar alterations of Δψm in rat precapillary PASMC and in 
precapillary PASMC isolated from mice exposed to 4 weeks of chronic hypoxia (Figure 26a-b); 2) for 
measurement of mitochondrial respiration a critical amount of cells is needed that can be more easily 
obtained from rats than from mice. Unstimulated mitochondrial respiration, oligomycin-inhibited 
respiration and maximal respiratory capacity after FCCP stimulation (given as pmol of O2 consumed per 
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minute per million cells) were significantly reduced in rat precapillary PASMC after 48h exposure to 1% 
O2 hypoxia (Figure 27a). Comparable results were found in precapillary PASMC isolated from rats with 
MCT-induced PH (Figure 27b).  
In parallel, mRNA and protein levels of LDHA, the key enzyme for anaerobic glycolysis, and PDK1, the 
key enzyme to inhibit mitochondrial pyruvate metabolism, were increased in precapillary PASMC from 
both models of PH, chronic hypoxia-induced PH in mice and MCT-induced PH in rats (Figure 27 c-g). 
Re-exposure of hypoxic precapillary PASMC (48h, 1%O2) to normoxia (Figure 27a), or treatment of 
precapillary PASMC isolated from MCT injected rats with 500.0 µM DCA restored endogenous 
mitochondrial respiration (Figure 27b). DCA is an inhibitor of the pyruvate dehydrogenase kinase194. 
Additionally, protein levels of PDK1 and LDHA returned to normal after re-exposure to normoxia for 24 
hours in precapillary PASMC (Figure 27 d-g). 
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Figure 27. Mitochondrial respiration and markers of anaerobic glycolysis in precapillary PASMC.  
a) Mitochondrial respiration after exposure of rat precapillary PASMC to 48h 1% O2 (48h 
Hypoxia) and after re-exposure of PASMC to 24h 21% O2 (48h Hypoxia-24h Normoxia) 
compared to normoxic controls (Normoxia). Data are given as respiration in pmol of O2 
consumed per minute per million cells where Routine is endogenous, unstimulated 
respiration; Oligomycin is oligomycin-inhibited respiration; FCCP represents respiration in 
the presence of FCCP. b) mRNA expression of key metabolic enzymes in precapillary 
PASMC isolated from mice (Mouse PASMC, 48h Hypoxia) and rat (Rat PASMC, 48h 
Hypoxia) after exposure to 48h 1% O2 and in precapillary PASMC isolated from rats with 
MCT-induced PH (Rat PASMC, MCT). Data are presented as fold change compared to 
appropriate controls. c and d) Protein expression of PDK1 (Pyruvate dehydrogenase, isoforme 
1) and LDHA (Lactate dehydrogenase A) in rat precapillary PASMC after exposure to 48h 
1% O2 (48h Hypoxia) and after re-exposure of PASMC to 24h normoxia (48h Hypoxia-24h 
Normoxia) compared to normoxic controls (Normoxia). e and f) Representative pictures of 
PDK1 and LDHA western blots from rat precapillary PASMC after exposure to 48h 1% O2 
(48h Hypoxia) and re-exposure to normoxia (48h Hypoxia-24h Normoxia). Data were 
obtained from ≥4 independent precapillary PASMC cell isolations. Mitochondrial respiration 
measurements were performed with 2.5-5.0 million cells per measurement. 
* p<0.05, ** p<0.01, ***p<0.001 compared to respective controls (Normoxia and Control) 
and # p<0.05, ## p<0.01 compared to 48h Hypoxia or MCT-induced PH, one-way ANOVA 
with Bonferroni post hoc test. 
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Re-exposure to 24h normoxia (21% O2) and treatment with 500µM DCA also reversed mitochondrial 
hyperpolarization found in precapillary PASMC isolated from rats with MCT-induced PH and after 
exposure of precapillary rat PASMC to 1% O2 for 48h, respectively (Figure 28a-b). 
 
 
Figure 28. Effect of re-exposure to normoxia on mitochondrial hyperpolarization in precapillary 
PASMC exposed to 48h 1% O2 and in precapillary PASMC isolated from rats with 
MCT-induced PH after DCA treatment.  
a) Δψm presented as percent of maximal FCCP-induced drop of Δψm in precapillary PASMC 
after 48h exposure to 1% O2 a (48h Hypoxia) and re-exposure to 24h normoxia (48h 
Hypoxia-24h Normoxia) compared to the FCCP-induced drop of Δψm in precapillary 
PASMC exposed to normoxia (Normoxia). b) Δψm presented as percent of maximal FCCP-
induced drop of Δψm in precapillary PASMC isolated from rats with MCT-induced PH in the 
absence (MCT) or in the presence of DCA (MCT+DCA) compared to the FCCP-induced 
drop of Δψm in precapillary PASMC isolated from healthy rats (Control). Data were obtained 
from ≥4 independent precapillary PASMC cell isolations and ≥24 individual cells each.  
** p<0.01, *** p<0.001 compared to respective control (Normoxia and Control) and # 
p<0.05 compared untreated cells (48h Hypoxia and MCT), one-way ANOVA with 
Bonferroni post hoc test. 
 
To test if the increase in Δψm in precapillary PASMC of the experimental models of PH was related to 
glycolytically produced ATP, an inhibitor of the ATP/ADP translocase, 50.0 µM BA, was applied. BA 
inhibited the increase of Δψm in precapillary PASMC induced by exposure to hypoxia (48h, 1% O2), as 
well as the increase of Δψm in PASMC isolated from rats with MCT-induced PH (Figure 29 a-b).  
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Figure 29. Effect of bongkrek acid, an inhibitor of the ADT/ATP translocase, on mitochondrial 
hyperpolarization in precapillary PASMC from experimental models of PH.  
a) Δψm presented as percent of maximal FCCP-induced drop of Δψm in precapillary PASMC 
in normoxia (Normoxia) or after exposure to 48h 1% O2 in the absence (48h Hypoxia) or in 
the presence of bongkrek acid (48h Hypoxia+BA). b) Δψm presented as percent of maximal 
FCCP-induced drop of Δψm in precapillary PASMC isolated from healthy control rats 
(Control) and from rats with MCT-induced PH in the absence (MCT) or in the presence of 
BA (MCT+BA). Data were obtained from ≥4 independent precapillary PASMC cell 
isolations and ≥15 individual cells each.  
** p<0.01, *** p<0.001 compared to appropriate controls (Normoxia and Control) and # 
p<0.05, ### p<0.001 compared untreated groups (48h Hypoxia and MCT), one-way ANOVA 
with Bonferroni post hoc test. 
 
3.2.2.2. Application of ROS scavengers and mitochondrial hyperpolarization in PH 
To elucidate the effect of ROS scavengers on mitochondrial hyperpolarization of precapillary PASMC in 
experimental PH, ROS scavengers (25µM NAC and 1µM TEMPO) were applied in precapillary PASMC 
exposed for 48 h to 1% O2 or precapillary PASMC isolated from rats with MCT-induced PH. In contrast 
to the effect of the ROS scavengers on acute hypoxia-induced mitochondrial hyperpolarization, where 
mitochondrial hyperpolarization was preserved in the presence of ROS scavengers, in experimental 
models of PH such as chronic hypoxic PH, as well as MCT-induced PH, treatment of PASMC with the 
ROS scavengers reversed the hyperpolarization of mitochondria (Figure 30 a-b).  
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Figure 30. Effect of ROS scavengers on mitochondrial hyperpolarization in precapillary PASMC 
from experimental models of PH.  
a) Δψm presented as percent of maximal FCCP-induced drop of Δψm in precapillary PASMC 
exposed to normoxia (Normoxia) or to 48h 1% O2 in the absence (48h Hypoxia) or in the 
presence of ROS scavengers (48h Hypoxia + NAC, TEMPO). b) Δψm presented as percent of 
maximal FCCP-induced drop of Δψm in precapillary PASMC isolated from healthy control 
rats (Control) and rats with MCT-induced PH in the absence (MCT) or in the presence of 
ROS scavengers (MCT + NAC, TEMPO). Data were obtained from ≥4 independent 
precapillary PASMC cell isolations and ≥30 individual cells each.  
* p<0.05, *** p<0.001 compared to appropriate controls (Normoxia and Control) and ### 
p<0.001 compared to untreated groups (48h Hypoxia and MCT), one-way ANOVA with 
Bonferroni post hoc test. 
 
3.2.2.3. mRNA and protein expression of UCP2 in PH 
To investigate the role of UCP2 in mitochondrial hyperpolarization in PH, the level of expression of 
mRNA of UCP2 was studied in chronic hypoxia-induced PH. Exposure of WT mice to four weeks of 
chronic hypoxia (10% O2) decreased mRNA expression of UCP2 determined in lung tissue homogenate 
and microdissected precapillary pulmonary arteries (Figure 31). 
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Figure 31. Effect of exposure of WT mice to 4 weeks of 10% O2 (chronic hypoxia) on UCP2 mRNA 
expression. 
UCP2 mRNA expression in mouse lung tissue (homogenate) and in laser microdissected 
small pulmonary vessels upon 4 weeks of 10% O2 (chronic hypoxia). Data are given as fold 
change compared to normoxic controls (n=4).  
* p<0.05 compared to normoxic controls with Student's t test.  
 
Additionally, the level of UCP2 protein expression in lung homogenate in chronic hypoxia-induced PH, 
MCT-induced PH and human IPAH was investigated. The exposure of WT mice to four weeks of chronic 
hypoxia (10% O2) and MCT injection in rats decreased the protein level of UCP2 determined in lung 
tissue homogenate (Figure 32 a-d). UCP2 protein expression was also decreased in lung homogenate of 
IPAH patients compared to donor (healthy) lung (Figure 32 e-f). 
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Figure 32. UCP2 protein expression in lungs of experimental models of PH and idiopathic 
pulmonary arterial hypertension (IPAH) patients.  
UCP2 protein expression in lung tissue (homogenate) of WT (wild type) mice exposed to 4 
weeks of 10% O2 (4w hypoxia, a-b, n=6 in each group), from rats with MCT-induced PH (c-
d, n=6 in each group) and from IPAH patients (e and f, n=5 in each group). Data presented 
as ratio of UCP2 to β-actin expression. Lung homogenate from UCP2-/- (knockout) mice 
served as negative control.  
* p<0.05 and ** p<0.001 compared to respective controls (lung tissue from control mice, 
control rats and human donor) with Student's t test.  
 
3.3. UCP2 and pulmonary vascular remodeling 
3.3.1. Effect of UCP2-/- on the pulmonary vasculature and right ventricle 
The increase of Δψm in animal models of PH and IPAH was associated with UCP2 downregulation; 
therefore, the effect of UCP2-/- on the pulmonary vasculature was determined. Under normoxic conditions 
UCP2-/- mice exhibited mild PH characterized by a slightly increased RVSP (Table 5) and higher ratio of 
RV mass to LV mass plus septum and RV mass to body weight compared to WT animals (Figure 33a-b). 
In contrast, systemic systolic pressure (Table 5) and ratio of LV mass to body weight was similar in both 
groups (Figure 33c). The heart rate was also similar in both animal groups (Table 5). 
 
Results  85 
Table 5. Hemodynamics of the right ventricle.  
 WT UCP2-/- 
n 6 6 
Heart rate, BPM 592.5±11.7 570.4±11.3 
Systemic systolic pressure, 
mmHg 
102.5±8.7 99.6±2.1 
RVSP, mmHg 29.5±0.4 35.5±0.9*** 
RVEDP, mmHg 1.4±0.4 2.1±0.4 
Max dP/dt, mmHg/s 3297.0±58.1 3309.0±200.5 
Min dP/dt, mmHg/s -3347.0±160.7 -2727.0±159.4* 
 
Abbreviations: WT - wild type mice; UCP2-/- - UCP2 deficiency mice; PAP - pulmonary arterial 
pressure; RVSP - right ventricular systolic pressure, RVEDP - right ventricular end-diastolic pressure; 
Max dP/dt and Min dP/dt - minimum and maximum rate of pressure change in the RV.  
* p<0.05, *** p<0.001 compared to WT control with Student's t test. 
 
Furthermore, UCP2-/- mice were characterized by an increase of the minimum rate of pressure change in 
the RV (Min dp/dt WT: -3347.0±160.7; UCP2-/-: -2727.0±159.4).  
 
 
Figure 33. Effect of UCP2-/- on the right ventricle. 
Ratio of right ventricle (RV) to left ventricle (LV) + septum (a), RV mass to body weight (b) 
and LV mass to body weight (c) in wild type (WT) and UCP2 knockout (UCP2-/-) mice.  
* p<0.05 compared to WT with Student's t test. n=9 each  
 
It was shown before, that lungs of UCP2-/- mice have an increased ratio of muscularized to non-
muscularized vessel (unpublished thesis of Timm Hoeres, Giessen). Morphometric analysis of the MWT 
of pulmonary vessels now also showed that gene deletion of UCP2 resulted in a prominent remodeling of 
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the pulmonary vasculature, mainly medial layer as indicated by the increase of MWT of small pulmonary 
arteries with a diameter of less that 100µm (Figure 34 a-b) compared to these arteries in WT mice.  
 
Figure 34. Effect of UCP2-/- on pulmonary vasculature remodeling.  
Representative pictures of pulmonary arteries of wild type (WT) and UCP2 knockout (UCP2-/-
) mice lungs stained for elastica according to common histopathological procedures (Van 
Gieson's stain). Nuclei were counterstaining by Nuclear Fast Red. MWT (medial wall 
thickness) was defined as the distance between the lamina elastica interna and lamina elastica 
externa. b) Increased MWT given as percentage of MWT that was examined by light 
microscopy using a computerized morphometric system calculated by the formula MWT = (2 
x wall thickness/external diameter) x 100. n=4 in each group.  
***p<0.001 compared to WT with Student's t test. 
 
α-smooth muscle actin staining of lung slides demonstrated that excessive pulmonary vascular 
remodeling in UCP2-/- mice was caused by the increase of the SMC layer (Figure35). 
 
 
Figure 35. Representative pictures of pulmonary arteries of WT and UCP2-/- mice.  
Mouse lung sections from wild type (WT) and UCP2 knockout (UCP2-/-) mice were stained 
with an anti-α-smooth muscle actin antibody (Purple color) and counterstained with methyl 
green (Greenishcolor). Arrow depicts the small pulmonary arteries 
 
3.3.2. Proliferation of precapillary PASMC isolated from UCP2-/- mice  
3.3.2.1. Effect of UCP2-/- on Δψm and O2•- release in precapillary PASMC  
Under normoxic conditions precapillary PASMC isolated from UCP2-/- mice showed a significantly 
higher Δψm than those from WT mice (Figure 36a). FCCP stimulation induced a significantly higher drop 
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of Δψm in precapillary PASMC isolated from UCP2-/- mice than in precapillary PASMC isolated from 
WT mice, which corresponded to a higher Δψm in UCP2-/- mice compared to WT mice (Figure 36b). 
Increased Δψm in precapillary PASMC was accompanied by enhanced O2•- levels in precapillary PASMC 
of UCP2-/- mice as measured by ESR spectroscopy (Figure 36c).  
 
Figure 36. Δψm and O2•- release in precapillary PASMC isolated from WT and UCP2-/- mice. 
a) 590/530 nm ratio of JC1 during measurement of Δψm in precapillary PASMC from wild 
type (WT) and UCP2 knockout (UCP2-/-) mice. b) Δψm presented as percent of maximal 
FCCP-induced drop of Δψm in precapillary PASMC from mice WT and UCP2-/- mice. c) O2•- 
production in precapillary PASMC from WT and UCP2-/- mice. Data were assessed by ESR 
spectroscopy. Data were obtained from ≥4 independent precapillary PASMC cell isolations. 
Δψm was measured ≥18 individual cells each.  O2•-  concentration is given in arbitrary units 
(AU) for 100 000 cells. 
** p<0.01, *** p<0.001 compared to WT with Student's t test. 
 
To verify the impact of precapillary PASMC in pulmonary vascular remodeling in UCP2-/- mice, the 
proliferation rate of precapillary PASMC isolated from UCP2-/- mice was studied. Precapillary PASMC 
isolated from UCP2-/- mice were characterized by a more prominent proliferation after FCS stimulation 
compared to precapillary PASMC isolated from WT mice (Figure 37). The proliferation rate was 
investigated by two different approaches: [3H]-Thymidine incorporation (Figure 37a) and colorimetric 
growth assay with 0.1% crystal violet staining (Figure 37b).   
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Figure 37. Proliferation of precapillary PASMC isolated from WT and UCP2-/- mice.  
Proliferation of precapillary PASMC isolated from wild type (WT) and UCP2 knockout 
(UCP2-/-) mice measured by [3H]-Thymidine incorporation (a) and by the colorimetric growth 
assay with 0.1% crystal violet staining of 4% paraformaldehyde fixed cells (b) upon FCS (fetal 
calf serum) stimulation. Data were obtained from ≥4 independent precapillary PASMC cell 
isolations. [3H]-Thymidine incorporation is displayed in counts per minute (CPM) per 8000 
cells. Crystal violet staining was evaluated in 10000 cells. 
*p<0.05, ** p<0.01 compared to corresponded WT. For Figure a one-way ANOVA with 
Tukey post hoc test was performed, for figure b, the Student's t test. 
 
3.3.2.2. Role of Δψm in proliferation of precapillary PASMC isolated from UCP2-/- mice  
Incubation with different doses of FCCP, 1.0 µM, 2.5 µM and 5.0 µM for 3 days resulted in a significant 
decrease of Δψm in precapillary PASMC isolated from UCP2-/- mice (38a). FCCP  doses of 2.5 and 5.0 
µM decreased ∆ψm in precapillary PASMC isolated from UCP2-/- mice to the level of Δψm in precapillary 
PASMC isolated from WT mice (Figure 38a). Incubation with the same concentrations of FCCP 
decreased the proliferation of precapillary PASMC isolated from UCP2-/- mice upon 20% FCS 
stimulation to the similar level as those measured in precapillary PASMC isolated from WT mice (Figure 
38b).  
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Figure 38. Effect of FCCP on Δψm and proliferation of precapillary PASMC isolated from UCP2-/- 
mice.  
a) Δψm in percent of maximal FCCP-induced uncoupling compared to the baseline values in 
the absence of FCCP (Control) and after 72h treatment with 1.0µM, 2.5µM and 5.0µM FCCP 
in precapillary PASMC isolated from wild type (WT) and UCP2 knockout (UCP2-/-) mice. b) 
Proliferation of precapillary PASMC from WT and UCP2-/- mice in the absence of FCCP 
(Control) and after 72h treatment with 1.0µM, 2.5µM and 5.0µM FCCP. Data were obtained 
from ≥4 independent precapillary PASMC cell isolations. Δψm was measured ≥19 individual 
cells each. Proliferation is displayed in counts per minute (CPM) per 8000 cells. 
*** p<0.001 compared to precapillary PASMC from WT mice without treatment and # 
p<0.05, ## p<0.01, ### p<0.001 compared to UCP2-/- untreated group with one-way ANOVA 
with Tukey post hoc test. 
 
3.3.2.3. Effect of UCP1 and UCP2 overexpression on proliferation of precapillary PASMC isolated 
from UCP2-/- mice 
Proliferation of precapillary PASMC after overexpression of UCP2 and UCP1, which is known to act 
solely via uncoupling, was determined. Overexpression of UCP1 and UCP2 decreased the proliferation of 
precapillary PASMC isolated from UCP2-/- mice upon 20% FCS stimulation (Figure 39). Overexpression 
of UCP1 and UCP2 were confirmed by a western blot (Figure 39b). 
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Figure 39. Effect of UCP1 and UCP2 overexpression on the proliferation of precapillary PASMC 
isolated from UCP2-/- mice.  
a) Proliferation of precapillary PASMC from UCP2 knockout (UCP2-/-) mice after 72h 
transfection with UCP1 or UCP2 over-expressing plasmids. b) Western blot with anti-DDK 
(plasmids contain UCP1 and UCP2 protein with c-terminal DDK tag) and anti β-actin 
(loading control) antibody. Data were obtained from ≥4 independent precapillary PASMC cell 
isolations. Proliferation is displayed in counts per minute (CPM) per 8000 cells. 
*** p<0.001 compared to UCP2-/- PASMC, ## p<0.05, ### p<0.001 compare empty plasmid 
group with one-way ANOVA with Tukey post hoc test. 
 
3.3.2.4. Role of ROS in proliferation of precapillary PASMC isolated from UCP2-/- mice. 
ROS scavenging by 25µM NAC and 1µM TEMPO inhibited the increased O2•- production (Figure 40a) 
and the enhanced proliferation (Figure 40b) in precapillary PASMC isolated from UCP2-/- mice compared 
to precapillary PASMC isolated from WT mice. Additionally, MnTBAP inhibited the increased 
proliferation of precapillary PASMC isolated from UCP2-/- mice (Figure 40c).  
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Figure 40. Effect of ROS scavengers on O2•- generation and proliferation of precapillary PASMC 
isolated from UCP2-/- mice.  
a) O2•- production in precapillary PASMC from wild type (WT) and UCP2 knockout (UCP2-/-
) mice in the absence (Control) or in presence of the unspecific radical scavengers NAC and 
TEMPO. Data were assessed by ESR spectroscopy. b) Proliferation of precapillary PASMC 
from UCP2-/- mice and WT mice in the absence (Control) or in presence of the unspecific 
radical scavengers NAC and TEMPO. c) Proliferation of precapillary PASMC isolated from 
UCP2-/- mice and WT mice in the absence (Control) or presence of MnTBAP. Data were 
obtained from ≥4 independent precapillary PASMC cell isolations. Proliferation is displayed 
as counts per minute (CPM) per 8000 cells. O2•-  concentration is given in arbitrary units (AU) 
for 100 000 cells. 
**p<0.01, ***p<0.001, ***p<0.001 compared to WT and †p<0.05, ††p<0.01, †††p<0.001 
compared to untreated UCP2-/- PASMC, one-way ANOVA with Tukey post hoc test.   
 
To support the hypothesis that increased Δψm in precapillary PASMC isolated from UCP2-/- mice was not 
a secondary effect of increased ROS in those cells, Δψm was measured after the application of ROS 
scavengers. No alterations in Δψm could be detected under these conditions (Figure 41). 
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Figure 41. Effect of ROS scavengers on Δψm in precapillary PASMC isolated from WT and UCP2-/- 
mice.  
Δψm presented as percent of maximal FCCP-induced drop of Δψm after 48h treatment of 
precapillary PASMC with ROS scavengers (NAC and TEMPO) or untreated precapillary 
PASMC of wild type (WT) and UCP2 knockout (UCP2-/-) mice (Control).  
Data were obtained from ≥4 independent precapillary PASMC cell isolations and ≥31 
individual cells each.   
**p<0.01 compared to WT without ROS scavengers with one-way ANOVA with Tukey post 
hoc test. 
 
3.3.2.5. Δψm, ROS release and proliferation of precapillary PASMC after UCP2 knockdown by 
siRNA  
Knockdown of UCP2 by specific siRNA in precapillary PASMC isolated from WT mice had the same 
effect as UCP2-/- and led to an increase of Δψm (Figure 42a-b), O2•- production (Figure 42c), and 
enhanced proliferation (Figure 42b). Success of siRNA transfection was confirmed by real-time PCR 
(Figure 42d).  
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Figure 42. Effect of UCP2 downregulation on Δψm and O2•- release in precapillary PASMC.  
590/530 nm ratio of JC1 during measurement of Δψm in precapillary PASMC transfected with 
scr (scr siRNA) or siRNA against UCP2 (siRNA UCP2). b) Δψm presented as percent of 
maximal FCCP-induced drop of Δψm in precapillary PASMC after transfection with scr (scr 
siRNA) or siRNA against UCP2 (siRNA UCP2). c) O2•- production of precapillary PASMC 
transfected by scr (scr siRNA) or siRNA against UCP2 (siRNA UCP2). Data were assessed 
by ESR spectroscopy. d) Real time PCR control of efficiency of UCP2 knockdown by 
specific siRNA. Data were obtained from ≥4 independent precapillary PASMC cell isolations. 
Δψm was measured ≥21 individual cells each. O2•- concentration is given in arbitrary units 
(AU) for 100 000 cells. 
**p<0.01, ***p<0.001, ***p<0.001 compared to scr siRNA with Student's t test. 
 
FCCP at a dose of 1.0 µM reversed the hyperpolarization of mitochondria in precapillary PASMC 
transfected with siRNA against UCP2 (Figure 43a) to the level of Δψm in precapillary PASMC 
transfected with scr siRNA. Incubation with the same dose, 1.0µM FCCP, decreased the enhanced 
proliferation of precapillary PASMC transfected with UCP2 siRNA (Figure 43b) to a similar level as in 
precapillary PASMC transfected with scr siRNA. FCCP in doses of 2.5 µM and 5.0 µM demonstrated an 
unspecific effect of FCCP on the proliferation of precapillary PASMC transfected with scr siRNA (Figure 
43b). 
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Figure 43. Effect of FCCP on Δψm and proliferation of precapillary PASMC after UCP2 
knockdown by siRNA.  
a) Δψm in percent of maximal FCCP-induced uncoupling compared to the baseline values in 
the absence of FCCP (Control) and after 72h treatment with 1.0µM, 2.5µM and 5.0µM FCCP 
in precapillary PASMC transfected with scr siRNA or siRNA UCP2. b) Proliferation of 
precapillary PASMC after 72h transfection with siRNA against UCP2 (siRNA UCP2) or scr 
siRNA in the absence (Control) of FCCP and after 72h treatment with 1.0µM, 2.5µM and 
5.0µM FCCP. Data were obtained from ≥4 independent precapillary PASMC cell isolations. 
Δψm was measured ≥12 individual cells each. Proliferation is displayed as counts per minute 
(CPM) per 8000 cells. 
*p<0.05, *** p<0.001 compared to PASMC after scr siRNA transfection without treatment 
and # p<0.05, ## p<0.01, ### p<0.001 compared siRNA UCP2 untreated group with one-way 
ANOVA with Tukey post hoc test. 
 
In line with the data obtained from precapillary UCP2-/- PASMC, ROS scavenging by 25µM NAC and 
1µM TEMPO inhibited the increased O2•- production (Figure 44a) and the enhanced proliferation (Figure 
44d) of precapillary PASMC after knockdown of UCP2 with siRNA. MnTBAP also inhibited the 
increased proliferation of precapillary PASMC after transfection with siRNA against UCP2 (Figure 44c). 
 
Results  95 
 
Figure 44. Effect of ROS scavengers on O2•- release and proliferation of precapillary PASMC after 
UCP2 knockdown by siRNA.  
a) O2•- production in precapillary PASMC treated with scr siRNA or siRNA against UCP2 in 
the absence (Control) or in the presence of the unspecific radical scavengers NAC and 
TEMPO. Data were assessed by ESR spectroscopy. b) Proliferation of precapillary PASMC 
after transfection with scr siRNA or siRNA against UCP2 in the absence (Control) or in the 
presence of the unspecific radical scavengers NAC and TEMPO. c) Proliferation of 
precapillary PASMC after transfection with scr siRNA or siRNA4 against UCP2 in the 
absence (Control) or presence of MnTBAP. Data were obtained from ≥4 independent 
precapillary PASMC cell isolations. Proliferation is displayed in counts per minute (CPM) per 
8000 cells. O2•-  concentration is given in arbitrary units (AU) for 100 000 cells. 
**p<0.01 compared to scr siRNA and # p<0.05, ## p<0.01 compared to siRNA UCP2 
transfected precapillary PASMC without treatment, one-way ANOVA with Tukey post hoc 
test. 
 
3.3.2.6. Effect of UCP2 knockout or knockdown on cyclin D1 expression in precapillary PASMC  
Cyclin D1, a well-known proliferative marker, builds a complex with the cyclin-dependent kinase (CDK) 
that activates DNA replication and cell division253. Knockdown of UCP2 by siRNA or knockout of UCP2 
in precapillary PASMC resulted in the increase of cyclin D1 expression (Figure 45). 
 
Results  96 
 
Figure 45. Effect of UCP2 on cyclin D1 expression in precapillary PASMC. 
a) Cyclin D1 expression in precapillary PASMC after 72 h transfection with scr (scr siRNA) 
or siRNA against UCP2 (siRNA UCP2). b) Cyclin D1 expression in precapillary PASMC 
isolated from wild type (WT) and UCP2 knockout (UCP2-/-) mice. Data are obtained from at 
least four independent precapillary PASMC cell isolations and presented as ratio of cyclin D1 
to β-actin expression. n=3 each. 
*p<0.05, ** p<0.01 compared control with Student's t test. 
 
3.3.2.7. Effect of UCP2 on mitochondrial respiration, [Ca2+]m, glucose and fatty acid metabolism in 
precapillary PASMC  
To investigate the role of UCP2 in pyruvate metabolism of precapillary PASMC, the effect of application 
of pyruvate on cellular respiration after transfection of precapillary PASMC with scr siRNA or siRNA 
against UCP2 and in isolated lung mitochondria from WT and UCP2-/- mice was studied. Both basal 
(routine) cellular respiration after transfection of siRNA against UCP2 (Figure 46b) and routine 
respiration of isolated mitochondria from UCP2-/- mice (Figure 46a) were similar to the level of cellular 
respiration after transfection with scr siRNA and in precapillary PASMC isolated from WT mice, 
respectively. Application of pyruvate did not result in any changes of mitochondrial respiration in 
precapillary PASMC after transfection of siRNA against UCP2 or in isolated mitochondria from UCP2-/- 
mice. Additionally, intracellular baseline levels of pyruvate in precapillary PASMC (Figure 46d) and after 
pyruvate stimulation in mitochondria (Figure 46e) were similar in both animal groups.  
The mRNA expression level of key components of the cellular fatty acid metabolism such as acyl-CoA 
thioesterase 1 (acot1), carnitine palmitoyltransferase 1a (cpt1b), carnitine palmitoyltransferase 2 (cpt2), 
carnitine/acylcarnitine translocase (Slc25a20), and hydratase/3-hydroxyacyl Coenzyme A dehydrogenase 
(ehhadh) was studied, to investigate the role of UCP2 in fatty acid metabolism. Their expression in 
precapillary PASMC isolated from UCP2-/- was similar to the level of their expression in WT mice 
(Figure 46c).  
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Figure 46. Effect of UCP2 on mitochondrial respiration, mitochondrial pyruvate and fatty acid 
metabolism.  
a) Respiration of isolated lung mitochondria from wild type (WT) and UCP2 knockout 
(UCP2-/-) mice (n=8 each group). Data are shown as the respiration in pmol of O2 consumed 
per minute per mg of mitochondria where Routine is endogenous, unstimulated respiration, 
and ADP (adenosine diphosphate,), Pyr (pyruvate), Rot (rotenone), suc (succinate), FCCP 
and Ant (antimycin A) are respiration after addition of those respective substances. b) 
Cellular respiration of precapillary PASMC after transfection with scr siRNA or siRNA 
UCP2 (n=7 each group). Data are given as respiration in pmol of O2 consumed per minute 
per million of cells. Cellular respiration measurements were performed with 2.5-5.0 million 
cells per measurement. c) mRNA expression of key components of fatty acid metabolism in 
precapillary PASMC isolated from WT and UCP2-/- mice where acot1/2 is acyl-CoA 
thioesterase 1 and 2, cpt1b is carnitine palmitoyltransferase 1b, cpt2 is carnitine 
palmitoyltransferase 2, Slc25a20 is carnitine/acylcarnitine translocase, ehhadh is enoyl-
Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase. Pyruvate concentration 
in precapillary PASMC (d) and in mitochondria after pyruvate stimulation (e) from WT and 
UCP2-/- mice (n=3, mitochondrial isolation). Cellular pyruvate concentration was measured 
in 10000 per measement. Data were obtained from ≥4 four independent precapillary 
precapillary PASMC cell isolations. No significant changes with Student's t test. 
 
To investigate the possibility that UCP2 acts as MCU, [Ca2+]m concentration in precapillary PASMC 
isolated from WT and UCP2-/- mice was studied by Rhod2 fluorescent dye. [Ca2+]m were in similar range 
in both animal groups measured by fluorescent microscopy, as well as by the microplate reader (Figure 
47a-b). 
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Figure 47. Effect of UCP2 on mitochondrial calcium concentration ([Ca2+]m).  
[Ca2+]m measured by fluorescence microscopy (a, n≥49 cells each) and multimode microplate 
reader (b, 10000 cells per measement measement) in precapillary PASMC isolated from wild 
type (WT) and UCP2 knockout (UCP2-/-) mice. Data were obtained from ≥4 four independent 
precapillary precapillary PASMC cell isolations.  
No significant changes with Student's t test. 
 
3.3.3. Effect of UCP2 on Δψm, respiration and glucose metabolism in PASMC during chronic 
hypoxia 
The level of Δψm of precapillary PASMC isolated from UCP2-/- mice with hypoxia-induced PH was 
similar to the level of Δψm in WT mice with chronic hypoxia-induced PH (Figure 48a). The decrease of 
mitochondrial respiration because of chronic hypoxic exposure was similar in precapillary PASMC 
transfected with scr siRNA or siRNA against UCP2 (Figure 48b). Additionally, hypoxic (48h, 1% O2) 
exposure of precapillary PASMC transfected with siRNA against UCP2 increased the mRNA expression 
of LDHA and PDK1 to the same levels as in precapillary PASMC transfected with scr siRNA (Figure 
48c). The same was true for precapillary PASMC isolated from UCP2-/- mice, where hypoxia (48h 1% 
O2) induced the same degree of anaerobic glucose pathway activation as in hypoxic WT precapillary 
PASMC (Figure 48 d-f) represented by higher levels of mRNA and protein expression of key components 
of anaerobic glycolysis metabolism within cells.  
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Figure 48. Effect of chronic hypoxic exposure on Δψm, mitochondrial respiration, and glucose 
metabolism in WT and UCP2-/- mice.  
a) Δψm presented as percent of maximal FCCP-induced drop of Δψm in precapillary PASMC 
isolated from wild type (WT) and UCP2 knockout (UCP2-/-) mice exposed to 4 weeks of 10% 
O2 (4w hypoxia) compared to maximal FCCP-induced drop of Δψm in precapillary PASMC 
isolated from normoxic animals (Normoxia). Δψm was measured ≥18 individual cells each. b) 
Cellular respiration of precapillary PASMC transfected with scr siRNA or siRNA UCP2 after 
exposure to 48h, 1% O2 (48h, 1% hypoxia) compared to normoxic control. Data are given as 
respiration in pmol of O2 consumed per minute per million cells where Routine is 
endogenous, unstimulated respiration; Oligomycin is oligomycin-inhibited respiration; FCCP 
represents respiration in the presence of FCCP. Cellular respiration measurements were 
performed with 2.5-5.0 million cells per measurement, n=3. c) mRNA expression of PDK1 
and LDHA in precapillary PASMC transfected with scr siRNA or siRNA against UCP2 after 
exposure to 48h, 1% O2. Data are presented as fold change compared to normoxic value. n=4. 
d) mRNA expression of enzymes of the anaerobic glycolysis in precapillary PASMC isolated 
from WT and UCP2-/- mice after exposure to 48h, 1% O2. Data are presented as a fold change 
compared to normoxic value where pfkfb3 is 6-phosphofructo-2-kinase/fructose-2,6-
biphosphatase 3, Pkm is pyruvate kinase, muscle form, LDHA - lactate dehydrogenase, Glut1 
is glucose transporter 1 and PDK1 is pyruvate dehydrogenase kinase 1. n=4 e) Protein 
expression of LDHA and PDK1 in WT and UCP2-/- precapillary PASMC after exposure to 
48h, 1% O2. Data are presented as a fold change compared to normoxic value. n=3 f) 
Representative pictures of protein expression of LDHA and PDK1 in WT and UCP2-/- 
precapillary PASMC after exposure to 48h, 1% O2 (48h HOX) compared to normoxia 
(NOX). Data were obtained from ≥4 independent precapillary precapillary PASMC cell 
isolations. 
*p<0.05, **p<0.01, *** p<0.001 compared to normoxic value; # p<0.05 compared to WT 
with one-way ANOVA with Tukey post hoc test. 
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4. Discussion 
Mitochondria have long been considered to be O2 sensing organelles taking part in the signaling cascade 
underlying HPV, as well as important factors in hypoxia and non-hypoxia dependent pulmonary vascular 
remodeling processes by participating in numerous proliferative and antiapoptotic/ proapoptotic signaling 
pathways1, 38. Nevertheless, the exact impact of mitochondria in these processes is still not clear1, 82. In 
particular, the role of Δψm, the most important portion of the proton-motive force that drives ATP 
synthesis and is coupled with the degree of mitochondrial ROS release, is still controversial in HPV and 
PH development. Evidences exist for and against a role of Δψm and ROS in these processes, as well as for 
an increase or a decrease of these factors in HPV and PH.  UCP2 is thought to be a negative regulator of 
Δψm and mitochondria-derived ROS219-221. UCP deficient mice have been shown to exhibit increased 
acute HPV and pulmonary vascular remodeling in baseline conditions179. Against this background, this 
studied aimed to investigate the role of Δψm in HPV and PH development and the effect of UCP2 
knockout on these processes. 
The following results were demonstrated by this study: 
• Acute hypoxia increased Δψm and ROS emission in isolated mouse and rat precapillary PASMC. 
• Potentiated HPV in UCP2 knockout mice was associated with augmented mitochondrial 
hyperpolarization and ROS emission in isolated precapillary PASMC during acute hypoxic 
exposure. 
• In animal models of PH, as well as human IPAH, Δψm was increased when compared to controls. 
• Factors that may promote mitochondrial hyperpolarization in PH are glycolytically produced ATP 
and UCP2 downregulation. 
• UCP2 knockout resulted in pulmonary vasculature remodeling and RV hypertrophy under 
normoxic baseline conditions. Pulmonary vascular remodeling was at least in part caused by 
increased proliferation of precapillary PASMC induced by increased Δψm and partially by 
increased ROS release of these cells. UCP2-/- mice may be used as an experimental model of 
moderate PH. 
• Increase of pulmonary vascular remodeling in UCP2-/- mice after chronic hypoxic exposure may 
be induced by additional metabolic alterations in PASMC of these mice. 
Our findings suggest that increases of Δψm and mitochondrial ROS regulate HPV and pulmonary vascular 
remodeling leading to PH. Additionally, metabolic alterations play a role in animal models of PH. 
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4.1. Role of Δψm in HPV 
4.1.1. Increase of Δψm and HPV 
Previously, it was shown by the Weissmann group that acute hypoxia induced a hyperpolarization of 
mitochondria, an increase of mitochondrial ROS emission and a rise of [Ca2+]i concentration in small 
precapillary PASMC isolated from pulmonary arteries of rabbits13. These effects were specific for 
precapillary PASMC and did not occur in renal or aortic SMC during acute hypoxia13. As a potential 
mechanism for the increased ROS, it was proposed that the complex IV sensed the lack of O2, initiating 
the increase of ROS emission by complex III of the respiratory chain13. The current study confirms the 
reaction of precapillary PASMC to acute hypoxia in other rodents. Acute hypoxic exposure of 
precapillary PASMC isolated from mice and rats induced the increase of Δψm and ROS emission. In line 
with our findings, previously published results demonstrated the inhibitory effect of chemical uncouplers, 
DNP and FCCP on HPV at high concentrations168. The effect of DNP was specific for HPV, as 100µM 
DNP did not inhibit the thromboxan mimetic U46619 induced vasoconstriction.  
Mitochondrial hyperpolarization as a response to acute hypoxia in precapillary PASMC was proven by 
measurement with two different fluorescent dyes, JC1 and TMRE (Figures 17 and 18). Several 
fluorescent membrane-permanent cationic dyes such as Rhod123 (rhodamine 123), Rhod123 derivatives 
(TMRE and TMRM [tetraethylrhodamine methyl]), DiOC6(3) (3,3´ - dihexyloxacarbocyanine iodide) and 
JC1 have been suggested for directly measuring the Δψm by fluorescent microscopy117. These positively 
charged dyes accumulate within negatively charged mitochondria in an inverse proportion to Δψm 
according to the Nernst equation117. Hyperpolarization of mitochondria evokes the increase of 
accumulation of cationic dyes within the mitochondrial matrix, and depolarized mitochondria accumulate 
less dye. There are merits and pitfalls of each of these dyes254. The main disadvantage of Rhod123 is its 
ability to form putative adducts with some components of the IMM that can lead to misleading results255. 
DiOC6(3), in addition to measurement of Δψm, is used to study the plasma membrane potential. Therefore, 
changes in the plasma membrane potential can mask the change of Δψm. The most commonly used dyes 
are TMRE or TMRM and JC1. TMRE and TMRM can be used in quenching or non-quenching modes118. 
In the quenching mode, an increased concentration of the dye leads to quenching of the fluorescent signal 
upon mitochondrial hyperpolarization. In the non-quenching mode a low concentration of these dyes 
accumulates in the mitochondria during hyperpolarization and their fluorescent signal increases118. Laser 
illumination of TMRM loaded in mitochondria at high concentrations (quenching mode) generates 
ROS256. Moreover, high concentrations of TMRE exhibit mitochondrial toxicity244. Therefore, the non-
quenching mode for TMRE with lower concentrations of the dye (10 nM TMRE) was used to study Δψm 
in precapillary PASMC during acute hypoxia. Although the quenching mode is very sensitive to changes 
in Δψm, it cannot be used to compare changes in baseline Δψm118. Additionally, TMRE distribution within 
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cells is dependent on plasma membrane potential. Changes in plasma membrane potential can lead to 
release of TMRE into extracellular buffer, even though Δψm remains unchanged257. Therefore, JC1 
fluorescence was used as an additional method to determine Δψm. It was shown that JC1 can measure 
Δψm with greater accuracy in intact cells compared to other cationic dyes255, 258. The advantage of JC1 is a 
ratiometric measurement of Δψm by monitoring the ratio of green/red (530/590nm) emission 
fluorescence257. Hyperpolarization of mitochondria increases the red fluorescence (590nm emission) and 
depolarization raises the green fluorescence (530nm emission). Both reactions are reversible. As a result, 
JC1 measurement is less sensitive to loss of staining, organelle swelling and dye bleaching259. However, 
JC1 used in doses greater than 1µM can be toxic for mitochondria257, and some publications demonstrated 
that JC1 can be a cause of artifacts in Δψm studies118.  
The mechanism for the increase of Δψm in acute hypoxia remains unclear, but the mitochondrial 
hyperpolarization may be induced by different factors. In principle at least, four mechanisms are possible: 
1) inhibition of ATP synthase, 2) modulation of mitochondrial membrane channels (e.g. UCPs, Ca2+ 
channels, ion exchangers), 3) improvement of H+/e- stoichiometry and 4) increase of mitochondrial 
respiration. In possibilities 1-3, additionally, the increased Δψm must not be compensated completely by a 
decreased electron flow through the respiratory chain. These possibilities are described in detail below. 1) 
As mitochondrial hyperpolarization was associated with slight inhibition of mitochondrial respiration13, a 
mechanism similar to the effect of NO on Δψm260 was suggested. In this scenario, inhibition of NO at 
complex IV would be mirrored by the lack of O2 inhibiting complex IV, resulting in increased glycolytic 
ATP production, which inhibits ATP synthase and increases Δψm. In this regard, it is a well known effect 
of inhibitors of ATP synthase to increase Δψm and consecutively decrease respiration according to the 
classical Mitchell theory, where there is a feedback mechanism of Δψm on electron flow119, 225, 261. 
Consequently, acute hypoxia could not only act via complex IV inhibition, but also have a direct effect on 
Δψm, and decreased respiration could be a result of mitochondrial hyperpolarization. Both hypotheses 
could explain why the decreased respiration in acute hypoxia was not associated with decreased Δψm, as 
could be expected. Additionally, mitochondrial respiration in acute hypoxia was only reduced by up to 
~10% in the range where Δψm was increased13. This is in line with many publications showing preserved 
cellular ATP levels during HPV, which argues against a substantial mitochondrial inhibition1. Thus, the 
slight decrease of respiration (and proton pumping across the membrane) may easily be counteracted by 
other mechanisms increasing Δψm such as inhibition of ATP synthase by glycolytic ATP as discussed 
above. 2) Keeping in mind that the reaction of acute O2 sensing must be very fast, another potential 
mechanism can account for mitochondrial hyperpolarization - the fine tuning of the proton leak by acute 
hypoxia, e.g. via modulation of UCP function. Changes of Δψm in the measurements of the current study 
were small (about 7-10% of basal Δψm). Therefore, the functional alterations of the proton leak may be 
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small, considering a high basal proton leak in resting cellular metabolic conditions, which is responsible 
for ∼20-30% of respiration (up to 50% in skeletal muscle156). The proton leak shuttles protons from the 
intermembrane space to the mitochondrial matrix, reducing the number of protons passing through ATP 
synthase. In fact, Gnaiger et al. described a decrease of the proton leak and uncoupled respiration in 
isolated mitochondria by unknown mechanisms during hypoxia262. Other possibilities for increasing Δψm 
are the modulation of mitochondrial channels including Ca2+ channels and VDAC230. Mitochondrial 
channels could change the Δψm by modulation of the activity of the respiratory chain or by use of a 
proton gradient to transfer ions across IMM230. Little is known about their function in acute hypoxia. 3) 
Another mechanism to increase Δψm despite decreased electron flow is to enhance the number of protons 
that are pumped per electron (called H+/e- stoichiometry)263. In this regard, Kwast et al. showed that in 
yeast cytochrome c oxidase subunit 5B (COX5b), the hypoxic isoform of COX5, is capable of pumping 
more protons across the IMM despite utilizing fewer O2 molecules, thereby producing a stable Δψm in 
hypoxia264. 4) An increase of mitochondrial respiration as the underlying mechanism for mitochondrial 
hyperpolarization seems unlikely, as a decrease of mitochondrial respiration in acute hypoxia was 
measured in Sommer’s study13. 
 
4.1.2. Increase of ROS and HPV 
In addition to the increase of Δψm, acute hypoxia also induced the increase of mitochondrial ROS 
production (Figures 19 and 21). The increase of ROS measured in this study supports the hypothesis of 
increased ROS as the underlying mechanism of HPV (“ROS hypothesis”) and questions the hypothesis 
that a decrease in the redox state (“redox hypothesis”) causes HPV3. The latter suggests that a reduced 
level of ROS elicits PASMC contraction through decreased Kv channel currents with subsequent plasma 
membrane depolarization and influx of Ca2+ into the cytosol37. Conversely, the concept of increased ROS 
proposes that an increase in ROS originating from mitochondria or other cellular sources orchestrates the 
[Ca2+]i increase in acute hypoxia1. In favor of this hypothesis, Weissmann et al. found an increase of O2•- 
release during acute hypoxia13, 248 and an inhibition of HPV by the O2•- scavenger, nitro blue tetrazolium 
in isolated perfused rabbit lungs265. In addition there are numerous reports of increased ROS 
concentrations in acute hypoxic signaling26, 77, 248, 266-269. Limitations of techniques for ROS measurements 
in vivo may be one of the reasons for the discrepancy in the models of ROS in HPV. To overcome this 
problem, ROS measurements were conducted by two different approaches: 1) MitoSOX for real-time 
measurements of O2•- in precapillary PASMC during acute hypoxia (Figure 21b), and 2) measurements 
with the HyPer plasmid for real-time investigation of H2O2 (Figure 21c). All of these measurements 
consistently provided evidence for an increase in ROS emission during acute hypoxia. 
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Numerous methods have been used for ROS detection such as cytochrome c reduction, 
chemiluminescence-based techniques, electron spin resonance [ESR or electron paramagnetic resonance 
(EPR)] spectroscopy], detection of products of the interaction of intracellular O2•- with dihydroethidium 
by high-performance liquid chromatography (HPLC), and fluorescent microscopy with ROS-sensitive 
fluorescent dyes270. Each of these approaches has potential pitfalls and benefits and there is no “ideal” 
approach or “gold standard” to measure intracellular ROS1, 270. Therefore, the choice of method for ROS 
detection depends on experimental conditions. Cytochrome c reduction and chemiluminescence-based 
techniques are not sensitive enough to detect small changes and are not capable of verifying a source of 
ROS. Additionally, measurement of ROS by cytochrome c reduction and HPLC-based detection of 
products of the interaction of intracellular O2•- with dihydroethidium cannot detect real-time changes of 
ROS in live precapillary PASMC270. Fluorescence microscopy with ROS-sensitive fluorescent dyes 
allows real-time monitoring of changes in intracellular ROS level and ESR spectroscopy is an elegant 
approach for quantitative detection of ROS in baseline conditions that overcomes the limitations of 
fluorescence based dyes265. Thus, fluorescence microscopy with ROS-sensitive fluorescent dyes was used 
in acute hypoxic experiments and ESR spectroscopy was used to detect the baseline level of ROS in 
precapillary PASMC. A variety of ROS fluorescent indicators are used nowadays including 
dihydroethidium (hydroethidine, HEt), dichlorofluorescein (DCF) with its derivatives, dihydrorhodamine 
123 (DHR123) and redox-sensitive recombinant proteins such as reduction-oxidation sensitive green 
fluorescent protein (roGFP), yellow fluorescent protein-based redox sensor (rxYFP), redox-sensitive 
FRET (Fluorescence resonance energy transfer) protein sensor and HyPer. They can detect different ROS 
species. For example, HEt and MitoSOX sense O2•- while DCF, DHR123, HyPer, and roGFP detect 
H2O2. However, their sensitivity for specific ROS species is very questionable259. As in the case of 
fluorescent dyes for Δψm measurement, ROS sensitive dyes have their benefits and limitations. For 
example, limitations of one of the most popular ROS fluorescent sensors, DCF includes the production of 
ROS upon exposure to light, detection of multiple types of ROS and irreversible nature of the reaction257. 
The aim of this study was to identify the real-time change of mitochondrial ROS production during acute 
hypoxia in precapillary PASMC. Due to this fact, MitoSOX was chosen to detect the O2•- in 
mitochondria271. MitoSOX is a mitochondrial targeted HEt, where the positively charged 
triphenylphosphonium moiety is conjugated to HEt to increase accumulation within mitochondrial 
matrix271. MitoSOX is oxidized by O2•- to form the hydroxylated product that becomes fluorescent257. 
MitoSOX has numerous pitfalls including mitochondrial toxicity, binding to DNA, reaction with ONOO- 
and HOCl271. Additionally, MitoSOX loading is dependent on Δψm272. Thus, change in Δψm can confound 
the MitoSOX data. O2•- produced by mitochondria can be dismutated by mitochondrial SOD2 to H2O2 
that can be released into the cytosol130. Therefore, a second fluorescent approach was used in this study to 
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confirm the MitoSOX data. The cellular level of H2O2 was measured by HyPer. HyPer consist of the 
circularly permuted yellow fluorescent protein and OxyR that is the H2O2 sensitive regulatory domain of 
Escherichia coli273. The cellular level of H2O2 was increased upon the acute hypoxic stimulus in 
precapillary PASMC isolated from different rodents (Figures 20 and 21). However, it is possible that the 
increased level of cytosolic H2O2 during the acute hypoxic challenge is a result of higher activity of other 
sources of H2O2 within cells such as NADPH oxidases1.  
The mechanism for the increase of mitochondrial ROS upon the acute hypoxic stimulus is not clear. Δψm 
hyperpolarization that was discussed above can be the reason for increased ROS production during acute 
hypoxia in precapillary PASMC. The mitochondrial electron transport chain is an inherent source of ROS 
and most experimental studies demonstrate that ROS production is directly coupled to Δψm142, 143. 
Application of an uncoupler decreased ROS production145 while a chemical that augments Δψm, also 
increased the rate of O2•- production146. Consequently, at higher Δψm the probability of increased ROS 
generation is also high,144, 274 and it is known that mitochondrial production of O2•- is disproportionately 
enhanced by the increase of ∆ψm275, 276. In addition, ROS production is more sensitive to uncoupling-
induced changes in ∆ψm than ATP synthesis148; Even a slight decrease of Δψm may lead to a marked 
decrease of ROS production in isolated mitochondria after succinate application123. The same is true for 
whole organ. Okuda et al. showed that infusion of an uncoupler decreased the H2O2 level in the perfused 
liver277. Therefore, an inducible proton leak (mild uncoupling) which could be reduced during acute 
hypoxia could be one possible mechanism of mitochondrial ROS production155. Another possibility for a 
hypoxia induced ROS increase may be that low O2 concentration leads to cytochrome c reduction and so 
limits its capability to scavenge O2•-121. In agreement with the concept that ROS increase is a trigger for 
HPV, exogenous O2•- and H2O2 initiate HPV in isolated pulmonary arteries278-281 and induce an increase 
in [Ca2+]i in cultured rat PASMC164 as well as in pulmonary rat arteries282. Additional evidence 
supporting our findings comes from a publication which demonstrated that overexpression of glutathione 
peroxidase (Gpx1)283 or mitochondrial catalase27, 283 augmented ROS removal and simultaneously 
attenuated the acute hypoxia induced ROS increase, whereas Gpx1 deletion had the opposite effect283. 
Gpx1 and catalase are essential parts of the ROS removal system within mitochondria and whole cells. 
Additionally, overexpression of Gpx1 and catalase attenuated the acute hypoxic increase of [Ca2+]i and 
contraction of freshly isolated mouse PASMC283. Furthermore, this study showed that the increase of Δψm 
is upstream of hypoxia-induced ROS release, based on the finding that application of ROS scavengers did 
not reverse mitochondrial hyperpolarization during acute hypoxia (Figure 22). 
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4.1.3. UCP2-/- and HPV 
The functional relevance of increased Δψm and ROS for HPV was supported by experiments in mice 
deficient for UCP2. Gene deficiency of UCP2 resulted in a higher increase of ROS and Δψm during acute 
hypoxia in PASMC isolated from UCP2-/- animals compared to WT animals (Figure 24). It was shown in 
a different study that UCP2-/- animals exhibited an increased HPV starting from similar normoxic 
pressures in the isolated ventilated and perfused lung (unpublished thesis of Timm Hoeres, Giessen). This 
effect of UCP2-/- on the pulmonary vasculature was specific for HPV as the thromboxan mimetic, U46619 
induced the same level of vasoconstriction in WT and UCP2-/- mice. 
Despite the controversy about the possible molecular mechanisms underlying the function of UCP2, there 
is a broad consensus that UCP2 negatively regulates ∆ψm and ROS production, at least when activated by 
certain stimuli210. Negre-Salvayre et al. first described a steep increase of mitochondrial ROS as a result 
of inhibition of UCP2 with guanosine diphosphate (GDP)219. Recently, it was shown that overexpression 
of UCP2 attenuated ROS production220, 221, and in conversely, UCP2 knockout resulted in an increase of 
mitochondrial ROS emission222. UCP2 gene transfer in the right tibialis anterior muscles of rats led to a 
significant reduction of Δψm284. It has been suggested that UCP2 alters ∆ψm and ROS emission via 
uncoupling (increase of the proton leak), due to the fact that its amino acid sequence is 59% identical to 
UCP1, which is a pure uncoupling protein285. However, there are some experiments that could not show 
an increase of ∆ψm in UCP2-/- mice210. Other possible mechanisms for UCP2 function have been 
suggested such as acting as a metabolic switch225 and regulating mitochondrial Ca2+ handling (see 
introduction for more details)229. Under these scenarios, UCP2 could decrease ROS production by 
inhibiting the entry of pyruvate into the oxidative pathway resulting in attenuation of the enormous redox 
pressure of pyruvate225. The increase of Ca2+ influx into mitochondria via UCP2 (if UCP2 is indeed a 
MCU) is also associated with a decrease of ∆ψm via the alteration of mitochondrial function286; however 
in that study the effects of acute hypoxia on pyruvate and fatty acid metabolism and [Ca2+]m were not 
tested. The discrepancy of the theories regarding UCP2 function can be explained by the fact that UCP2 
functions may change in tissue-specific or stimulus-dependent manners.  
Along these lines, it is possible that in UCP2-/- mice the essential mechanism to regulate excess ROS 
production during acute hypoxia by tuning of ∆ψm was absent. The enhanced ROS emission in these mice 
induced by acute hypoxia may be responsible for the higher response of the pulmonary vasculature to the 
hypoxic stimulus compared to WT mice. The mechanism by which acute hypoxia alters UCP2 functions 
and thus magnifies the increase of mitochondrial hyperpolarization in UCP2-/- mice remains unclear. It 
may be either a direct activation of UCP2 in WT cells during acute hypoxia which is inhibited in UCP2-/- 
precapillary PASMC, or a passive effect of Δψm properties. The first could be achieved via O2•- or its by-
products, especially 4-HNE (4-hydroxynonenal), which seems improbable, as ROS scavengers did not 
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affect the acute hypoxia-induced hyperpolarization in PASMC. However, Echtay et al. demonstrated that 
only matrix-targeted antioxidants, such as mitoQ (mitoquinone mesylate: [10-(4,5-dimethoxy-2-methyl-
3,6-dioxo-1,4-cycloheexadienl-yl) and mitoE [2-(2-(triphenylphosphonio)ethyl)-3,4-dihydro-2,5,7,8-
tetramethyl-2H-1-benzopyran-6-ol bromide] could prevent the UCP2 activation by O2•- released into the 
mitochondrial matrix, while non-mitochondrial antioxidants were unable to prevent the UCP2-induced 
proton leak287. The authors concluded that O2•- released into the mitochondrial matrix is responsible for 
UCP2 activation287. Therefore, further investigation should be conducted to explore the effect of O2•- 
released into the mitochondrial matrix on UCP2 activity and mitochondrial hyperpolarization during 
acute hypoxia. Recently Mailloux et al. have suggested another mechanism of UCP2 activation288. They 
showed that glutathionylation of UCP2 by H2O2 can play a key role in controlling the ROS-induced 
proton leak through UCP2. H2O2-induced glutathionylation of UCP2 in this model serves as trigger of an 
increase of the proton leak that decreases ∆ψm and ROS production.  
On the other hand the enhanced increase of Δψm can be the result of the non-ohmic behavior of the 
mitochondrial proton conductance, which states that the mitochondrial proton leak rises exponentially 
with increasing Δψm 156. In conditions of decreased proton conductance, e.g. in UCP2-/- mice, the same 
increase of the Δψm can result in a lower increase of the proton leak and thus higher final Δψm than under 
conditions of a relatively high proton conductance. In case of the UCP2-/- mice the lower proton leak 
would attenuate the increased Δψm in acute hypoxia less than in WT cells. In conclusion, acute hypoxia 
evokes an increase of ∆ψm and ROS emission in precapillary PASMC, probably via alteration of the 
proton leak. Therefore, UCP2-/- mice, which have higher Δψm hyperpolarization and ROS emission 
during acute hypoxia in PASMC, have higher HPV response in the isolated lung experiment.  
 
4.2. Role of Δψm in PH 
This study provided evidence that mitochondrial hyperpolarization in precapillary PASMC may act as a 
novel mechanism for development of PH. Furthermore, possible up- and downstream signaling 
mechanisms were identified. This finding was supported by the fact that 1) PASMC from two different 
animal models of PH (experimental PH) and PASMC from IPAH patients showed hyperpolarized 
mitochondria (Figure 26), 2) reversal of mitochondrial hyperpolarization by re-exposure to normoxia in 
precapillary PASMC exposed to chronic hypoxia and by application of 500µM DCA in PASMC isolated 
from rats with MCT-induced PH was associated with reversal of PH194 (Figure 28), and 3) UCP2-/- mice, 
that had hyperpolarized mitochondria in their PASMC, showed increased PASMC proliferation and 
pulmonary vascular remodeling (Figures 37-44). As a possible mechanism for the increase of Δψm in PH 
our own study identified ATP produced by enhanced anaerobic glycolysis (Figure 29), and 
downregulation of UCP2 (Figures 31 and 32). 
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Δψm was increased in PASMC isolated from patients with IPAH, in precapillary PASMC of rats with 
MCT-induced PH and mice with chronic hypoxia-induced PH. Additionally, isolated precapillary 
PASMC that were incubated in hypoxia for 48 hours showed hyperpolarized mitochondria. This model 
can be used to simulate effects occurring under chronic hypoxia in pulmonary vascular cells25. Δψm was 
measured in the presence and absence of a mitochondrial uncoupler, FCCP, to attain maximum 
depolarization of mitochondria (Figure 15). The change of Δψm upon FCCP stimulation can be used as a 
measure of  Δψm to avoid artifacts, e.g. from loading of the cells with the fluorescent dye289. These data 
are in accordance with a previous study showing mitochondrial hyperpolarization in animal models of 
PH13, 34. Recently, Chen et al. published data that exposure to 24h of 5% O2 leads to a significant 
hyperpolarization of human PASMC and the authors linked this finding to the decrease of mitochondrial 
permeability and attenuated apoptosis205. Conversely, another study conducted by Hu et al. that used the 
same cell lines purchased from PromoCell GmbH (Heidelberg, Germany) and the same approach for Δψm 
measurement, rhodamine-123 fluorescence, reported a depolarization of the Δψm during chronic hypoxic 
exposure of isolated human PASMC concomitant with increased H2O2 production204. Hu et al. found the 
opening mitoKATP was responsible for the depolarization of Δψm and the inhibition of human PASMC 
apoptosis through the attenuation of the release of cytochrome c from mitochondria and the activation of 
caspase-dependent mechanisms204. The reason for this discrepancy remains to be elucidated, however, in 
our own study, PASMC isolated from small precapillary arteries were used (that is main site of 
pulmonary vascular remodeling290), while both Chen et al. 205 and Hu et al. 204 used PASMC from bigger 
vessels. Despite the fact that Hu et al. demonstrated the opposite result concerning the chronic hypoxia-
induced change in Δψm, they also found an increase of ROS, as in this study204.  
The increase of ∆ψm in chronic hypoxia could be a characteristic of metabolic adaptation (metabolic shift) 
due to the lack of O2. Therefore, one possible mechanism of Δψm increase could be the inhibition of ATP 
synthase induced by an increased production of anaerobic ATP as discussed for acute hypoxia. Moncada 
et al. showed that NO could inhibit mitochondrial respiration and simultaneously increase Δψm by 
reversal of the function of the ATP synthase that was associated with the increased glycolytic ATP 
production291. Furthermore, glycolytically produced ATP was necessary for Δψm hyperpolarization during 
application of NO in astrocytes260. Along these lines, it has been shown that chronic hypoxia292 as well as 
MCT-induced PH293 and IPAH190 led to a metabolic shift in favor of anaerobic glycolysis. Furthermore, 
normalization of mitochondrial metabolism can reverse PH195, 293. In addition, chronic hypoxia caused a 
metabolic shift characterized by decreased mitochondrial respiration and increased glycolytic activity in 
pulmonary EC294. It seems that HIF-1α stabilization plays a key role in metabolic shift induced either by 
chronic hypoxia26 or MCT188 and IPAH190. However, the impact of the metabolic shift in precapillary 
PASMC that occurs during the pathological changes in PH is not yet fully resolved. The current study 
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also showed that precapillary PASMC incubated for 48h of hypoxia as well as precapillary PASMC 
isolated from rats with MCT-induced PH showed signs of a metabolic shift (Figure 27). Such precapillary 
PASMC exhibited decreased mitochondrial respiration and increased expression of glycolytic enzymes, 
including increased expression of PDK1, which negatively regulates the conversion of pyruvate to acetyl-
CoA by inhibiting the enzyme pyruvate dehydrogenase, and increased expression of LDHA that 
metabolizes pyruvate anaerobically. Thus, glycolytically produced ATP, might also promote 
mitochondrial hyperpolarization under conditions of chronic hypoxia or other stimuli of PH. In line with 
this hypothesis, inhibition of the ATP/ADP translocase in precapillary PASMC by BA inhibited the 
increase of Δψm induced by chronic hypoxic incubation and in MCT-induced PH (Figure 29). ATP/ADP 
translocase can exchange mitochondrial matrix ADP for cytosolic ATP which is necessary for inhibition 
of ATP synthase260, 291. It was shown that Adenine nucleotide translocator (ANT2) imported 
glycolytically produced ATP into the mitochondrial matrix in cancer cells, when oxidative 
phosphorylation was impaired295. Additionally, it was shown that human pluripotent cells hydrolyzed 
glycolytic ATP to maintain ∆ψm that was required for their proliferation and survival237. Nevertheless, it 
remains to be elucidated, if glycolytically produced ATP is responsible for ∆ψm hyperpolarization by 
interaction with the ATP synthase or other mitochondrial membrane channels. The data here presented 
suggest that alterations in mitochondrial respiration and metabolism are directly linked to increased Δψm, 
as restoration of mitochondrial metabolism by re-exposure to normoxia of precapillary PASMC exposed 
to chronic hypoxia, and DCA treatment of precapillary PASMC isolated from rats with MCT-induced 
PH, reversed mitochondrial respiration as well as the Δψm to control values. The data further suggest that 
the increase of Δψm is downstream of repressed mitochondrial respiration, because mitochondrial 
respiration was not altered during chronic hypoxia in rat precapillary PASMC treated with siRNA for 
UCP2, which showed increased Δψm (Figure 46). 
As another factor promoting mitochondrial hyperpolarization during chronic hypoxia, namely, 
downregulation of UCP2 mRNA in lung homogenate and laser microdissected small precapillary vessel 
with a diameter less than 100µm from WT mice exposed to 4 weeks of normobaric hypoxia (10% O2), 
was found (Figure 31). Western blot confirmed results from real-time PCR (Figure 32a-b). 
Downregulation of UCP2 may be a second mechanism to increase ∆ψm in WT mice in chronic hypoxic 
conditions, as UCP2 was suggested to decrease Δψm, as discussed above. This finding is in line with the 
effect of hypoxia in adipose cells where hypoxia is a cause of UCP2 downregulation296. Furthermore, 
UCP2 is highly expressed in the lung compared to other tissue212, and its expression in lungs increases 
after birth297 which may be evidence of O2 dependent expression of UCP2. In our own study proton leak 
was lower in precapillary PASMC after 48h 1% hypoxia (oligomycin-stimulated respiration, Figure 27) 
which suggests that decrease of a proton leak may occur via UCP2 downregulation. Additionally, UCP2 
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protein expression was decreased in lung homogenate of rats with MCT-induced PH as well as in lung 
homogenate of IPAH patients compared to control rats and donor lungs, respectively (Figure 32 c-f). This 
finding can be explained by the fact that despite discrepancies in the pathogenesis of different forms of 
PH, they shared similar molecular pathways. As discussed above, in chronic hypoxia-induced PH in mice, 
in MCT-induced PH in rats, and in IPAH the HIF-1α dependent metabolic shift in favor of the anaerobic 
glycolysis has been found26, 190, 292, 293. 
Although the experiments described in this thesis with isolated precapillary PASMC support the 
conclusion that increased Δψm in experimental models of PH is maintained by ATP produced via 
anaerobic glycolysis and UCP2 downregulation, it cannot be excluded that other mechanisms participate 
in mitochondrial hyperpolarization. In this regard, it has been shown that chronic hypoxia causes an 
alteration in expression of proteins located in the mitochondrial membrane including VDAC298-300. There 
is a large body of evidence that alterations in VDAC function can cause depolarization and swelling of 
mitochondria, and lead to apoptosis/cell death301. Furthermore, hypoxia-induced alteration in expression 
of F1FO-ATP synthase may also contribute to hypoxic Δψm hyperpolarization302. 
In contrast to mitochondrial hyperpolarization induced by acute hypoxia where the ROS scavengers did 
not have any influence on hyperpolarization, the increase of Δψm during chronic hypoxia was negatively 
regulated by application of ROS scavengers. Δψm hyperpolarization of precapillary PASMC due to MCT-
induced PH was also reversed by the application of ROS scavengers (Figure 30). These findings suggest 
that ROS modulates Δψm in chronic hypoxic PH and MCT-induced PH in a different manner than during 
acute hypoxia. It is possible that ROS produced during chronic hypoxia can interfere with diverse 
pathways that may regulate Δψm in this condition. Numerous experiments showed the interaction between 
the induction of ROS emission and the Warburg effect26, 38, 181 or HIF-1α expression and stability38, both 
pathways which may regulate the metabolic shift and thus hyperpolarization of Δψm caused by 
glycolytically produced ATP. In line with these findings, Bell et al. demonstrated that ROS regulates 
HIF-1α protein stabilization in cancer cell lines and the antioxidant, NAC, abolishes the effect of ROS-
induced HIF-1α protein stabilization on increased tumorgenesis303. In summary, our own findings suggest 
that ROS regulates the metabolic shift, which in turn regulates mitochondrial hyperpolarization. However, 
the exact mechanism needs to be elucidated in further studies. 
In contrast to acute hypoxia where increased Δψm was specifically found in precapillary PASMC but not 
in SMC from systemic vessels13, chronic hypoxia caused mitochondrial hyperpolarization also in other 
cell types such as rat skeletal muscle cells298. Interestingly, in cell cancer lines chronic hypoxia can evoke 
either hyperpolarization299, 300 or depolarization304 of mitochondria.  
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4.2.1 Effect of UCP2 downregulation on the pulmonary vasculature and PASMC proliferation. 
In our own study, MCT injection as well as chronic hypoxic exposure resulted in the downregulation of 
UCP2. Therefore, we investigated the effect of UCP2 knockout on the pulmonary vasculature. Gene 
deficiency of UCP2, in addition to increased HPV, resulted in development of mild PH and moderate 
pulmonary vascular remodeling179. Both phenomena are connected by the fact that they can be induced by 
chronic exposure to hypoxia. In this study both, increased HPV and PH in UCP2-/- mice were associated 
with increased Δψm and ROS production. Thus, UCP2-/- mice may serve as a new experimental model of 
PH. 
UCP2-/- mice demonstrated signs of PH under normoxic baseline conditions179. UCP2-/- mice had a slight 
increase of RVSP, hypertrophy of the RV and prominent vasculature remodeling compared to WT mice 
(Table 5, Figures 33-35). Echocardiography confirmed the findings of this study on the right heart, 
showing an increase of RV wall thickness179. The discrepancy between prominent pulmonary vascular 
remodeling and only a slight increase of RVSP may be resolved by RV dysfunction in UCP2-/- mice179. 
As pulmonary vascular resistance is determined by the quotient of PAP and cardiac output, an increase of 
RVSP or unchanged or reduced RVSP concomitant with a decrease of cardiac output can result in 
increased vascular resistance179. Indeed, RV dysfunction represented by increased Tei index and 
decreased cardiac output was found in UCP2-/- mice, both parameters measured by echocardiography179. 
Additionally, Min dP/dt was increased in UCP2-/- mice indicating the impairment of diastolic function of 
the RV (Table 5)305. However, it cannot be excluded that the manifestations of RV dysfunction was the 
result of a direct effect of UCP2 knockout on the heart. It was shown, for example, that alterations in 
UCP2 function have a direct effect on rat cardiomyocyte function306.  
In view of the fact that the most prominent remodeling in UCP2 knockout mice was found in the medial 
layer (Figures 34-35), the current study focused on the proliferation of precapillary PASMC isolated from 
these mice. UCP2 knockout or knockdown increased Δψm, mitochondrial O2•- generation and 
subsequently precapillary PASMC proliferation (Figures 37, 38, 40, 43, 44). Additionally, UCP2 
knockout or knockdown increased the expression of the pro-proliferative marker, cyclin D1253 in 
precapillary PASMC. In line with the findings of the current study, modulation of UCP2 expression 
affected the proliferation of different cells types226, 232, 233, 307, 308. Derdak et al.232 and Nino Fong et al.233 
described that UCP2-deficient mice had increased oxidative stress along with enhanced NF-kB activation 
that induced proliferation and decreased apoptosis in intestinal epithelial cells and pancreatic β-cells, 
respectively. Additionally, Chen et al. showed that UCP2 downregulation was important for myogenic 
differentiation238. In contrast, overexpression of UCP2-GFP in chick embryo fibroblasts and HeLa cells 
decreased their proliferation235.  
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Increased ROS in UCP2-deficient precapillary PASMC were responsible for enhanced proliferation of 
these cells, as application of unspecific ROS scavengers consisting of NAC and TEMPO or MnTBAP 
that act as a SOD mimetic, catalase mimetic309 and OONO-  scavenger310 partially inhibited the increased 
proliferation of precapillary PASMC isolated from UCP2-/- mice or precapillary PASMC isolated from 
WT mice after siRNA UCP2 knockdown. To estimate the influence of ROS on precapillary PASMC 
proliferation, ESR spectroscopy with the spin probe CMH (that stabilizes unstable ROS) was used 
(Figures 40 and 44). ESR is based on absorption of microwave radiation by unpaired electrons in an 
electromagnetic field 121. Absorption of microwave energy occurs by transition of unpaired electrons 
(ROS molecules have unpaired electrons) to a higher energetic state in an applied magnetic field and the 
number of unpaired electrons presented in the sample is proportional to the amplitude of the ESR 
signal270. The ESR signal was measured in precapillary PASMC with or without cell-permeable pSOD 
that revealed the ESR signal that comes from O2•-.  
As in case of HPV there are two contrary opinions about the role ROS in PH development. The redox 
hypothesis suggests that a similar sequence of events to that which is responsible for HPV, is involved in 
pulmonary vasculature remodeling in PH164. According to this theory, the trigger of pulmonary 
vasculature remodeling is the decrease of ROS that is the consequence of a hypoxia-induced decline of 
mitochondrial respiration and evokes downregulation of Kv 1.5 channels and HIF-1α stabilization34, 95, 165. 
The opposite theory has more supportive evidences311 that demonstrate: 1) increased oxidative status in 
patients with PH including enhanced lipid312, DNA313 and protein311 oxidations in PH patients; 2) 
decreased expression of lung antioxidants including SOD and GPx314; 3) beneficial effect of antioxidant 
treatment such as NAC315, Tempol (4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl)316, erdosteine [2- ((2-
oxothiolan-3-yl)carbamoylmethyl-sulfanyl)acetic acid]317 and EUK-134318 in experimental PH. However, 
it is still not completely verified which downstream signaling pathways in PH are depended on increased 
ROS. The importance of ROS was shown in HIF-1α stabilization38, regulation of cytosolic Ca2+ 
concentration201, mitochondrial function and protein modifications311. In line with the results of this 
study, publications demonstrated: 1) that mild elevation of O2•- and H2O2 stimulates growth responses in 
a variety of cell types via an activation of early growth-related genes, an alteration in the activity of 
protein kinases, and an oxidative inactivation of phosphatases, 2) the ability of O2•- and other O2 radicals 
to promote a cellular transformation to a cancer cell type, and 3) the direct or indirect inhibitory effect of 
a mild increase in intracellular ROS on apoptosis in tumor cells319, 320. Additionally, the data of this study 
are in accordance with studies showing a decrease of proliferation after SOD2 overexpression in cancer 
cells, including breast cancer, prostate cancer, pancreatic carcinoma cell lines, myeloma321-323 and cardiac 
fibroblasts324. These studies prove the importance of O2•- in proliferative cellular processes. The 
discrepancy of the studies investigating the role of ROS in PH can be attributed to the methodological 
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problem of ROS measurement (there is no “ideal” method for intracellular ROS detection) and to the 
probability of different PH-induced alterations in ROS expression depending on the cellular 
compartment38, 165.  
To support the hypothesis that UCP2 acted via the increased Δψm and that the increased Δψm was not a 
secondary effect of increased ROS in these mice, Δψm was measured after application of ROS 
scavengers. In the experiments of this study, no alterations in Δψm could be detected under these 
conditions (Figure 41). However, as discussed above, Echtay et al. demonstrated that only matrix-targeted 
antioxidants could prevent the UCP2 activation by the O2•- released into the mitochondrial matrix, while 
the non-mitochondrial antioxidants were unable to prevent the UCP2-induced proton leak287. Therefore, 
further investigations are necessary.  
To prove that mitochondrial hyperpolarization was the trigger of increased proliferation of precapillary 
PASMC after UCP2 knockout or knockdown, precapillary PASMC were incubated with different doses 
of FCCP for 3 days. Application of FCCP resulted in a significant decrease of Δψm and proliferation in 
those cells (Figures 38 and 43). Interestly, in contrast to ROS scavengers that only partially reversed the 
enhanced proliferation of precapillary PASMC isolated from UCP2-/- mice, FCCP application completely 
reversed the abnormal proliferation in those cells suggesting the probability of yet to be discovered 
signaling mechanisms activated by mitochondrial hyperpolarization. However, the interpretation of these 
results may be limited, as FCCP application has some unspecific effects such as modulation of 
mitochondrial respiration and alteration of ROS production325. Stockl et al. demonstrated that FCCP 
decreased the proliferation of human fibroblasts in a dose dependent manner and simultaneously 
increased ROS levels325. In contrast, Guimaraes et al. found that FCCP decreased ROS production and at 
the same time decreased the proliferation of hepatic stellate cells326. Carriere et al. established that other 
chemical uncoupler, CCCP (Carbonyl cyanide 3-chlorophenylhydrazone) induced an attenuation of 
preadipocytes proliferation and simultaneously decreased ROS generation327. This discrepancy can be 
attributed to cell-type-specific effects of uncouplers on regulation of ROS. However, further 
investigations remain to be conducted to finally resolve these discrepancies. Additionally, FCCP 
application leads to quantitative modifications of mitochondrial protein content328. All of these factors 
could influence the effects of FCCP application on proliferation that were observed in precapillary 
PASMC isolated from WT mice. To overcome the limitations of FCCP application, overexpression of 
UCP1 and UCP2 proteins in precapillary PASMC isolated from UCP2-/- mice was performed (Figure 39). 
UCP2 overexpression decreased the enhanced proliferation of UCP2-/- precapillary PASMC to the same 
degree as UCP1 overexpression, which is known to act solely via uncoupling225. Thus, UCP2 may act by 
a similar mechanism to UCP1 on proliferation of precapillary PASMC, i.e., via Δψm. 
Discussion  114 
Although the experiments with isolated precapillary PASMC support the conclusion that increased 
vascular remodeling of UCP2 deficient mice was caused by alterations of precapillary PASMC, it cannot 
be excluded that other cell types contributed to the development of pulmonary vascular remodeling in 
these animals. In this regard, it has been shown that UCP2 located in pulmonary vascular cells as well as 
in immune cells, contributes to the pulmonary UCP2 expression329. Furthermore, recently a study was 
published that showed a decrease of the bioavailability of NO in endothelium probably via an increase of 
ROS production in UCP2-/- mice330. Therefore, decrease of NO release can contribute to increased PAP in 
UCP2-/- mice.  
In summary the data of our own study suggests that increased pulmonary vascular remodeling in UCP2 
deficient mice is due to increased PASMC proliferation , which is caused by increased Δψm and partially 
byROS production, which is in accordance with UCP2 acting as a regulator of  Δψm, e.g. via uncoupling 
as suggest by the literature. 
 
4.2.2. Effect of UCP2 downregulation on [Ca2+]m, glucose and fatty acid metabolism. 
As discussed above, the molecular mechanism by which UCP2 regulates Δψm and ROS is still under 
debate (see introduction, Figure 11), and functions of UCP2 in addition to its role as an uncoupler were 
also investigated in this study. 
Trenker et al. showed that UCP2 can act as a MCU and it increased the mitochondrial sequestration of 
Ca2+, thus serving as carrier for Ca2+ from the cytosol into the mitochondrial matrix in response to a 
histamine stimulus229. However, in contrast, Mattiasson et al. demonstrated that UCP2 overexpression in 
brain protected against ischemic stress probably via a decrease of [Ca2+]m overload. This challenges the 
theory suggesting that UCP2 acts as a Ca2+ uniporter331. In order to investigate the effect of UCP2 
downregulation on mitochondrial calcium, [Ca2+]m was measured by Rhod2 fluorescent dye in 
precapillary PASMC isolated from WT and UCP2-/- mice (Figure 47). Rhod2 is a high affinity fluorescent 
Ca2+ probe that selectively targets mitochondria332. Similar levels of [Ca2+]m in both animal groups were 
found which makes changes in mitochondrial Ca2+ metabolism as reason for increased proliferation in 
UCP2 deficient precapillary PASMC unlikely. However, Rhod2 has many pitfalls including direct effects 
on mitochondrial structure333. Therefore, the result of the Rhod2 experiments should be evaluated with 
care, and additional experiments should be performed in future studies. An additional argument that 
UCP2 is not a MCU has been recently revealed: two independent groups of scientists have discovered the 
molecular bases of MCU334, 335. Thus, the data from Trenker et al. have been ascribed to an indirect effect 
on ATP production and hence ER Ca2+ loading336. 
Another possible mechanism of UCP2 may be that UCP2 is a key regulator of substrate supply for 
mitochondrial ATP production337. According to this theory, UCP2 increases fatty acid based and 
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decreases pyruvate based mitochondrial respiration225 upon different stimuli. A decrease of consumption 
of pyruvate by mitochondria leads to its accumulation within the cytosol and activation of anaerobic 
glycolysis225, 226, 288. In terms of PH development, decreased mitochondrial pyruvate consumption may 
either result in a) a "metabolic switch" similar to that which has been shown in PH, and thus promote 
pulmonary vascular remodeling or b) reduced substrate pressure on the respiratory chain and thus 
decreased ROS production and PH development. In this study, downregulation of UCP2 was found in 
experimental models of PH, as well as in IPAH patients, which according to the metabolic hypothesis of 
UCP2 function could either act as positive or negative factor in PH. However, in this study, no evidence 
for UCP2 acting as a metabolic regulator in PASMC in normoxia could be found (Figure 46). Basal 
(routine respiration) and the pyruvate-stimulated mitochondrial respiration was similar in mitochondria 
isolated from UCP2-/- mice, as well as in precapillary PASMC after transfection with siRNA against 
UCP2 compared to WT mitochondria and precapillary PASMC transfected with scr siRNA, respectively 
(Figure 46a-b). Also, the intracellular pyruvate concentration was not different in precapillary PASMC 
isolated from WT and UCP-/- mice (Figure 46 d). Furthermore, pyruvate concentration was similar in 
isolated mitochondria from those mice after pyruvate stimulation for 2 min (Figure 46e). In addition, key 
components of the fatty acid metabolism were studied. Real time PCR of gene expression of key 
components of fatty acid metabolism did not show any significant differences in their expression in 
precapillary PASMC isolated from UCP2-/- compared to WT mice (Figure 46c). Crucial components of 
anaerobic glycolysis such as Ldha and Pdk1 also were not upregulated in precapillary PASMC from 
UCP2-/- compared to WT (Figure 48f). Thus, in precapillary PASMC and isolated pulmonary 
mitochondria, UCP2 could not be shown to be the “metabolic switch” or pyruvate uniporter, at least not 
under baseline conditions. In addition, Herzig S. et al. recently identified the DNA/protein sequence of a 
mitochondrial pyruvate carrier that differs from the UCP2 DNA/protein sequence338. Therefore, it seems 
unlikely that UCP2 acts as a pyruvate carrier.  
Despite these findings, it cannot be excluded that UCP2 indeed acts as “metabolic switch” or MCU upon 
different pathological stimuli or in different cell types. Additionally, UCP2 may play a dual role as an 
uncoupling protein and a “metabolic switch”, depending on the circumstances213. In this regard, it has to 
be pointed out, that the respiration experiments were performed either in isolated mitochondria or 
permeabilized PASMC, in order to be able to apply pyruvate as a mitochondrial substrate. These 
experimental conditions may have resulted in loss of cellular factors activating UCP2, such as O2•- or 
fatty acids. However, even in intact cells, respiration without stimulation by any substrate was not 
different in PASMC isolated from UCP2-/- and WT or in PASMC transfected with siRNA against UCP2. 
Thus, it is highly unlikely that differences in respiration contributed to increased PASMC proliferation in 
UCP2-/- PASMC. This finding is in accordance with studies that did not show a decrease of mitochondrial 
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respiration in UCP2-/- mice339. Even an opposite effect was observed in murine embryonic fibroblasts 
where UCP2 knockout lead to an increase of mitochondrial respiration226.  
 
4.3. UCP2-/- and chronic hypoxia 
UCP2-/- mice exposed to 4 weeks of 10% O2 did not display any differences in mitochondrial 
hyperpolarization (Figure 48), degree of right heart hypertrophy or  severity of pulmonary vascular 
remodeling compared to WT controls (unpublished thesis of Timm Hoeres, Giessen). These findings can 
be explained by downregulation of UCP2 in precapillary PASMC during chronic hypoxia in WT mice 
resulting in an increased Δψm as in UCP2-/- mice. Precapillary PASMC isolated from UCP2-/- mice 
already had hyperpolarized mitochondria, therefore they could not be further hyperpolarized by 
downregulation of UCP2 during chronic hypoxia (Figure 48a). This explanation was supported by the 
finding that chronic hypoxia decreases UCP2 mRNA in precapillary arteries of mice as well as UCP2 
protein expression. As UCP2-/- mice still developed hypoxia-induced PH, a mechanism in addition to 
mitochondrial hyperpolarization had to be active in these mice. Indeed, in precapillary PASMC from 
UCP2-/- mice the metabolic shift was observed to the same level as in precapillary PASMC isolated from 
WT mice. This observation could explain chronic hypoxia-induced remodeling in UCP2-/-, despite 
unchanged Δψm and be additional evidence against the “metabolic theory” of UCP2 action (Figure 48c-f). 
If UCP2 is responsible for the metabolic switch from pyruvate to fatty acid metabolism, hypoxia- 
stimulated expression of key enzymes of anaerobic glycolysis should be less in UCP2-/- mice exposed to 
chronic hypoxia compared to WT mice.   
 
4.4. Conclusion 
This study provides evidence for mitochondrial hyperpolarization as a novel mechanism for regulation of 
HPV and development of vascular remodeling in PH, and deciphered possible up- and downstream 
signaling mechanisms. A short summary is presented in Figure 49. Acute hypoxia increased Δψm and 
ROS emission (O2•- and H2O2) in precapillary PASMC (Figure 49a). UCP2 knockout potentiated this 
process by further increase of Δψm and ROS, probably through a lack of fine tuning of Δψm (Figure 49a). 
Different triggers of PH increased Δψm in precapillary PASMC (Figure 49b). This increase was probably 
promoted by glycolytically produced ATP as a result of increased anaerobic glycolysis and decreased 
mitochondrial respiration. Additionally, experimental PH (4 weeks chronic hypoxic exposure of mice and 
MCT injection in rats) as well as IPAH increased Δψm hyperpolarization at least partially via UCP2 
downregulation (Figure 49b). Increased ROS may be a link between the activation of anaerobic glycolysis 
and the increase of Δψm, as ROS scavengers inhibited mitochondrial hyperpolarization. However, in acute 
hypoxia Δψm was not influenced by not mitochondrially targeted ROS scavengers. Gene deficiency of 
UCP2 mimicked the development of PH under normoxic conditions by an increase of proliferation of 
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precapillary PASMC caused by enhanced Δψm and partially caused by increased ROS in those cells. 
Alteration of the pulmonary vasculature in UCP2-/- mice, thus can be suggested as a new model of 
moderate PH. The increase of PH in UCP2-/- mice in chronic hypoxia was probably due to the preserved 
change of cellular metabolism characterized by decreased mitochondrial respiration and increased 
anaerobic glycolysis. 
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Figure 49. Proposed role of Δψm and UCP2 in HPV and in pulmonary vasculature remodeling 
during PH.  
a) Acute hypoxia sensed by mitochondria causes an increase of Δψm and mitochondrial ROS 
emission which may trigger or regulate HPV. UCP2-/- potentiates HPV by enhancement of 
the increase of Δψm and mitochondrial ROS emission probably due to the lack of regulation 
of Δψm by UCP2. 
b) Triggers of PH including chronic hypoxia in mice and MCT injection in rats, cause an 
metabolic switch that is characterized by a decrease of mitochondrial respiration and increase 
of glycolytic enzymes. Δψm hyperpolarization in PH can be a result of increased 
glycolytically produced ATP and increased ROS production. Additionally, experimental PH 
(4 weeks chronic hypoxic exposure of mice and MCT injection in rats) as well as IPAH were 
associated with downregulation of UCP2. 
UCP2-/- mice exhibited PH under normoxic conditions promoted by proliferation of 
precapillary PASMC due to the Δψm hyperpolarization and partially to the increased 
mitochondrial ROS emission. In chronic hypoxia UCP2-/- developed PH to a similar degree 
as WT mice, probably via sustained metabolic alterations. 
Abbreviations: ATP - Adenosine-5'-triphosphate; Δψm - mitochondrial membrane potential; 
UCP2-/- - knockout of uncoupling protein 2; MCT - monocrotaline-induced pulmonary 
hypertension; ROS - reactive oxygen species. 
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5. Summary 
The pulmonary vasculature constricts in response to acute alveolar hypoxia to redirect blood from poorly 
to better ventilated areas of the lung, which is an essential self-regulatory physiological response of the 
pulmonary vessels termed hypoxic pulmonary vasoconstriction (HPV). In contrast, different triggers of 
pulmonary hypertension (PH), including chronic hypoxia, lead to pathological reactions of the pulmonary 
vasculature, resulting in pulmonary vasculature remodeling that is characterized by excessive 
proliferation and attenuated apoptosis of vascular cells concomitant with reduction in the vascular lumen 
area. Despite intensive research in the last decades, the underlying mechanisms of HPV and vascular 
proliferation in PH have not yet been fully elucidated. It has been suggested that mitochondria play a key 
role in HPV, as well as in hypoxia and non-hypoxia dependent pathways that underlie pulmonary 
vascular remodeling. In both processes the mitochondrial membrane potential (Δψm), which is an 
important characteristic of mitochondrial function and the main factor regulating the release of 
mitochondrial reactive oxygen species (ROS), could play a crucial role. It was hypothesized that 
knockout of the mitochondrial uncoupling protein 2 (UCP2) results in an increase of Δψm and ROS 
emission that can regulate HPV and vascular remodeling in PH. 
Acute hypoxia induced an increase of Δψm and ROS emission (O2•-, as well as H2O2) in pulmonary artery 
smooth muscle cells (PASMC) isolated from small precapillary arteries of rats and mice. Δψm was also 
increased in precapillary PASMC isolated from experimental models of PH (chronic hypoxia-induced PH 
and monocrotaline [MCT]-induced PH) and from patients with idiopathic pulmonary arterial hypertension 
(IPAH) compared to respective controls. The increase of Δψm in PH could have been the result of the 
utilization of increased glycolytically produced ATP, while concomitantly mitochondrial respiration was 
decreased in precapillary PASMC. Additionally, mitochondrial hyperpolarization could have also been 
mediated by UCP2 downregulation. UCP2 deficiency (UCP2-/-) caused an increase of Δψm and ROS in 
small precapillary PASMC during normoxic baseline conditions and potentiated the increase of Δψm and 
ROS in acute hypoxia. In parallel, UCP2 deficiency potentiated HPV and showed an increase of right 
ventricular systolic pressure (RVSP), right ventricle (RV) hypertrophy and vascular remodeling, thus 
mimicking PH in normoxic baseline conditions. The latter effect can at least partially be attributed to 
enhanced precapillary PASMC proliferation in UCP2 deficient mice that could be completely reversed by 
the application of the mitochondrial uncoupler, FCCP and partially by the treatment with ROS 
scavengers. These findings indicate a crucial role for mitochondrial hyperpolarization and increase of 
mitochondrial ROS emission in the development of PH. UCP2-/- mice exposed to 4 weeks of hypoxia did 
not display any differences in Δψm compared to wild type (WT) controls. This finding can be explained 
by downregulation of UCP2 during chronic hypoxia as possible mechanisms to increase Δψm in WT 
mice, which could not be activated in UCP2-/- mice during chronic hypoxia.  
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The data of the current study thus suggest that an increase of Δψm and ROS release could regulate HPV 
and vascular remodeling in PH. The mechanism for mitochondrial hyperpolarization in PH may be 
metabolic alterations and downregulation of UCP2 and was regulated by ROS. UCP2-/- deficiency lead to 
the development of the PH phenotype in mice via increase of Δψm and partially via enhance of ROS 
emission in precapillary PASMC. 
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6. Zusammenfassung 
  
Die pulmonalvaskuläre Vasokonstriktion als Reaktion auf akute alveoläre Hypoxie dient der 
Umverteilung der pulmonalen Durchblutung von schlecht zu besser ventilierten Arealen der Lunge und 
ist ein essentieller selbstregulatorischer Prozess der Lungengefäße, der „hypoxische pulmonale 
Vasokonstriktion (HPV)“ genannt wird. Im Gegensatz dazu führen verschiedene Auslöser, inklusive 
akuter Hypoxie, zu pulmonaler Hypertonie (PH), einer pathologischen Reaktion der Lungengefäße, die 
durch exzessive Proliferation und verminderte Apoptose von Gefäßzellen charakterisiert ist. Trotz 
intensiver Forschung in den letzten Jahrzehnten konnte der zugrundeliegende Mechanismus der HPV und 
der vaskulären Proliferation bei der PH noch nicht vollständig geklärt werden. Mitochondrien wurden als 
Schlüsselfaktor sowohl bei der Entstehung der HPV, als auch in Hypoxie-abhängigen und -unabhängigen 
Signalwegen des pulmonalvaskulären Gefäßumbauprozesses vorgeschlagen. Bei beiden Vorgängen 
könnte das mitochondriale Membranpotential (Δψm), das eine wichtige Charakteristik der 
mitochondrialen Funktion und ein Hauptfaktor bei der Regulation der Freisetzung von mitochondrialen 
reactive Sauerstoffspesies (ROS) ist, eine wichtige Rolle spielen. Es wurde daher die Hypothese 
aufgestellt, dass die Ausschaltung des mitochondrialen Entkopplungsproteins „uncoupling protein 2 
(UCP2)“ zu einem Anstieg des Δψm und der ROS Freisetzung führt, die die HPV und den vaskulären 
Gefäßumbau in der PH regulieren kann.    
Akute Hypoxie induzierte einen Anstieg des Δψm und der ROS Freisetzung [Superoxid (O2•-), sowie 
Wasserstoffperoxid (H2O2)] in pulmonalen glatten Gefäßmuskelzellen (PASMC), die von kleinen 
präkapillären Arterien aus Ratten und Mäusen isoliert worden waren. Das Δψm war auch in präkapillären 
PASMC isoliert aus experimentellen Modellen der PH [chronisch Hypoxie-induzierte PH und 
Monocrotalin (MCT)-induzierte PH] und von Patienten mit idiopathischer pulmonal-arterieller 
Hypertonie im Vergleich zu den entsprechenden Kontrollen erhöht. Der Anstieg des Δψm in der PH 
könnte das Ergebnis einer Nutzung von vermehrt glykolytisch produziertem ATP gewesen sein, bei 
gleichzeitig verminderter mitochondrialer Respiration in präkapillären PASMC. Zusätzlich war die 
mitochondriale Hyperpolarisation möglicherweise auch durch eine UCP2 Herunterregulierung verursacht. 
UCP2 Gendefizienz bewirkte einen Anstieg des Δψm und der ROS Konzentration in kleinen präkapillären 
PASMC während basaler, normoxischer Bedingungen und verstärkte den Anstieg des Δψm und der 
mitochondrialen ROS Konzentration während akuter Hypoxie. Parallel dazu erhöhte die UCP2 
Gendefizienz die HPV und UCP2-gendefiziente Tiere zeigten einen erhöhten rechtsventrikulären 
systolischen Druck, rechtsventrikuläre Hypertrophie und pulmonalvaskulären Gefäßumbau. Somit wurde 
durch die UCP2 Gendefizienz eine PH unter basalen, normoxischen Bedingungen imitiert. Dieses konnte 
wenigstens teilweise auf eine erhöhte präkapilläre PASMC Proliferation bei UCP2 defizienten Mäusen 
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zurückgeführt werden, die komplett durch die Applikation des mitochondrialen Entkopplers, FCCP, und 
teilweise durch die Behandlung mit ROS Fängern rückgängig gemacht werden konnte. Dies spricht für 
eine entscheidene Rolle der mitochondrialen Hyperpolarisation und des Anstiegs der ROS Freisetzung bei 
der Entstehung der PH. Nach 4 Wochen Hypoxieexposition zeigten UCP2-/- Mäuse keinen Unterschied 
im Δψm verglichen mit den Wildtyp (WT) Kontrollen. Dies kann durch die Herunterregulierung von 
UCP2 während chronischer Hypoxie als möglichem Mechanismus für die Δψm Erhöhung in WT Mäusen 
erklärt werden, so daß dieser Mechanismus nicht bei den UCP2-/- Mäusen während chronischer Hypoxie 
aktiviert werden konnte.        
Die Daten dieser Studie legen daher nahe, dass ein Anstieg des Δψm und der ROS Freisetzung die HPV 
und den vaskuläre Gefäßumbau bei der PH regulieren können. Der Mechanismus, der die mitochondriale 
Hyperpolarisation im Falle des vaskulären Gefäßumbaus verursacht, ist möglicherweise in metabolischen 
Veränderungen und einer Herunterregulierung von UCP2 begründet und wird durch ROS reguliert. Der 
Phänotyp der PH in UCP2-/- defizienten Mäusen wird durch ein erhöhtes Δψm und teilweise durch eine 
erhöhte ROS Freisetzung in präkapillären PASMC unabhängig von metabolischen Veränderungen 
begünstigt.    
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